SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

  ;
SciELO - Scientific Electronic Library Online

    1. Martí J. Pilar Belaval. El Federalista [Internet], edición literaria. México, 5 de marzo de 1876 [citado 22 Ago 2016]. Disponible en: http://www.josemarti.cu/wp-content/uploads/2014/06/032-PILAR-BELAVAL-El -Federalista-edicion-literaria.pdf [ Links ]

    2. Fulgueiras JA. Cardiocentro Ernesto Che Guevara: A corazón latiente. Periódico Granma, La Habana, miércoles 21 de julio de 2004. [ Links ]

    1. Pérez Cárdenas M. La ética en salud. Evolución histórica y tendencias contemporáneas de desarrollo. [Internet]. [citado 4 Feb 2017]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/infodir /la_etica_en_salud._evolucion_y_tendencias.pdf [ Links ]

    2. Martínez G, Rodríguez N. Implicaciones éticas y jurídicas de los procedimientos invasivos en cardiología. Rev Cub Med Mil [Internet]. 2012 [citado 21 Mar 2017];41:302-16. Disponible en: http://scielo.sld.cu/pdf/mil/v41n3/mil10312.pdf [ Links ]

    3. Gracia D. Ética Médica. En: Farreras R, ed. Medicina Interna. 13a Ed. Barcelona: Elsevier; 1996. p. 1-7. [ Links ]

    4. Asociación Médica Mundial. Manual de ética médica. Cedex: AMM; 2005. [ Links ]

    5. López Barreda R. Modelos de análisis de casos en ética clínica. Acta Bioethica 2015;21:281-90. [ Links ]

    6. Dickert N, Emanuel E. Ética en medicina cardiovascular. En: Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald. Tratado de Cardiología. 10ma Ed. Madrid: Elsevier; 2015. p. 29-33. [ Links ]

    7. Ministerio de Salud Pública. Anuario Estadístico de Salud 2015. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2016. [ Links ]

    8. Achury Saldaña DM. Cuidado paliativo en el paciente con insuficiencia cardíaca terminal. Rev Mex Enferm Cardiol. 2013;21:118-22. [ Links ]

    9. Auría Fernández MC. Cuidados a la persona con enfermedad terminal. Logroño: Universidad de la Rioja; 2015. [ Links ]

    10. Formiga F, Manito M, Pujol R. Insuficiencia cardíaca terminal. Med Clin (Barc). 2007;128:263-7. [ Links ]

    11. Falces Salvador C, Camafort Babkowski M, Bosch Genover X, Pérez Villa F, Castillo Valldeperas M, Canalias Reverter M. Insuficiencia cardiaca crónica avanzada. En: López Soto A, Masanés Torán F, Farrús Lucaya B. Documento de consenso en enfermedad terminal no oncológica: Identificación y recomendaciones asistenciales. Barcelona: Comité de Ética Asistencial; 2014. p. 11-3. [ Links ]

    12. Martínez-Sellés M, Vidán MT, López-Palop R, Rexach L, Sánchez E, Datino T, et al. El anciano con cardiopatía terminal. Rev Esp Cardiol. 2009;62:409-21. [ Links ]

    13. Martínez Sellés M. La muerte: Reflexiones desde la bioética. Madrid: ICOMEM; 2010. [ Links ]

    14. Ghashghaei R, Yousefzai R, Adler E. Palliative care in heart failure. Prog Cardiovasc Dis. 2016;58:455-60. [ Links ]

    15. Padrón Chacón R. El paciente en estado terminal. Bioética 2008;8:15-9. [ Links ]

    16. Acosta Sariego JR. Bioética desde una perspectiva cubana. 2da Ed. La Habana: Centro Félix Varela; 1998. [ Links ]

    17. Zamora Marín R. Ética en el cuidado del paciente grave y terminal. Rev Cubana Salud Pública [Internet]. 2006 [citado 21 Mar 2017];32. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 -34662006000400010&lng=es [ Links ]

    18. Frank C, Heyland DK, Chen B, Farquhar D, Myers K, Iwaasa K. Determining resuscitation preferences of elderly inpatients: a review of the literature. CMAJ. 2003;169:795-9. [ Links ]

    19. Martínez-Sellés M, Gallego L, Ruiz J, Fernández Avilés F. Órdenes de no reanimar y cuidados paliativos en pacientes fallecidos en un servicio de cardiología. ¿Qué podemos mejorar? Rev Esp Card. 2010;63:233-7. [ Links ]

    20. Hauptman PJ. Palliation in heart failure: when less and more are more. Am J Hosp Palliat Care. 2006;23:150-2. [ Links ]

    21. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7:1008-26. [ Links ]

    22. Padeletti L, Arnar DO, Boncinelli L, Brachman J, Camm JA, Daubert JC, et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010;12:1480-9. [ Links ]

    1. Seldin DC, Berk JL. Amiloidosis. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J, eds.Harrison. Principios de Medicina Interna, 19ª ed. México DF: McGraw-Hill; 2016. p.719-23. [ Links ]

    2. González I, Jadue N, Trejo C, Carvallo A. Amiloidosis: Revisión a propósito de un caso clínico. Rev Chil Reumatol. 2010;26:285-9. [ Links ]

    3. Fikrle M, Palecek T, Kuchynka P, Nemecek E, Bauerova L, Straub J, et al. Cardiac amyloidosis: A comprehensive review. Cor et Vasa. 2013;55:e60-75. [ Links ]

    4. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120:1203-12. [ Links ]

    5. Calero Núnez S, Tercero Martínez A, García López JC, Jiménez-Mazuecos J. Amiloidosis cardiaca senil y estenosis aórtica degenerativa: 2 enfermedades interrelacionadas en el anciano. Rev Esp Geriatr Gerontol. 2017;52:167-70. [ Links ]

    6. Barge-Caballero G, Couto-Mallón D, Barge-Caballero E, Paniagua-Martín MJ, Barriales-Villa R, Pombo-Otero J, et al. ¿Cómo enfrentarse a una sospecha clínica de amiloidosis cardíaca? Un enfoque práctico para el diagnóstico. Cardiocore. 2017;52:27-34. [ Links ]

    7. Gómez-Bueno M, Segovia J, García-Pavía P, Barceló JM, Krsnik I, Sánchez-Turrión V, et al. Amiloidosis cardiaca: la importancia del manejo multidisciplinario. Rev Esp Cardiol. 2009;62:698-702. [ Links ]

    8. Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol.2010;7:398-408. [ Links ]

    9. Idiazabal U, García-Pavía P, Azcárate PM, Idoate F, Mercado MR. Amiloidosis cardiaca por transtiretina: la gammagrafía mostró el camino. Rev Colomb Cardiol. 2016;23:71.e1-5. [ Links ]

    10. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232-9. [ Links ]

    11. Vargas Vergara D, Olaya A, Andrade RE, Mora G. Bloqueo auriculoventricular completo como manifestación de amiloidosis cardiaca. Rev Colomb Cardiol. 2016;23:150.e1-5. [ Links ]

    12. García-Pavía P, Tomé-Esteban MT, Rapezzi C. Amiloidosis. También una enfermedad del corazón. Rev Esp Cardiol. 2011;64:797-808. [ Links ]

    13. Cyrille NB, Goldsmith J, Alvarez J, Maurer MS. Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. Am J Cardiol. 2014;114:1089-93. [ Links ]

    14. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3:155-64. [ Links ]

    15. Dungu JN, Valencia O, Pinney JH, Gibbs SD, Rowczenio D, Gilbertson JA, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:133-42. [ Links ]

    16. López-Fernández T, Saura D, Rodríguez-Palomares JF, Aguadé-Bruix S, Pérez de Isla L, Barba-Cosials J. Selección de temas de actualidad en imagen cardiaca 2015. Rev Esp Cardiol. 2016;69:286-93. [ Links ]

    17. Sekijima Y, Tojo K, Morita H, Koyama J, Ikeda S. Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid. 2015;22:79-83. [ Links ]

    18. Westermark P, Westermark GT, Suhr OB, Berg S. Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014;119:223-8. [ Links ]

    19. Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015;28:201-7. [ Links ]

    1. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18):S444-64. [ Links ]

    2. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement or healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86. [ Links ]

    3. Lockhart PB. Antibiotic prophylaxis for dental procedures: are we drilling in the wrong direction? Circulation. 2012;126:11-2. [ Links ]

    4. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-128. [ Links ]

    5. Barton TL, Mottram PM, Stuart RL, Cameron JD, Moir S. Transthoracic echocardiography is still useful in the initial evaluation of patients with suspected infective endocarditis: evaluation of a large cohort at a tertiary referral center. Mayo Clin Proc. 2014;89:799-805. [ Links ]

    6. Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ, Reguera JM, Plata A, Ruiz J, et al. Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis. 2010;10:17. [ Links ]

    7. Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol. 2011;57:794-801. [ Links ]

    8. García Reyes J. Reanimación cerebrocardiopulmonar prolongada exitosa en un paciente con muerte súbita: un reporte de caso. Rev Colomb Anestesiol. 2014;42:229-33. [ Links ]

    9. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics - 2017 Update: A report from the American Heart Association. Circulation. 2017;135:e146-e603. [ Links ]

    10. Dupuis JY, Wang F, Nathan H, Lam M, Grimes S, Bourke M. The cardiac anesthesia risk evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology. 2001;94:194-204. [ Links ]

    11. Ranucci M. Anaesthesia and cardiopulmonary bypass aspects of fast track. Eur Heart J Suppl. 2017;19:A15-7. [ Links ]

    12. Barry AE, Chaney MA, London MJ. Anesthetic management during cardiopulmonary bypass: a systematic review. Anesth Analg. 2015;120:749-69. [ Links ]

    13. Samad K, Hashmi M. Anesthetic management for open heart surgery and extracorporeal circulation. Anaesth Intensive Care. 2016;20:S140-5. [ Links ]

    14. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200-9. [ Links ]

    15. Evangelista A, González-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614-7. [ Links ]

    16. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: A propensity analysis. Eur Heart J. 2011;32:2027-33. [ Links ]

    17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466-73. [ Links ]

    18. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, et al. Outcomes for endocarditis surgery in North America: A simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141:98-106.e1-e2. [ Links ]

    1. Frank RE. Myocardial bridging. J Insur Med. 1999;31;31-4. [ Links ]

    2. Angelini P, Trivellato M, Donis J, Leachman RD. Myocardial bridges: a review. Prog Cardiovasc Dis. 1983;26:75-88. [ Links ]

    3. Carrascosa P, Martín López E, Capuñay C, Deviggiano A, Vallejos J, Carrascosa J. Prevalencia y características de los puentes miocárdicos en estudios de angiografía coronaria por tomografía computarizada multidetector. Rev Argent Cardiol. 2009;77:268-73. [ Links ]

    4. Alegria JR, Herrmann J, Holmes DR, Lerman A, Rihal CS. Myocardial bridging. Eur Heart J. 2005;26:1159-68. [ Links ]

    5. Juilliére Y, Berder V, Suty-Selton C, Buffet P, Danchin N, Cherrier F. Isolated myocardial bridges with angiographic milking of the left anterior descending coronary artery: a long-term follow-up study. Am Heart J. 1995;129:663-5. [ Links ]

    6. Loukas M, Curry B, Bowers M, Louis RG, Bartczak A, Kiedrowski M, et al. The relationship of myocardial bridges to coronary artery dominance in the adult human heart. J Anat. 2006;209:43-50. [ Links ]

    7. Ishikawa Y, Kawawa Y, Kohda E, Shimada K, Ishii T. Significance of the anatomical properties of a myocardial bridge in coronary heart disease. Circ J. 2011;75:1559-66. [ Links ]

    8. Rossi L, Dander B, Nidasio GP, Arbustini E, Paris B, Vassanelli C, et al. Myocardial bridges and ischemic heart disease. Eur Heart J. 1980;1:239-45. [ Links ]

    9. Tauth J, Sullebarger T. Myocardial infarction associated with myocardial bridging: case history and review of the literature. Cathet Cardiovasc Diagn. 1997;40:364-7. [ Links ]

    10. Sakuma M, Kamishirado H, Inoue T, Ichihara M, Takayanagi K, Hayashi T, et al. Acute myocardial infarction associated with myocardial bridge and coronary artery vasospasm. Int J Clin Pract. 2002;56:721-2. [ Links ]

    11. Berry JF, von Mering GO, Schmalfuss C, Hill JA, Kerensky RA. Systolic compression of the left anterior descending coronary artery: a case series, review of the literature, and therapeutic options including stenting. Catheter Cardiovasc Interv. 2002;56:58-63. [ Links ]

    12. Tio RA, Ebels T. Ventricular septal rupture caused by myocardial bridging. Ann Thorac Surg. 2001;72:1369-70. [ Links ]

    13. Feld H, Guadanino V, Hollander G, Greengart A, Lichstein E, Shani J. Exercise-induced ventricular tachycardia in association with a myocardial bridge. Chest. 1991;99:1295-6. [ Links ]

    14. Roul G, Sens P, Germain P, Bareiss P. Myocardial bridging as a cause of acute transient left heart dysfunction. Chest. 1999;116:574-80. [ Links ]

    15. Bestetti RB, Costa RS, Kazava DK, Oliveira JS. Can isolated myocardial bridging of the left anterior descending coronary artery be associated with sudden death during exercise? Acta Cardiol. 1991;46:27-30. [ Links ]

    16. Tio RA, Van Gelder IC, Boonstra PW, Crijns HJ. Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart. 1997;77:280-2. [ Links ]

    17. Cutler D, Wallace JM. Myocardial bridging in a young patient with sudden death. Clin Cardiol. 1997;20:581-3. [ Links ]

    18. Navarro-López F, Soler J, Magriña J, Esplugues E, Pare JC, Sanz G, et al. Systolic compression of coronary artery in hypertrophic cardiomyopathy. Int J Cardiol. 1986;12:309-20. [ Links ]

    19. Arnau Vives MA, Martínez Dolz LV, Almenar Bonet L, Lalaguna LA, Ten Morro F, Palencia Pérez M. Puente miocárdico como causa de isquemia aguda. Descripción del caso y revisión de la bibliografía. Rev Esp Cardiol. 1999;52:441-4. [ Links ]

    20. Montenegro F, Cisneros M, Ledesma R and Zampa C. Puentes musculares. Relación de los porcentajes de acortamiento segmentarios y respuesta al tratamiento. Rev Fed Arg Cardiol. 2003;32:220-6. [ Links ]

    1. LeWinter MM, Tischler MD. Pericardial diseases. En: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9na ed. Philadelphia: Saunders Elsevier; 2011. p. 1651-71. [ Links ]

    2. Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113:1622-32. [ Links ]

    3. Sagristà-Sauleda J. Síndromes de constricción cardiaca. Rev Esp Cardiol. 2008;61(Supl 2):33-40. [ Links ]

    4. Castañón-González JA, Amézquita-Landeros JA, Velasco-Ortega EC, Deseano-Estudillo JL, León-Gutiérrez MA. Pericarditis constrictiva: historia de un corazón oprimido. Cir Cir. 2010;78:342-6. [ Links ]

    5. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Rev Esp Cardiol. 2015;68:1126.e1-e46. [ Links ]

    6. Lage López LM, Quintana Cañizárez GR, Tessa Negrín Valdés T. Pericarditis constrictiva en una mujer de 36 años. CorSalud [Internet]. 2012 [citado 3 Ene 2017];4:221-4. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n3a12/pericarditis.html [ Links ]

    7. Doshi S, Ramakrishnan S, Gupta SK. Invasive hemodynamics of constrictive pericarditis. Indian Heart J. 2015;67:175-82. [ Links ]

    8. Inamdar KY, Aikebaier M, Lijunhong, Abudunaibi, Mulati A. Pericardiectomy: prompt surgical management of constrictive pericarditis. Heart Surg Forum. 2014;17:E319-22. [ Links ]

    9. Pinamonti B, Habjan S, De Luca A, Proclemer A, Morea G, Abate E, et al. Work-up and management of constrictive pericarditis: a critical review. G Ital Cardiol (Rome). 2016;17:197-207. [ Links ]

    1. Domínguez M. El regreso de Voltaire. Barcelona: Destino; 2007. [ Links ]

    2. Domínguez M. Voltaire. Biblioteca de Grandes Pensadores. Madrid: Editorial Gredos; 2010. [ Links ]

    3. Winterbottom M, Ogilvie RM. Cornelii Taciti, Opera minora. Oxford: Clarendon Press; 1975. [ Links ]

    4. Cohn LH. History of cardiac surgery at the Peter Bent Brigham and Brigham and Women's Hospital, Boston, Massachusetts. Semin Thorac Cardiovasc Surg. 2015;27:398-402. [ Links ]

    5. Armstrong EJ, Waltenberger J, Rogers JH. Percutaneous coronary intervention in patients with diabetes: current concepts and future directions. J Diabetes Sci Technol. 2014;8:581-9. [ Links ]

    6. Bowthorpe M, Tavakoli M, Becher H, Howe R. Smith predictor-based robot control for ultrasound-guided teleoperated beating-heart surgery. IEEE J Biomed Health Inform. 2014;18:157-66. [ Links ]

    7. Clayton ZE, Sadeghipour S, Patel S. Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis. Int J Cardiol. 2015;197:116-22. [ Links ]

    8. Martel S. Swimming microorganisms acting as nanorobots versus artificial nanorobotic agents: A perspective view from an historical retrospective on the future of medical nanorobotics in the largest known three-dimensional biomicrofluidic networks. Biomicrofluidics [Internet]. 2016 [citado 4 Ago 2016];10:021301. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841799/pdf/BIOMGB-000010-021301_1.pdf [ Links ]

    1. Silva Paradela S, Torres Senra L, Rodríguez Rodríguez AI. Isquemia silente en cuidados intensivos: una amenaza potencial. Rev Cubana Med Intensiv Emerg [Internet]. 2006 [citado 14 Mar 2016];5:469-86. Disponible en: http://bvs.sld.cu/revistas/mie/vol5_3_06/mie07306.pdf [ Links ]

    2. Castillo Arocha I, Armas Rojas NB, Dueñas Herrera A, González Greck OR, Arocha Mariño C, Castillo Guzmán A. Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/apolipoproteína A1. Rev Cubana Invest Bioméd [Internet]. 2010 [citado 14 Mar 2016];29:479-88. Disponible en: http://scielo.sld.cu/pdf/ibi/v29n4/ibi08410.pdf [ Links ]

    3. Leone A. Hypertension and sudden cardiac death: their relationship in postinfarction cardiac rupture. J Am Soc Hypertens. 2015;9(Supl. 4S):e59 [Resumen]. [ Links ]

    4. Delcán Domínguez J. Cardiopatía Isquémica. Madrid: Cardigam Multimedia; 1999. p. 557-91. [ Links ]

    5. Antman EM, Morrow DA. Infarto de miocardio con elevación del segmento ST: tratamiento. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, editores. Braunwald Tratado de Cardiología: Texto de Medicina Cardiovascular. 9na. Ed. Barcelona: Elsevier; 2013. p. 1123-91. [ Links ]

    6. Yamada H, Sakurai A, Higurashi A, Takeda K. Cardiac CT for intraseptal pseudoaneurysm: impending double rupture of ventricular septum and left ventricular free wall. BMJ Case Rep [Internet]. 2015 [citado 14 Mar 2016];2015:bcr2014207352. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322251/pdf /bcr-2014-207352.pdf [ Links ]

    7. Murgueitio R, Merlano S, Rodríguez EJ. Consideraciones sobre el valor pronóstico de los estudios de perfusión miocárdica. Rev Colomb Cardiol. 2014;21:95-7. [ Links ]

    8. Bonet Gorbea M, Varona Pérez P, Chang La Rosa M, García Roche RG, Suárez Medina R, Arcia Montes de Oca N, et al. III Encuesta de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. La Habana: Editorial Ciencias Médicas; 2014. [ Links ]

    9. Vargas-Barrón J, Roldán FJ, Romero-Cárdenas Á, Vázquez-Antona CA. Intramyocardial dissecting hematoma and postinfarction cardiac rupture. Echocardiography. 2013;30:106-13. [ Links ]

    10. Unsöld B, Kaul A, Sbroggiò M, Schubert C, Regitz-Zagrosek V, Brancaccio M, et al. Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction. Cardiovasc Res. 2014;101:97-107. [ Links ]

    11. Díaz Águila H, Santos Monzón Y, Fragoso Estévez A, Rivero Nóbrega Y, Alonso Freire JL. Rotura del septo interventricular después de infarto agudo de miocardio con apertura y cierre intermitentes. CorSalud [Internet]. 2013 [citado 31 Mar 2016];5:122-6. Disponible en: http://www.corsalud.sld.cu/sumario/2013 /v5n1a13/civ.html [ Links ]

    12. De Gennaro L, Brunetti ND, Ramunni G, Buquicchio F, Corriero F, De Tommasi E, et al. Septal rupture with right ventricular Wall dissecting haematoma communicating with left ventricle after inferior myocardial infarction. Eur J Echocardiogr. 2010:11:477-81. [ Links ]

    13. Espinosa-Ledesma A, Ramírez-Orozco F, Herrera-Camacho G, Macías-Amezcua MD, González-Ojeda A, Fuentes-Orozco C. Mortalidad de la ruptura del septum interventricular posterior a infarto agudo del miocardio con manejo quirúrgico. Cir Ciruj. 2012;80:496-503. [ Links ]

    14. Qian G, Liu Hb, Wang JW, Wu C, Chen YD. Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage. J Zhejiang Univ Sci B. 2013;14:736-42. [ Links ]

    15. Ptaszyñska-Kopczyñska K, Sobolewska D, Ko¿uch M, Dobrzycki S, Sobkowicz B, Hirnle T, et al. Efficacy of invasive treatment and the occurrence of cardiac rupture in acute ST-elevation myocardial infarction. Kardiol Pol. 2011;69:795-800. [ Links ]

    16. Lahoz Tornos Á, Ray López VG, Arcas Meca R, Falcón Araña L. Rotura de pared libre de ventrículo izquierdo tras infarto agudo de miocardio. A propósito de un caso. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2011 [citado 31 Mar 2016];17:102-05. Disponible en: http://www.bvs.sld.cu/revistas/car/vol17_1_11/car13111.pdf [ Links ]

    17. Qian G, Wu C, Chen YD, Tu CC, Wang JW, Qian YA. Predictive factors of cardiac rupture in patients with ST-elevation myocardial infarction. J Zhejiang Univ Sci B. 2014;15:1048-54. [ Links ]

    18. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2014. [ Links ]

    19. Baena Díez JM, del Val García JL, Alemany Vilches L, Martínez Martínez JL, Tomás Pelegrina J, González Tejón I, et al. Riesgo de presentación de eventos cardiovasculares según la agrupación de los factores de riesgo modificables en la población mayor de 15 años de un centro de salud de Barcelona. Rev Esp Salud Pública. 2005;79:365-78. [ Links ]

    20. Honda S, Asaumi Y, Yamane T, Kawakami S, Nagai T, Noguchi T, et al. Long term trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction. J Card Fail. 2014;20:S156-7 [Resumen]. [ Links ]

    21. Steg G, James SK, Atar D, Badano LP, Blomstrom Lundqvist C, Borger MA, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2013;66:53.e1-e46. [ Links ]

    22. Bueno H, Martínez-Sellés M, Pérez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J. 2005;26:1705-11. [ Links ]

    23. Ikeda N, Yasu T, Kubo N, Hirahara T, Sugawara Y, Kobayashi N, et al. Effect of reperfusion therapy on cardiac rupture after myocardial infarction in Japanese. Circ J. 2004;68:422-6. [ Links ]

    24. Markowicz-Pawlus E, Nozyñski J, Sedkowska A, Jarski P, Hawranek M, Streb W, et al. Cardiac rupture risk estimation in patients with acute myocardial infarction treated with percutaneous coronary intervention. Cardiol J. 2007;14:538-43. [ Links ]

    25. Massel DR. How sound is the evidence that thrombolysis increases the risk of cardiac rupture? Br Heart J. 1993;69:284-7. [ Links ]

    26. Nakamura T, Masuda K, Hitomi E, Osaka Y, Nakao T, Yoshimura N. Successful emergency department thoracotomy for traumatic cardiac rupture: effective utilization of a fret sternum saw. Ulus Travma Acil Cerrahi Derg. 2014;20:217-20. [ Links ]

    27. González Muñoz MF, Morera Domínguez O, Guevara de Arma E. Evaluación de los resultados de la trombólisis sistémica en el anciano. AMC [Internet]. 2008 [citado 31 Mar 2016];12:[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/pdf/amc/v12n3/amc11308.pdf [ Links ]

    28. Espinosa Brito AD, Alvarez Li FC, Borges Rodríguez E, Quintana Pérez S, Fernández Turner M. Estudio clínico-patológico de 460 fallecidos con infarto miocárdico agudo. Informe de dos series (1985-1987 y 1991-1993) Clín Cardiovasc (España). 2000;35:449-61. [ Links ]

    29. Hernández Molina AC, Soria Pérez R, Merencio Leyva N, López Torres Y, Carmenate Pousada D. Correspondencia clínica y anátomo-patológica del infarto agudo de miocardio en el municipio de Mayarí. CCM [Internet]. 2014 [citado 31 Mar 2016];18:238-47. Disponible en: http://scielo.sld.cu/pdf/ccm/v18n2/ccm07214.pdf [ Links ]

    1. Casas Piedrahita MC, Chavarro LM, Cardona Rivas D. Adherencia a un programa estatal de control de la hipertensión arterial. Estudio de caso en dos municipios de Colombia. 2010-2011 [tesis de maestría en Internet]. Colombia: Universidad Autónoma; 2012 [11 Dic 2016]. Disponible en: http://repositorio.autonoma.edu.co/jspui/bitstream/11182/366/1/D.%20adh.%20Dorada-Viterbo -dic%2009%202012%20DCR%20(1)%20-%20copia.pdf [ Links ]

    2. Barajas AS, Gómez Ochoa AM. Grados de riesgo para la adherencia terapéutica en personas con hipertensión arterial. AvEnferm [Internet]. 2014 [citado 11 Dic 2016];32. Disponible en: http://www.scielo.org.co/pdf/aven/v32n1/v32n1a04.pdf [ Links ]

    3. Álvarez Álvarez G. Propuesta de un subprograma integral para la atención de la hipertensión arterial esencial en la Atención Primaria de Salud [tesis doctoral en Internet]. Villa Clara: Universidad de Ciencias Médicas; 2010 [citado 11-12-2016]. Disponible en: http://tesis.repo.sld.cu/434/ [ Links ]

    4. Herrera E. Adherencia al tratamiento en personas con hipertensión arterial. AvEnferm [Internet]. 2012 [citado 18 Dic 2016];30. Disponible en: http://www.scielo.org.co/pdf/aven/v30n2/v30n2a06.pdf [ Links ]

    5. Rojas MZ, Morales SY. Adherencia farmacológica al tratamiento antihipertensivo: ¿Un reto o una realidad? Rev Col Enf [Internet]. 2014 [citado 18 Dic 2016];9:133-41. Disponible en: http://www.uelbosque.edu.co/sites/default/files/publicaciones/revistas/revista_colombiana_enfermeria/volumen9/016-articulo14.pdf [ Links ]

    6. Artacho Pino R, Prados Torres JD, Barnestein Fonseca P, Aguiar García C, García Ruiz A, Leiva Fernández F. Cumplimiento terapéutico en pacientes con hipertensión arterial. ¿Ha cambiado con el paso del tiempo? Med Fam Andal [Internet]. 2012 [citado 18 Dic 2016];13:95-106. Disponible en: http://www.samfyc.es/Revista/PDF/v13n2/v13n2_04_original.pdf [ Links ]

    7. Sánchez A, Martínez-Acitores JS. Farmacología de la hipertensión arterial, la insuficiencia vascular periférica y la angiogénesis. En: Flórez J. Farmacología humana. España: Elsevier; 2014. p. 633- 60. [ Links ]

    8. Martín Alfonso L, Bayarre Vea H, Corugedo Rodríguez MC, VentoIznaga F, La Rosa Matos Y, Orbay Araña MC. Adherencia al tratamiento en hipertensos atendidos en áreas de salud de tres provincias cubanas. Rev Cubana Salud Púb. [Internet]. 2015 [citado 18 Dic 2016];41. Disponible en: http://www.scielosp.org/pdf/rcsp/v41n1/spu04115.pdf [ Links ]

    9. Ministerio de Salud Pública. Anuario Estadístico de Salud 2012. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2013. [ Links ]

    10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, And Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. [ Links ]

    11. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guidelinefor the management of high blood pressure in adults: Report from the panel members appointed to the Eighth JointNational Committee (JNC 8). JAMA. 2014;311:507-20. [ Links ]

    12. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-219. [ Links ]

    13. Hernández Vázquez LM, Pérez Martínez VT, De la Vega Pažitková T. Caracterización de pacientes hipertensos mayores de18 años del consultorio médico 3 del Policlínico Docente "Ana Betancourt". Rev Cubana Med Gen Integr [Internet]. 2014 [citado 18 Dic 2016];30:59-70. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252014000100006&lng=es&nrm=iso&tlng=es [ Links ]

    14. Michel T, Hoffman BB. Tratamiento de la isquemia del miocardio y de la hipertensión. En: Brunton LL. Goodman &Gilman. Las bases farmacológicas de la terapéutica. México: McGraw-Hill; 2012. p. 745-88. [ Links ]

    15. Pérez M. Guías para diagnóstico y tratamiento de la hipertensión arterial en el siglo XXI. Rev Cubana Med [Internet]. 2013 [citado 12 Dic 2016];52:286-94. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232013000400008 [ Links ]

    16. Salcedo Barajas A. Grados de riesgo para la adherencia terapéutica en los tratamientos farmacológicos y no farmacológicos en personas con hipertensión arterial [tesis de maestría en Internet]. Colombia: Universidad Nacional; 2011 [citado 12 Dic 2016]. Disponible en: http://www.bdigital.unal.edu.co/4164/1 /539474.2011.pdf [ Links ]

    17. Lira MT. Impacto de la hipertensión arterial como factor de riesgo cardiovascular. Rev Med Clin Condes. 2015;26:156-63. [ Links ]

    18. Hirschberg S, Donatti S, Rijana I, Selan V. La relación entre adherencia terapéutica y calidad de vida en la hipertensión arterial. Psiencia [Internet]. 2014 [citado 12 Dic 2016];6. Disponible en: http://www.psiencia.org/ojs/index.php/psiencia/article/view/128 [ Links ]

    19. Escobar Tobar CA. Adherencia y resistencia de los pacientes hipertensos al tratamiento médico que incluye cambios en el modo de vida [tesis de maestría en Internet]. Chile: Facultad de Ciencias Sociales; 2011 [citado 12 Dic 2016]. Disponible en: http://repositorio.uchile. cl/tesis/uchile/2011/cs-escobar_c/pdfAmont/cs-escobar_c.pdf [ Links ]

    20. Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento antihipertensivo Martín Bayarré Grau. RevMéd Risaralda [Internet]. 2011 [citado 18 Dic 2016];17. Disponible en: http://dialnet.unirioja.es/descarga/articulo/3954826.pdf [ Links ]

    21. Kunert JA. Adherencia al tratamiento antihipertensivo en pacientes ambulatoriosde un hospital urbano. Rev Virtual SocParagMedInt. 2015;2:43-51. [ Links ]

    22. Carhuallanqui R, Diestra-Cabrera G, Tang-Herrera J, Málaga G. Adherencia al tratamiento farmacológico en pacientes hipertensos atendidos en un hospital general. RevMedHered [Internet]. 2010 [citado 18 Dic 2016];21. Disponible en: http://www.scielo.org.pe/pdf/rmh/v21n4/v21n4ao4.pdf [ Links ]

    23. Buitargo F. Adherencia terapéutica. ¡Qué difícil es cumplir! Aten Primaria [Internet]. 2011 [citado 16 Dic 2016];43:343-4. Disponible en: http://www.elsevierinstituciones.com/ficheros/pdf/27 /27v43n07a90023817pdf001.pdf [ Links ]

    24. Corugedo MC, Martín L, Bayarre H. Adherencia terapéutica en pacientes con hipertensión arterial del Policlínico Universitario "Manuel Fajardo" en el Municipio Cruces, Cienfuegos, 2009. Rev Cubana Med Gen Integr [Internet]. 2011 [citado 16 Dic 2016];27. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252011000400009 [ Links ]

    25. Díaz Molina M, Herrera Preval Y, Matéu López L. Adherencia al tratamiento antihipertensivo en pacientes del municipio San Miguel del Padrón. Rev Cubana Farm [Internet]. 2014 [citado 16 Dic 2016];48:588-97. Disponible en: http://www.bvs.sld.cu/revistas/far/vol48_4_14/far08414.htm [ Links ]

    26. Véliz-Rojas L, Mendoza-Parra S, Barriga OA. Adherencia terapéutica y control de los factores de riesgo cardiovasculares en usuarios de atención primaria. Enferm Univ [Internet]. 2015 [citado 16 Dic 2016];12:3-11. Disponible en: http://www.scielo.org.mx/pdf/eu/v12n1/v12n1a2.pdf [ Links ]

    27. Varleta P, Akel C, Acevedo M, Salinas C, Pino J, Opazo V, et al. Prevalencia y determinantes de adherencia a terapia antihipertensiva en pacientes de la Región Metropolitana. Rev Med Chile. 2015;143:569-76. [ Links ]

    28. Ribera Guixá M, Caballero Humet I. Crisis hipertensiva. AMF. 2014;10:89-94. [ Links ]

    29. Gordo Remartinez S, Micheloud Giménez D, Palazuelos Molinero V, Gargallo García E. Hipertensión arterial en Urgencias. Manejo clínico y terapéutico. Medicine. 2011;10:6096-102. [ Links ]

    30. Di Caro VG. Adherencia a las medidas de prevención y tratamiento de la hipertensión arterial en pacientes mayores de 65 años [tesis en Internet]. Argentina: Universidad Abierta Interamericana; 2012 [citado 16 Dic 2016]. Disponible en: http://imgbiblio.vaneduc.edu.ar/fulltext/files/TC111904.pdf [ Links ]

    31. Franco Bonal A, Silva Valido JA, Soto Martínez O, Franco Bonal A. Evaluación de adherencia terapéutica antihipertensiva en el adulto mayor. Rev Info Cien Guantánamo [Internet]. 2010 [citado 16-12-2016];68:2-6. Disponible en: http://www.gtm.sld.cu/sitios/ojs243/index.php/ric/article/view/427/412 [ Links ]

    32. Ramos Morales LE. La adherencia al tratamiento en las enfermedades crónicas. Rev Cubana Angiol Cir Vasc [Internet]. 2015 [citado 18 Dic 2016];16. Disponible en: http://bvs.sld.cu/revistas/ang/vol16_2_15 /ang06215.htm [ Links ]

    33. Martín Alfonso L, Grau Ábalo JA, Espinosa Brito AD. Marco conceptual para la evaluación y mejora de la adherencia a los tratamientos médicos en enfermedades crónicas. Rev Cubana Salud Pub. [Internet]. 2014 [citado 12 Dic 2016];40:222-38. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0864-34662014000200007&lng=es [ Links ]

    34. Chacón J, Sandoval D, Muñoz R, Romero T. Evaluación del control de la presión arterial y la adherencia terapéutica en hipertensos seguidos en el Programa de Salud Cardiovascular (PSCV). Asociación con características clínicas, socioeconómicas y psicosociales. Rev Chil Cardiol [Internet]. 2015 [citado 18 Sep 2015];34:18-27. [ Links ]

    35. Del Castillo Arévalo F, Salido González M, Losada García A, García García M, Fernández Prieto T, Blanco Gutiérrez ML. Valoración de la adherencia en el seguimiento del paciente diabético y uso de lenguaje enfermero. Enferm Glob [Internet]. 2013 [citado 18 Dic 2016];12:18-27. Disponible en: http://scielo.isciii.es/pdf/eg/v12n30/clinica2.pdf [ Links ]

    36. Bohórquez Gallego M. Uso adecuado de medicamentos en pacientes inscritos en el programa de hipertensión arterial de la ESE Hospital San Vicente de Paul del municipio de Pueblo Rico _ Antioquia[tesis en Internet]. Medellín: Universidad Nacional Abierta; 2014 [citado 18 Dic 2016]. Disponible en: http://repository.unad.edu.co/handle/10596/2804 [ Links ]

    37. Furones Mourelles J. Hipertensión arterial. En: Morón Rodríguez FJ. Farmacología clínica. La Habana: Editorial Ciencias Médicas; 2009. p. 133- 58. [ Links ]

    38. Márquez-Hernández VV, Granados Gámez G, Roales-Nieto Gil JG. Aplicación de un programa de mejora de la adherencia en pacientes hipertensos debutantes. Aten Primaria. 2015;47:83-9. [ Links ]

    1. Cleveland Clinic. Sudden cardiac death (Sudden cardiac arrest) [Internet]. Ohio: Cleveland Clinic; 2016 [citado 31 Oct 2016]. Disponible en: http://my.clevelandclinic.org/services/heart/disorders/arrhythmia /sudden-cardiac-death [ Links ]

    2. Sovari AA. Sudden cardiac death: Practice essentials [Internet]. Atlanta: WebMD LLC; 2014[citado 31 Oct 2016]. Disponible en: http://emedicine.medscape.com/article/151907-overview [ Links ]

    3. Smith LA, Hatcher-Ross JL, Wertheimer R, Kahn RS. Rethinking race/ethnicity, income, and childhood asthma: racial/ethnic disparities concentrated among the very poor. Public Health Rep. 2005;120(2):109-16. [ Links ]

    4. Healthcare Cost and Utilization Project (HCUP). Overview of the Kids´ Inpatient Database (KID) [Internet]. Rockville: Agency for Healthcare Research and Quality; 2014 [citado 31 Oct 2016]. Disponible en: https://www.hcup-us.ahrq.gov/kidoverview.jsp [ Links ]

    5. The Institute for Community Health. Hallmark Health System. Community Benefits Needs Assessment: ExecutiveSummary and Final Report [Internet].Cambridge: Institute for Community Health; 2013 [citado 31 Oct 2016]. Disponible en: http://icommunityhealth.org/wp/wp-content/uploads/2014/04/Hallmark.pdf [ Links ]

    1. Morentín B, Suárez-Mier MP, Audicana C, Aguilera B, Garamendi PM, Elexpe X. Incidencia y causas de muerte súbita en menores de 36 años. Med Clin (Barc). 2001;116:281-5. [ Links ]

    2. Byard RW, Cohle SD. Sudden death in infancy, childhood and adolescence. Cambridge: Cambridge University Press; 1994. [ Links ]

    3. Arnau Vives MA, Giner Blasco J, Izquierdo Macián MI, Molina Aguilar P, Zorio Grima E. Abordaje multidisciplinar de la muerte súbita infantil. En: Grupo de Trabajo de Muerte Súbita Infantil (Asociación Española de Pediatría). Libro Blanco de la muerte súbita infantil. 3ª Ed. Madrid: Ergon Creación, 2013. p. 19-28. [ Links ]

    4. Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics. 2004;114:234-8. [ Links ]

    5. Filiano JJ, Kinney HC. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol Neonate. 1994;65:194-7. [ Links ]

    6. Willinger M, Hoffman HJ, Hardford RB. Infant sleep position and risk for suddent infant death syndrome: Report of meeting held January 13 and 14, 1994, National Institutes of Health, Bethesda, MD. Pediatrics. 1994;93(5):814-9. [ Links ]

    7. Ponsonby AL, Dwyer T, Gibbons LE, Cochrane JA, Wang YG. Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med. 1993;329(6):377-82. [ Links ]

    8. Vilar de Saráchaga D, Albanese O, Daraio MC, Spaghi B, Cohen Arazi J, Lomuto C, et al. Nuevas recomendaciones para la disminución del riesgo del síndrome de muerte súbita del lactante. Arch Argent Pediatr. 2000;98(4):239-43. [ Links ]

    9. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2004 period linked birth/infant death data set. Natl Vital Stat Rep. 2007;55(14):1-32. [ Links ]

    1. Montagud Balaguer V. Muerte súbita [Internet]. Fundación Española del Corazón [citado 31 Ago 2016]. Disponible en: http://www.fundaciondelcorazon.com/informacion-para-pacientes/enfermedades -cardiovasculares/muerte-subita.html [ Links ]

    2. Gutiérrez Báez YM, Castellanos Rojas R, Ferrer Herrera I, Cabrera Peláez Y, Ávila Frómeta IW, Hernández Julbec JA. Muerte súbita cardiovascular. Rev Finlay [Internet]. 2015 [citado 31 Ago 2016];5:198-203. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/343/1429 [ Links ]

    3. Ochoa Montes LA, González Lugo M, Tamayo Vicente ND, Gómez de Haz HJ, Correa Azahares DP, Miguélez Nodarse R, et al. Epidemiología de la muerte súbita cardíaca. Rev Cubana Hig Epidemiol [Internet]. 2012 [citado 31 Ago 2016];50:14-24. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032012000100003 [ Links ]

    4. Ochoa Montes LA. Exclusión social y muerte súbita cardíaca. Rev Cubana Salud Pública [Internet]. 2010 [citado 31 Ago 2016];36:266-70. Disponible en: http://scielo.sld.cu/pdf/rcsp/v36n3/spu12310.pdf [ Links ]

    5. Bayés de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012;65:1039-52. [ Links ]

    6. Rodríguez-Reyes H, Muñoz Gutiérrez M, Márquez MF, Pozas Garza G, Asensio Lafuente E, Ortiz Galván F, et al. Muerte súbita cardíaca. Estratificación de riesgo, prevención y tratamiento. Arch Cardiol Mex. 2015;85:329-36 [ Links ]

    7. Moss AJ, Goldenberg I. Prevention of sudden cardiac death: Need for a plaque stabilizer. Am Heart J. 2010;159:15-6. [ Links ]

    8. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043-52. [ Links ]

    9. Rothman K. Epidemiología moderna. 1ª ed. Madrid: Ediciones Díaz de Santos; 1987. [ Links ]

    10. OPS. La Estandarización: Un método epidemiológico clásico para la comparación de tasas. Bol Epidemiol OPS. 2002;23:9-12. [ Links ]

    11. Useros Fernández JL. Ajuste o estandarización de tasas y cálculo de los años potenciales de vida perdidos (APVP). Diplomado en Salud Pública [Internet]. Instituto de Estudios de Ciencias de la Salud de Castilla y León [citado 31 Ago 2016]. Disponible en: http://studylib.es/doc/5286369/ajuste-o-estandarizacion-de-tasas -y-c%C3%A1lculo-de-los [ Links ]

    12. Servizo Galego de Saúde. Epidat 4: Ayuda de ajuste de tasas [Internet]. Octubre 2014 [citado 31 Ago 2016]. Disponible en: https://www.sergas.es/Saude-publica/Documents/1895 /Ayuda_Epidat_4_Ajuste_de_tasas_Octubre2014.pdf [ Links ]

    1. González Valcárcel K, Hernández Díaz D, Pedraza Alonso NE. Compatibilidad entre el diagnóstico clínico y anatomopatológico en los servicios del Hospital Universitario Arnaldo Milián Castro. Medicent Electrón [Internet]. 2014 [citado 22 Ago 2016];18:163-70. Disponible en: http://www.medicentro.sld.cu/index.php /medicentro/article/view/1396/1405 [ Links ]

    2. Bürgesser MV, Camps D, Calafat P, Diller A. Discrepancias entre diagnósticos clínicos y hallazgos de autopsia. Medicina. 2011;71:135-8. [ Links ]

    3. Verdú F. Autopsia clínica: Un necesario resurgir. Gac Int Cienc Forense. 2012;2:1-2. [ Links ]

    4. Hurtado de Mendoza Amat J. Autopsia. Garantía de calidad en la medicina [Internet]. La Habana: Ciencias Médicas; 2009 [citado 22 Ago 2016]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/scap /librocompleto.pdf [ Links ]

    5. Hurtado de Mendoza Amat J, Álvarez Santana R, Borrajero Martínez I. Discrepancias diagnósticas en las causas de muerte identificadas por autopsias. Cuba 1994-2003. Primera parte. Patol Rev Latinoam. 2008;46:85-95. [ Links ]

    6. Pedraza Alonso NE, Igualada Correa I. Correlación clínico patológica en autopsia. Estudios de dos años. X Congreso Virtual Hispanoamericano de Anatomía Patológica [Internet]. España: Sociedad Española de Anatomía Patológica; 2009 [citado 22 Ago 2016]. Disponible en: http://www.conganat.org/10congreso/trabajo.asp?id_trabajo=1950&tipo=2 [ Links ]

    7. Organización Mundial de la Salud. Clasificación estadística internacional de enfermedades y problemas relacionados con la salud (CIE-10). Vol. 2. Ginebra: OMS; 2009. p. 26-39. [ Links ]

    8. Hurtado de Mendoza AJ, Álvarez SR, Borrajero MI. Discrepancias diagnósticas en las causas de muerte identificadas por autopsias. Cuba 1994-2003. Cuarta parte. Patol Rev Latinoam. 2010;48:3-7. [ Links ]

    9. Rodríguez Maroto O, Llorente Álvarez S, Casanueva Gutierrez M, Álvarez Álvarez B, Menéndez Somoano P, de la Riva Miranda G. Mortalidad en un Servicio de Urgencias Hospitalarias. Características clínico epidemiológicas. Emergencias. 2004;16:17-22. [ Links ]

    10. García Montero A, Quiñónez Zamora A, Gómez Sánchez A, Montero González T. Correlación anátomo-clínica de los fallecidos en la Unidad de Cuidados Intensivos de Emergencias. Rev Cubana Med Int Emerg 2003;2:9-14. Disponible en: http://bvs.sld.cu/revistas/mie/vol2_2_03/mie03104.pdf [ Links ]

    11. Santiago Guervos M, Muñoz Álvarez D, Rodríguez C. La mortalidad en el Servicio de Urgencias Generales del Hospital de Área de Ávila. Un estudio descriptivo. Emergencias. 1994;6:172-5. [ Links ]

    12. Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública [Internet]. 2015 [citado 01 Sep 2016];41:298-323. Disponible en: http://scielo.sld.cu/pdf/rcsp/v41n2/spu10215.pdf [ Links ]

    13. Pérez de Corcho Rodríguez MA, Pérez Assef JJ, Sevilla Pérez B, Mayola Alberto CC, Díaz Mizos FA. Estrategia con enfoque comunitario para prevenir los factores de riesgo de muerte súbita. Mediciego [Internet]. 2011 [citado 01 Sep 2016];17:[aprox. 8 p.]. Disponible en: http://bvs.sld.cu/revistas/mciego/Vol17_01_%202011/pdf/T18.pdf [ Links ]

    14. Ochoa Montes LA, González Lugo M, Vilches Izquierdo E, Fernández-Britto Rodríguez JE, Araujo González RE. Muerte súbita cardiovascular en poblaciones de riesgo. CorSalud [Internet]. 2014 [citado 04 Ago 2016];6(Supl. 1):71-8. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/pob-riesgo.html [ Links ]

    15. Carter-Monroe N, Virmani R. Tendencias actuales en la clasificación de la muerte súbita cardiaca según los datos de autopsias: una revisión de los estudios sobre la etiología de la muerte súbita cardiaca. Rev Esp Cardiol. 2011;64:10-12. [ Links ]

    16. Ochoa Montes LA, Miguélez Nodarse R, Vilches Izquierdo E, Pernas Sánchez Y. El desafío mundial de la muerte súbita cardíaca en el nuevo milenio. Resumen de un estudio cubano. CorSalud [Internet]. 2012 [citado 04 Ago 2016];4:278-86. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n4a12/ms.html [ Links ]

    17. Hurtado de Mendoza Amat J, Álvarez Santana R. Situación de la autopsia en Cuba y el mundo. La necesidad de su mejor empleo. Patol Rev Latinoam. 2008;46:3-8. [ Links ]

    1. Hurtado de Mendoza Amat J. Autopsia. Garantía de calidad en la medicina [Internet]. La Habana: Ciencias Médicas; 2009 [citado 22 Ago 2016]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/scap /librocompleto.pdf [ Links ]

    2. Desmond GJ. Muerte cardíaca súbita. En: Bennet JC, Plum F, editores. Cecil Tratado de Medicina Interna. 10ma ed. México: McGraw-Hill Interamericana; 1983. p.152-8. [ Links ]

    3. Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública [Internet]. 2015 [citado 01 Sep 2016];41:298-323. Disponible en: http://scielo.sld.cu/pdf/rcsp/v41n2/spu10215.pdf [ Links ]

    4. Pérez de Corcho Rodríguez MA, Pérez Assef JJ, Sevilla Pérez B, Mayola Alberto CC, Díaz Mizos FA. Estrategia con enfoque comunitario para prevenir los factores de riesgo de muerte súbita. Mediciego [Internet]. 2011 [citado 01 Sep 2016];17:[aprox. 8 p.]. Disponible en: http://bvs.sld.cu/revistas/mciego/Vol17_01_%202011/pdf/T18.pdf [ Links ]

    5. Neira JA, Bosque L, Gelpi F, Neira P. Manual de socorrismo básico para escuelas. Ministerio de Cultura y Educación de la Nación. Buenos Aires: Sociedad Argentina de Terapia Intensiva; 1999. [ Links ]

    6. Spirgi R. Manual de atención médica de emergencia en situaciones de desastres naturales o producidas por el hombre. España: Ministerio de Sanidad y Consumo; 1989. p. 55. [ Links ]

    7. Ochoa Montes LA, González Lugo M, Vilches Izquierdo E, Fernández-Britto Rodríguez JE, Araujo González RE. Muerte súbita cardiovascular en poblaciones de riesgo. CorSalud [Internet]. 2014 [citado 04 Ago 2016];6(Supl. 1):71-8. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/pob-riesgo.html [ Links ]

    8. Muratore C, Belziti C, Di Toro D, Gant López J, Mulassi A, Barrios A, et al. Precisión del certificado de defunción comparado con la autopsia verbal. Estudio PRISMA. Rev Argent Cardiol. 2006;74:211-6. [ Links ]

    9. Carter-Monroe N, Virmani R. Tendencias actuales en la clasificación de la muerte súbita cardiaca según los datos de autopsias: una revisión de los estudios sobre la etiología de la muerte súbita cardiaca. Rev Esp Cardiol. 2011;64:10-2. [ Links ]

    10. Ochoa Montes LA, Miguélez Nodarse R, Vilches Izquierdo E, Pernas Sánchez Y. El desafío mundial de la muerte súbita cardíaca en el nuevo milenio. Resumen de un estudio cubano. CorSalud [Internet]. 2012 [citado 04 Ago 2016];4:278-86. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n4a12/ms.html [ Links ]

    1. Ochoa Montes LA, Ferrer Marrero D, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, et al. Proyecciones del Grupo de Investigación en Muerte Súbita 20 años después de su creación. CorSalud [Internet]. 2015 [citado 20 Mar 2017];7:300-8. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/77/169 [ Links ]

    2. Tamayo Vicente ND, Ochoa Montes LA, Vilches Izquierdo E, González Lugo M, García Ones D. Infarto miocárdico crónico como factor de riesgo de muerte súbita cardíaca. Rev Cubana Invest Bioméd [Internet]. 2015 [citado 20 Mar 2017];34:145-56. Disponible en: http://bvs.sld.cu/revistas/ibi/vol34_02_15/ibi05215.htm [ Links ]

    3. Bayés de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012;65:1039-52. [ Links ]

    4. Lahoz Tornos A, Ray López VG, Arcas Meca R, Falcón Arana L. Rotura de pared libre de ventrículo izquierdo tras infarto agudo de miocardio. A propósito de un caso. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2011 [citado 20 Mar 2017];17:102-5. Disponible en: http://www.bvs.sld.cu/revistas/car/vol17_1_11 /car13111.pdf [ Links ]

    5. Antman EM, Morrow DA. Infarto de miocardio con elevación del segmento ST: tratamiento. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, Eds. Braunwald Tratado de Cardiología: Texto de medicina cardiovascular. 9ª ed. Barcelona: Elsevier España; 2013. p. 1123-91. [ Links ]

    6. Pell JP. Anuario 2012: Puntuaciones de riesgo cardiovascular. Las revistas de las Sociedades Nacionales presentan una selección de las investigaciones que han impulsado avances recientes en Cardiología Clínica. CorSalud [Internet]. 2013 [citado 20 Mar 2017];5:6-16. Disponible en: http://bvs.sld.cu/revistas/cors/pdf/2013/v5n1a13/es/almanac-riesgo.pdf [ Links ]

    7. Steg G, James SK, Atar D, Badano LP, Blomstrom Lundqvist C, Borger MA, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol [Internet]. 2013 [citado 20 Mar 2017];66:53e1-e46. Disponible en: http://www.revespcardiol.org/es/pdf/90180910/S300/ [ Links ]

    8. González-Rosas IA, Hernández-Santamaría I, Vázquez-Martínez de Velasco A, Pérez-Salgado H, López Gómez LM, García-Aguilar BS, et al. Complicaciones mecánicas del infarto: rotura de pared libre ventricular. Presentación de un caso. Rev Mex Cardiol. 2014;25:36-42. [ Links ]

    9. Kutty RS, Jones N, Moorjani N. Mechanical complications of acute myocardial infarction. Cardiol Clin. 2013;31:519-31. [ Links ]

    10. Figueras J, Alcalde O, Barrabés JA, Serra V, Alguersuari J, Cortadellas J, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008;118:2783-9. [ Links ]

    11. Solís C, Pujol D, Mauro V. Rotura de la pared libre del ventrículo izquierdo secundaria a infarto agudo de miocárdico. Rev Argent Cardiol. 2009;77:395-404. [ Links ]

    12. Markowicz-Pawlus E, No¿yñski J, Duszañska A, Hawranek M, Jarski P, Kalarus Z. The impact of a previous history of ischaemic episodes on the occurrence of left ventricular free wall rupture in the setting of myocardial infarction. Kardiol Pol. 2012;70:713-7. [ Links ]

    13. Gruppo Italiano per lo Studio della Streptochinasi nell'infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402. [ Links ]

    14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-60. [ Links ]

    15. Bueno H, Martínez-Sellés M, Pérez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J. 2005;26:1705-11. [ Links ]

    16. Magalhães P, Mateus P, Carvalho S, Leão S, Cordeiro F, Moreira JI, et al. Relationship between treatment delay and type of reperfusion therapy and mechanical complications of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2016;5:468-74. [ Links ]

    17. Pohjola-Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, et al. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the multicenter investigation of limitation of infarct size. Am Heart J. 1989;117:809-18. [ Links ]

    18. Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003;91:1055-9. [ Links ]

    19. Bazzino O. Tercera definición universal de infarto de miocardio. Implicancias en la práctica clínica. Rev Urug Cardiol. 2013;28:403-11. [ Links ]

    20. de Abreu M, Mariani J, Guridi C, González-Villa-Monte G, Gastaldello N, Potito M, et al. Asociación entre marcadores bioquímicos y disfunción ventricular izquierda en infarto con elevación del segmento ST. Arch Cardiol Mex. 2014;84:243-9. [ Links ]

    1. Aguilera Tapia B, Suárez Mier MP. Muerte súbita cardiaca. Rev Electrón Autops [Internet]. 2003 [citado 31 Mar 2017];1(1):21-34. Disponible en: http://rea.uninet.edu/index.php/ejautopsy/article/view/4/4 [ Links ]

    2. Marrugat J, Elosua R, Gil M. Epidemiología de la muerte súbita cardíaca en España. Rev Esp Cardiol. 1999;52(9):717-25. [ Links ]

    3. Valero Moreno S, Barreto Martín MP, Pérez Marín M. Familia y duelo: el apego y los acontecimientos vitales estresantes como predictores del desarrollo de duelo complicado. Fam Rev Ciencic Orientac Fam. 2016;53:57-70. [ Links ]

    4. Barreto Martin P, Soler Saiz C, editores. Muerte y duelo. Madrid: Editorial Síntesis; 2007. [ Links ]

    5. Chaurand A, Feixas G, Neimeyer R, Salla M, Trujillo A. Historia de pérdidas y sintomatología depresiva. Rev Argent Clín Psicol. 2015;XXIV(2):179-88. [ Links ]

    6. Barreto-Martín P, Pérez-Marín M, Yi P. Predictors in complicated grief: Supporting Families in palliative care dealing with grief. En: Chang E, Johnson A, eds. Contemporary and Innovative Practice in Palliative Care [Internet]. InTech; 2012 [citado 31 Mar 2017]. Disponible en: https://www.intechopen.com/books/contemporary-and-innovative-practice-in-palliative-care/predictors-in-complicated-grief-supporting-families-in -palliative-care-dealing-with-grief [ Links ]

    7. Parris RJ. Initial management of bereaved relatives following trauma. Trauma. 2012;14(2):139-55. [ Links ]

    8. Sandín B, Valiente RM, Chorot P, Santed MA, Lostao L. SA-45: forma abreviada del SCL-90. Psichothema. 2008;20(2):290-6. [ Links ]

    9. Davison ML, Bershadsky B, Bieber J, Silversmith D, Maruish ME, Kane RL. Development of a brief, multidimensional, self-report instrument for treatment outcomes assessment in psychiatric settings: Preliminary findings. Assessment. 1997;4(3):259-76. [ Links ]

    10. Bartholomew K, Horowitz LM. Attachment styles among young adults: A test of a four-category model. J Pers Soc Psychol. 1991;61(2):226-44. [ Links ]

    11. Alonso-Arbiol I, Balluerka N, Shaver PR. A Spanish version of the experiences in close relationships (ECR) adult attachment questionnaire. Pers Relationship. 2007;14(1):45-63. [ Links ]

    12. Melero R, Cantero MJ. Los estilos afectivos en la población española: un cuestionario de evaluación del apego adulto. Clín Salud. 2008;19(1):83-100. [ Links ]

    13. Limonero JT, Lacasta MA, García JA, Maté J, Prigerson HG. Adaptación al castellano del inventario de duelo complicado. Med Paliativa. 2009;16(5):291-7. [ Links ]

    14. Soler MC, Barreto Martin P, Yi P. Estudio sobre la implantación de la atención al duelo en el estado español. Construcción de un instrumento de evaluación y programa de intervención [Memoria de Investigación]. Valencia: Escuela Valenciana de Estudios para la Salud; 2002. [ Links ]

    15. Stroebe MS, Hansson RO, Schut H, Stroebe W. Handbook of Bereavement Research and Practice: Advances in Theory and Intervention. Washington DC: American Psychological Association; 2008. [ Links ]

    16. Cassidy J, Shaver PR. Handbook of attachment: Theory, Research, and Clinical Applications. 2ª Ed. New York: Guilford Press; 2008. [ Links ]

    17. Parkes CM, Prigerson HG. Bereavement: Studies of grief in adult life. 4ª Ed. London: Routledge; 2010. [ Links ]

    1. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452(1):11-8. [ Links ]

    2. Basso C, Carturan E, Pilichou K, Rizzo S, Corrado D, Thiene G. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol. 2010;19(6):321-5. [ Links ]

    3. Thiene G, Carturan E, Corrado D, Basso C. Prevention of sudden cardiac death in the young and in athletes: Dream or reality? Cardiovasc Pathol. 2010;19(4):207-17. [ Links ]

    4. Thiene G, Corrado D, Basso C. Sudden Cardiac Death in the Young and Athletes. Milan: Springer; 2016. [ Links ]

    5. Thiene G. Sudden cardiac death and cardiovascular pathology: From anatomic theater to double helix. Am J Cardiol. 2014;114(12):1930-6. [ Links ]

    1. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-79. [ Links ]

    2. O´Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al. A novel clinical risk prediction model for sudden cardiac death in Hypertrophic Cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35(30):2010-20. [ Links ]

    3. Vriesendorp PA, Schinkel AF, Liebregts M, Theuns DA, van Cleemput J, Ten Cate FJ, et al. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(4):829-35. [ Links ]

    4. Fernández A, Quiroga A, Ochoa JP, Mysuta M, Casabé JH, Biagetti M, et al. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in hypertrophic cardiomyopathy in a reference center in South America. Am J Cardiol. 2016;118(1):121-6. [ Links ]

    5. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS, et al. Independent assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. Am J Cardiol. 2015;116(5):757-64. [ Links ]

    1. Soar J, Nolan JP. Airway management in cardiopulmonary resuscitation. Curr Opin Crit Care. 2013;19(3):181-7. [ Links ]

    2. Wang HE, Yealy DM. Managing the airway during cardiac arrest. JAMA. 2013;309(3):285-6. [ Links ]

    3. Nolan JP, Hazinski MF, Billi JE, Boettiger BW, Bossaert L, de Caen AR, et al. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation. 2010;81(Supl. 1):e1-25. [ Links ]

    4. Hasegawa K, Hiraide A, Chang Y, Brown DF. Association of prehospital advanced airway management with neurologic outcome and survival in patients with out-of-hospital cardiac arrest. JAMA. 2013;309(3):257-66. [ Links ]

    5. Bobrow BJ, Clark LL, Ewy GA, Chikani V, Sanders AB, Berg RA, et al. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest. JAMA. 2008;299(10):1158-65. [ Links ]

    6. Shin SD, Ahn KO, Song KJ, Park CB, Lee EJ. Out-of-hospital airway management and cardiac arrest outcomes: A propensity score matched analysis. Resuscitation. 2012;83(3):313-9. [ Links ]

    7. Fischer H, Hochbrugger E, Fast A, Hager H, Steinlechner B, Koinig H, et al. Performance of supraglottic airway devices and 12 month skill retention: a randomized controlled study with manikins. Resuscitation. 2011;82(3):326-31. [ Links ]

    8. Hasegawa K, Hagiwara Y, Chiba T, Watase H, Walls RM, Brown DF, et al. Emergency airway management in Japan: Interim analysis of a multi-center prospective observational study. Resuscitation. 2012;83(4):428-33. [ Links ]

    9. Wang HE. Emergency airway management: The need to refine _and redefine_ The "state of the art". Resuscitation. 2012; 83(4):405-6. [ Links ]

    10. Bernhard M, Becker TK, Böttiger BW. Prehospital airway management for out-of-hospital cardiac arrest. JAMA. 2013;309(18):1888. [ Links ]

    1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011. [ Links ]

    2. Organización Mundial de la Salud. Informe sobre la situación mundial de las enfermedades no transmisibles 2010. Resumen de orientación [Internet]. Ginebra: OMS; 2011 [citado 31 Oct 2016]. Disponible en: http://www.who.int/nmh/publications/ncd_report_summary_es.pdf [ Links ]

    3. Brugada R. La muerte súbita en el corazón sano. Rev Esp Cardiol. 2010;10(Supl. A):78-84. [ Links ]

    4. Ochoa Montes LA, González Lugo M, Vilches Izquierdo E, Fernández-Britto Rodríguez JE, Araujo González RE. Muerte súbita cardiovascular en poblaciones de riesgo. CorSalud [Internet]. 2014;6(Supl. 1):71-8. [citado 31 Oct 2016]. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/pob-riesgo.html [ Links ]

    5. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18):2158-63. [ Links ]

    6. Ochoa Montes LA. Exclusión social y muerte súbita cardíaca. Rev Cubana Salud Pública [Internet]. 2010 [citado 31 Oct 2016];36(3): 266-70. Disponible en: http://scielo.sld.cu/pdf/rcsp/v36n3/spu12310.pdf [ Links ]

    7. Organización Panamericana de la Salud, Organización Mundial de la Salud. CIE-10: Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión [Internet]. Washington DC: OPS-OMS; 2008 [citado 31 Oct 2016]. Disponible en: http://ais.paho.org/classifications/Chapters/pdf/Volume1.pdf [ Links ]

    8. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2014. [ Links ]

    9. Ministerio de Salud Pública. Anuario Estadístico de Salud 2016. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2017. [ Links ]

    10. Ochoa Montes LA. Muerte súbita cardíaca en comunidades de Arroyo Naranjo en el período 2000-2010 [Tesis doctoral]. La Habana: Universidad de Ciencias Médicas; 2012 [citado 31 Oct 2016]. Disponible en: http://tesis.repo.sld.cu/639/1/Luis_Alberto_Ochoa_Montes.pdf [ Links ]

    11. Carter-Monroe N, Virmani R. Tendencias actuales en la clasificación de la muerte súbita cardiaca según los datos de autopsias: una revisión de los estudios sobre la etiología de la muerte súbita cardiaca. Rev Esp Cardiol. 2011;64(1):10-2. [ Links ]

    12. Falcón Vilaú L, Fernández-Britto Rodríguez JE. Aterosclerosis y muerte súbita: Aplicación de una metodología para su estudio integral. Rev Cubana Invest Bioméd [Internet]. 1998 [citado 31 Oct 2016];17(2):152-64. Disponible en: http://scielo.sld.cu/pdf/ibi/v17n2/ibi05298.pdf [ Links ]

    13. Fernández-Britto JE, Falcon L, Campos R, Guski H, Hufnagl P. Coronary atherosclerosis in sudden death: A comparative study applying an atherometric system. Gegenbaurs Morphol Jahrb. 1989;135(1):183-4. [ Links ]

    14. Basso C, Burke M, Fornes P, Gallagher PJ, De Gouveia RH, Sheppard M, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452(1):11-8. [ Links ]

    15. Castellá García J, Medallo Muñiz J, Marrón Moya T. Aspectos medicolegales de la muerte súbita cardiaca. Rev Esp Cardiol. 2013;13(Supl. A):30-7. [ Links ]

    16. Rea TD, Page RL. Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. Circulation. 2010;121(9):1134-40. [ Links ]

    17. Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública [Internet]. 2015 [citado 31 Oct 2016];41(2):298-323. Disponible en: http://scielo.sld.cu/pdf/rcsp/v41n2/spu10215.pdf [ Links ]

    18. Muratore C, Belziti C, Di Toro D, Gant López J, Mulassi A, Barrios A, et al. Precisión del certificado de defunción comparado con la autopsia verbal. Estudio PRISMA. Rev Argent Cardiol. 2006;74(6):441-6. [ Links ]

    19. Ferrer Marrero D, Pantoja Vacaflor SP. Un encuentro con la Patología Forense Cubana. La Paz: Universidad Mayor de San Andrés; 2005. [ Links ]

    20. Ferrer Marrero D. La Patología Forense en Cuba [Internet]. La Habana: Instituto de Medicina Legal; 2012 [citado 31 Oct 2016]. Disponible en: http://medicinalegal.edu.uy/bibliografia/archivos/pf-cuba.pdf [ Links ]

    21. Virgilí Jiménez D, Ferrer Marrero D, Leal Rivero Y. La violencia en salud, como problema médico legal y ético. Rev Haban Cienc Méd [Internet] 2013 [citado 31 Oct 2016];12(2):286-93. Disponible en: http://scielo.sld.cu/pdf/rhcm/v12n2/rhcm16213.pdf [ Links ]

    22. Wilhelm M, Bolliger SA, Bartsch C, Fokstuen S, Gräni C, Martos V, et al. Sudden cardiac death in forensic medicine _ Swiss recommendations for a multidisciplinary approach. Swiss Med Wkly [Internet]. 2015 [citado 31 Oct 2016];145:w14129. Disponible en: https://smw.ch/resource/jf/journal/file/download/article /smw.2015.14129/smw.2015.14129.pdf/ [ Links ]

    23. Ferrer Marrero D. Muerte súbita del adulto. Módulo 3. Tema 9. Máster en Medicina Forense. 11ª Ed. Valencia: Universidad de Valencia; 2014. [ Links ]

    24. Gallagher PJ. The pathological investigation of sudden cardiac death. Curr Diagn Pathol. 2007;13(5):366-74. [ Links ]

    25. Nanavati PP, Mounsey JP, Pursell IW, Simpson RJ, Lewis ME, Mehta ND, et al. Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results. Open Heart [Internet]. 2014 [citado 31 Oct 2016];1:e000150. Disponible en: http://openheart.bmj.com/content/1/1/e000150.full.pdf [ Links ]

    26. Hurtado de Mendoza Amat J. Autopsia. Garantía de calidad en la medicina. La Habana: Ecimed; 2009. [ Links ]

    27. Morales Martínez PE. Muerte Súbita de Origen Cardiovascular. En: Gutiérrez-Hoyos A, Etxeberria Gabilondo F, Eds. Segundo Curso de Patología Forense. Donostia-San Sebastián: Universidad del País Vasco, 2001; p. 207-21. [ Links ]

    28. Fernández-Britto JE, Falcon L, Campos R, Contreras D, Guski H. Cardiac sudden death: A morphometric study applying an atherometric system. Pathol Res Pract. 1987;182(4):489 [Resumen]. [ Links ]

    29. Fernández-Britto JE, Carlevaro, PV, Bacallao J, Koch AS, Guski H. The lesional state vector: a new approach to characterize atherosclerotic lesions. Zentralbl Allg Pathol. 1987;133(4):361-8. [ Links ]

    30. Fernández-Britto JE, Bacallao J, Carlevaro PV, Koch AS, Guski H, Campos R, et al. Atherosclerotic lesion of the circle of Willis: its study applying an atherometric system using multivariate statistical techniques. Cor Vasa. 1991;33(3):188-96. [ Links ]

    31. Fernández-Britto JE, Carlevaro PV. Atherometric system: morphometric standardized methodology to study atherosclerosis and its consequences. Gegenbaurs Morphol Jahrb. 1989;135(1):2-12. [ Links ]

    32. Fernández-Britto JE, Bacallao J, Wong R, Campos R, Falcon L, Castillo J. Aterosclerosis, lesión miocárdica y lipidograma. Estudio multiarterial patomorfológico y morfométrico utilizando el sistema aterométrico y la correlación canónica. Aterosclerosis al día II. Progresos en Ciencias Médicas. Caracas: Ediciones Galénicas; 1993. p. 85-98. [ Links ]

    33. Fernández-Britto JE, Carlevaro PV. Sistema aterométrico: metodología estandarizada para el estudio de la lesión aterosclerótica y sus consecuencias. Rev Cubana Invest Bioméd. 1988;7(3):113-23. [ Links ]

    34. Holman RL, McGill HC, Strong JP, Geer JC. Technic for studying atherosclerotic lesions. Lab Invest. 1958;7(1):42-7. [ Links ]

    35. Rodríguez H. La peritación de la violencia: algunas cuestiones éticas. Rev Psiquiatr Urug. 2010;74(1):38-44. [ Links ]

    36. American Psychiatric Association. Opinions of the Ethics Committee on the Principles of Medical Ethics with Annotations Especially Applicable to Psychiatry [Internet]. Arlington, Virginia: American Psychiatric Association; 2016 [citado 31 Mar 2017]. Disponible en: http://www.psychiatry.org/File%20Library /Psychiatrists/Practice/Ethics/Opinions-of-the-Ethics-Committee.pdf [ Links ]

    37. Berro G. Bioética y actividad pericial. Rev Psiquiatr Urug. 2007;71(1):20-4. [ Links ]

    38. Colectivo de Autores. Principios de la Ética Médica. Ciudad de La Habana: Editora Política; 1983. [ Links ]

    39. González J, Rapún A, Altisent R, Irigoyen J. Principios éticos y legales en la práctica pericial psiquiátrica. Cuad Med Forense. 2005;42:275-85. [ Links ]

    40. Piga Rivero A. Ética en la pericia médico-legal. Med Leg Costa Rica. 2000;17(1):7-8. [ Links ]

    41. Hutchins GM, Berman JJ, Moore GW, Hanzlick R. Practice guidelines for autopsy pathology: Autopsy reporting. Arch Pathol Lab Med. 1999;123(11):1085-92. [ Links ]

    42. Ochoa Montes LA, López Messa JB, Ferrer Marrero D, Fernández Viera MR. Los registros estadísticos en la muerte súbita cardiovascular. CorSalud [Internet]. 2014 [citado 31 Oct 2016];6(Supl. 1):98-100. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/mesas.html#mesa3 [ Links ]

    1. Fellner JP, Navari CA. Investigación médico legal de la muerte súbita no violenta. Cuad Med Forense (Argentina) [Internet]. 2003 [citado 30 Nov 2016];2(2):7. Disponible en: http://www.csjn.gov.ar/cmfcs/files/pdf /_Tomo-2(2003)/Numero-2/CMF2-2-7.doc [ Links ]

    2. Castellá García J, Medallo Muñiz J, Marrón Moya T. Aspectos medicolegales de la muerte súbita cardiaca. Rev Esp Cardiol. 2013;13(Supl. A):30-7. [ Links ]

    3. Pérez Álvarez H, Ferrer Marrero D. Aspectos médico-legales de la muerte súbita cardiovascular. CorSalud [Internet]. 2014 [citado 30 Nov 2016];6(Supl. 1):65-70 Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/legal.html [ Links ]

    4. Gisbert Calabuig, JA. Medicina Legal y Toxicología. 6ta Ed. Barcelona: Masson, SA; 2005. [ Links ]

    5. Vargas Alvarado E. Medicina Forense y Deontología Médica. México: Trillas; 2005. [ Links ]

    6. Ochoa Montes LA, González Lugo M, Tamayo Vicente ND, Gómez de Haz HJ, Correa Azahares DP, Miguélez Nodarse R, et al. Epidemiología de la muerte súbita cardíaca. Rev Cubana Hig Epidemiol [Internet]. 2012 [citado 30 Nov 2016];50(1): 14-24. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032012000100003&lng=es&nrm=iso&tlng=es [ Links ]

    7. Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública [Internet]. 2015 [citado 30 Nov 2016];41(2):298-323. Disponible en: http://scielo.sld.cu/pdf/rcsp/v41n2/spu10215.pdf [ Links ]

    8. Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58(12):1254-61. [ Links ]

    9. Dorantes Sánchez M. Canalopatías iónicas: generalidades y panorámica actual. Rev Cubana Invest Bioméd [Internet]. 2012 [citado 30 Nov 2016];31(1):1-15. Disponible en: http://scielo.sld.cu/pdf/ibi/v31n1/ibi01112.pdf [ Links ]

    10. Cruz Cardentey M. Síndrome de QT corto. Rev Cubana Invest Bioméd [Internet]. 2012 [citado 30 Nov 2016];31(2):145-56. Disponible en: http://scielo.sld.cu/pdf/ibi/v31n2/ibi02212.pdf [ Links ]

    11. Romero García A, Fernández Chelala FI, Domínguez Pérez RJ, Padrosa Santos D, Santos Hernández AM. Síndrome de Brugada. Reporte de caso. CCM [Internet]. 2014 [citado 30 Nov 2016];18(2):363-71. Disponible en: http://scielo.sld.cu/pdf/ccm/v18n2/ccm22214.pdf [ Links ]

    12. Rodríguez Font E, Viñolas Prat X. Causas de muerte súbita. Problemas a la hora de establecer y clasificar los tipos de muerte. Rev Esp Cardiol. 1999;52(11):1004-14. [ Links ]

    1. Guijarro R, Trujillo-Santos J, Bernal-Lopez MR, de Miguel-Díez J, Villalobos A, Salazar C, et al. Trend and seasonality in hospitalizations for pulmonary embolism: a time-series analysis. J ThrombHaemost. 2015;13(1):23-30. [ Links ]

    2. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Eur Heart J. 2014;35(43):3033-69, 3069a-3069k. [ Links ]

    3. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-867. [ Links ]

    1. Rodríguez-Reyes H, Muñoz Gutiérrez M, Márquez MF, Pozas Garza G, Asensio Lafuente E, Ortíz Galván F, et al. Muerte súbita cardiaca. Estratificación de riesgo, prevención y tratamiento. Arch Cardiol Mex. 2015;85(4):329-36. [ Links ]

    2. Goyal V, Jassal DS, Dhalla NS. Pathophysiology and prevention of sudden cardiac death. Can J Physiol Pharmacol. 2016;94(3):237-44. [ Links ]

    3. Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 2015;116(12):1887-906. [ Links ]

    4. Drajer S. Papel de los sistemas de emergencia médica en la muerte súbita, CorSalud [Internet]. 2017 [citado 15 Oct 2017];9(3):227-8. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view /262/545 [ Links ]

    5. Lam SS, Zhang J, Zhang ZC, Oh HC, Overton J, Ng YY, et al. Dynamic ambulance reallocation for the reduction of ambulance response times using system status management. Am J Emerg Med. 2015 Feb;33(2):159-66. [ Links ]

    6. Dorantes Sánchez M, Ponce Paredes E, Falcón Rodríguez R. Extrasístoles ventriculares con intervalo corto de acoplamiento como detonantes de arritmias malignas. CorSalud [Internet]. 2016 [citado 15 Jun 2017];8(3):144-52. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/134/319 [ Links ]

    7. Cordero Escobar I. La enseñanza de la reanimación cardiopulmonar y cerebral. CorSalud [Internet]. 2017 [citado 15 Oct 2017];9(3):279-81. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view /263/546 [ Links ]

    8. Bagnall RD, Weintraub RG, Ingles J, Duflou J, Yeates L, Lam L, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med. 2016;374(25):2441-52. [ Links ]

    9. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-867. [ Links ]

    10. Lerma C, Glass L. Predicting the risk of sudden cardiac death. J Physiol. 2016;594(9):2445-58. [ Links ]

    11. Deyell MW, Krahn AD, Goldberger JJ. Sudden cardiac death risk stratification. Circ Res. 2015;116(12):1907-18. [ Links ]

    12. Moreno-Martínez FL, Chávez-González E, Moreno-Valdés MT, Oroz Moreno R. Promoción de salud para reducir el retraso en buscar atención médica de los pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2016;69(7):713. [ Links ]

    13. de León Ojeda NE. Determinantes genéticas de la muerte súbita cardiovascular. CorSalud [Internet]. 2014 [citado 15 Jun 2017];6(Supl 1):30-41. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14 /genetica.html [ Links ]

    14. Cleland JG. Is aspirin useful in primary prevention? Eur Heart J. 2013;34(44):3412-8. [ Links ]

    1. Gurger M, Turkoglu A, Atescelik M, Bork T, Tokdemir M, Alatas OD, et al. Sudden suspected death in emergency department: Autopsy results. Turk J Emerg Med. 2016;14(3):115-20. [ Links ]

    2. Ewy GA, Ornato JP. 31st Bethesda Conference. Emergency Cardiac Care. Task force 1: Cardiac arrest. J Am Coll Cardiol. 2000;35(4):832-46. [ Links ]

    3. Pell JP, Sirel JM, Marsden AK, Ford I, Cobbe SM. Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. BMJ. 2001;322(7299):1385-8. [ Links ]

    4. Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions; Board on Health Sciences Policy; Institute of Medicine; Graham R, McCoy MA, Schultz AM, editors. Strategies to improve cardiac arrest survival: A time to act. Washington (DC): National Academies Press (US); 2015. [ Links ]

    5. Girotra S, van Diepen S, Nallamothu BK, Carrel M, Vellano K, Anderson ML, et al. Regional variation in out-of-hospital cardiac arrest survival in the United States. Circulation. 2016;133(22):2159-68. [ Links ]

    6. Rafecas Ventosa A, Bañeras J, Milà L, Buera I, Rueda F, Barrabés JA, et al. ¿Tienen los supervivientes de un paro cardiaco extrahospitalario mejor pronóstico si han sido tratados con un desfibrilador externo automático de uso público? Rev Esp Cardiol. 2016:69(Supl. 1):508 [Resumen]. [ Links ]

    1. Zamorano JL, Mayordomo J, Evangelista A, San Román JA, Bañuelos C, Gil Aguado M. Guías de práctica clínica de la Sociedad Española de Cardiología en enfermedades de la aorta. Rev Esp Cardiol. 2000;53(4):531-41. [ Links ]

    2. Evangelista Masip A. Avances en el síndrome aórtico agudo. Rev Esp Cardiol. 2007;60(4):428-39. [ Links ]

    3. Clouse WD, Hallett JW, Schaff HV, Spittell PC, Rowland CM, Ilstrup DM, et al. Acute aortic dissection: Population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. 2004;79(2):176-80. [ Links ]

    4. Pape LA, Awais M, Woznicki EM, Suzuki T, Trimarchi S, Evangelista A, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol. 2015;66(4):350-8. [ Links ]

    5. Li Y, Li L, Mu HS, Fan SL, He FG, Wang ZY. Aortic dissection and sudden unexpected deaths: A Retrospective study of 31 forensic autopsy cases. J Forensic Sci. 2015;60(5):1206-11. [ Links ]

    6. Moreira PC, Santos A. Sudden death secondary to acute aortic syndromes in the North of Portugal: Medico-legal study. Rev Port Cir Cardiotorac Vasc. 2013;20(4):191-8. [ Links ]

    7. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis? Circulation. 1992;85(1):205-11. [ Links ]

    8. Stefanadis CI, Karayannacos PE, Boudoulas HK, Stratos CG, Vlachopoulos CV, Dontas IA, et al. Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. Cardiovasc Res. 1993;27(6):951-6. [ Links ]

    9. von Kodolitsch Y, Aydin MA, Koschyk DH, Loose R, Schalwat I, Karck M, et al. Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol. 2002;39(4):617-24. [ Links ]

    10. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55(14):e27-e129. [ Links ]

    11. Bailey K, Duflou J, Puranik R. Fatal cases of aortic dissection: An autopsy study. Int J Cardiol. 2012;158(1):148-9. [ Links ]

    12. Nallamothu BK, Mehta RH, Saint S, Llovet A, Bossone E, Cooper JV, et al. Syncope in acute aortic dissection: Diagnostic, prognostic, and clinical implications. Am J Med. 2002;113(6):468-71. [ Links ]

    13. Masuda Y, Yamada Z, Morooka N, Watanabe S, Inagaki Y. Prognosis of patients with medically treated aortic dissections. Circulation. 1991;84(5 Supl. III):7-13. [ Links ]

    14. Pineault J, Ouimet D, Pichette V, Vallée M. A case of an aortic dissection in a young adult: A refresher of the literature of this "great masquerader". Int J Gen Med. 2011;4:889-93. [ Links ]

    1. Girbau ML, Terradellas BJ. Arritmias cardíacas. En: Rozman C, Cardellach F, eds. Medicina interna. 17ma ed. Barcelona: Elsevier; 2012. p. 431-60. [ Links ]

    2. Myerburg JR, Castellanos A. Parada cardíaca y muerte súbita cardíaca. En: Bonow OR, Mann LD, Zipes PD, Libby P, eds. Braunwald Tratado de Cardiología: Texto de Medicina Cardiovascular. 9na ed. Barcelona: Elsevier; 2013. p. 853-93. [ Links ]

    3. Paulin LF, Exner VD. Sudden Cardiac Death: Implantable Cardioverter-Defibrilattors. In: Vicent JL, Abraham E, Moore AF, Kochanek MP, Fink PM, eds. Textbook of Critical Care. 6ta ed. Philadelphia: Elsevier; 2011. p. 594-603. [ Links ]

    4. Chitnis N, Vooturi S, Hygriv Rao B. Sudden cardiac death early after ST elevation myocardial infarction with and without severe left ventricular dysfunction. Indian Heart J. 2014;66:569-73. [ Links ]

    5. Bonny A, Ngantcha M, Amougou SN, Kane A, Marrakchi S, Okello E, et al. Rationale and design of the Pan-African Sudden Cardiac Death survey: the Pan-African SCD study. Cardiovasc J Afr. 2014;25:176-84. [ Links ]

    6. Braggion-Santos MF, Volpe GJ, Pazin-Filho A, Maciel BC, Marin-Neto JA, Schmidt A. Sudden cardiac death in Brazil: a community-based autopsy series (2006-2010). Arq Bras Cardiol. 2015;104:120-7. [ Links ]

    7. Wu Q, Zhang L, Zheng J, Zhao Q, Wu Y, Yin K, et al. Forensic pathological study of 1656 cases of sudden cardiac death in southern China. Medicine (Baltimore) [Internet]. 2016 [citado 10 Jun 2016];95:e2707. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748930/pdf/medi-95-e2707.pdf [ Links ]

    8. Wang H, Yao Q, Zhu S, Zhang G, Wang Z, Li Z, et al. The autopsy study of 553 cases of sudden cardiac death in Chinese adults. Heart Vessels. 2014;29:486-95. [ Links ]

    9. Ochoa Montes LA, González Lugo M, Tamayo Vicente ND, Romero del Sol JM, Rodríguez Hernández N, Fernández-Britto Rodríguez JE. Estudio clínico patológico sobre muerte súbita cardíaca. Rev Cubana Invest Bioméd [Internet]. 2010 [citado 28 Jun 2016];29:339-44: Disponible en: http://scielo.sld.cu/pdf/ibi/v29n3/ibi04310.pdf [ Links ]

    10. Betensky BP, Dixit S. Sudden cardiac death in patients with nonischemic cardiomyopathy. Indian Heart J. 2014;66:S35-45. [ Links ]

    11. Ullal AJ, Abdelfattah RS, Ashley EA, Froelicher VF. Hypertrophic cardiomyopathy as a cause of sudden cardiac death in the young: A meta-analysis. Am J Med. 2016;129:486-96.e2. [ Links ]

    12. Lewis EM, Lin CF, Nanavati P, Mehta N, Mounsey L, Nwosu A, et al. Estimated incidence and risk factors of sudden unexpected death. Open Heart [Internet]. 2016 [citado 21 Jun 2016];3:e000321. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809187/pdf/openhrt-2015-000321.pdf [ Links ]

    13. Arntz HR, Willich SN, Schreiber C, Brüggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J. 2000;21:315-20. [ Links ]

    14. Ben Ahmed H, Allouche M, Zoghlami B, Shimi M, Razghallah R, Gloulou F, et al. Diurnal, weekly and seasonal variation of sudden cardiac death in northern Tunisia. Presse Med. 2014;43(4 Pt 1):e39-45. [ Links ]

    15. López-Messa JB, Alonso-Fernández JI, Andrés-de Llano JM, Garmendia-Leiza JR, Ardura-Fernández J, de Castro-Rodríguez F, et al. Ritmo circadiano y variaciones temporales en el paro cardiaco súbito extrahospitalario. Med Intensiva. 2012;36:402-9. [ Links ]

    16. Garmendia Leiza JR, Andrés de Llano JM, Lopez Messa JB, Alberola López C, Ardura Fernández J, ARIAM Study Group. New insights into the circadian rhythm of acute myocardial infarction in subgroups. Chronobiol Int. 2007;24:129-41. [ Links ]

    17. Reddy PR, Reinier K, Singh T, Mariani R, Gunson K, Jui J, et al. Physical activity as a trigger of sudden cardiac arrest: The Oregon Sudden Unexpected Death Study. Int J Cardiol. 2009;131:345-9. [ Links ]

    1. Acosta Tieles N. Muerte súbita en el niño: Un enigma del Siglo XX. La Habana: Editorial Científico-Técnica; 2003. [ Links ]

    2. Pérez Álvarez H, Ferrer Marrero D. Aspectos médico-legales de la muerte súbita cardiovascular. CorSalud [Internet]. 2014 [citado 30 Oct 2016];6(Supl. 1):65-70. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/legal.html [ Links ]

    3. Ochoa Montes LA. Muerte súbita cardíaca en comunidades de Arroyo Naranjo en el período 2000-2010 [Tesis doctoral]. La Habana: Universidad de Ciencias Médicas; 2012 [citado 31 Oct 2016]. Disponible en: http://tesis.repo.sld.cu/639/1/Luis_Alberto_Ochoa_Montes.pdf [ Links ]

    4. Lancís F, Fournier I, Ponce F, González J, Valdéz L, Pons M. Medicina Legal. La Habana: Editorial Ciencias Médicas, 1999. [ Links ]

    5. Calabuig G, Villanueva E, eds. Medicina Legal y Toxicología. 6ª ed. Barcelona: Masson; 2004. [ Links ]

    6. Camarasa Piquer F. Evolución histórica del síndrome de la muerte súbita del lactante (SMSL) en España. En: Grupo de Trabajo de Muerte Súbita Infantil (Asociación Española de Pediatría). Libro Blanco de la muerte súbita infantil. 3ª Ed. Madrid: Ergon Creación, 2013. p. 37-46. [ Links ]

    7. Ferrer Marrero D, Sánchez Ojeda Y, Alfonso Barrios G, Palma Machado L. Aspectos epidemiológicos y diagnósticos del síndrome de muerte súbita infantil. AMC [Internet]. 2014 [citado 31 Oct 2016]; 18(3):328-41. Disponible en: http://scielo.sld.cu/pdf/amc/v18n3/amc08030314.pdf [ Links ]

    8. Quirós González G, Bolívar Porras M, Solano Tenorio N. Muerte súbita del lactante. Med Leg Costa Rica. 2016;33(1):44-56. [ Links ]

    9. Blasco CP, Giner Blasco J. Implicaciones médico-legales de la MSI. Diagnóstico diferencial con la muerte violenta. En: Grupo de Trabajo de Muerte Súbita Infantil (Asociación Española de Pediatría). Libro Blanco de la muerte súbita infantil. 3ª Ed. Madrid: Ergon Creación, 2013. p. 227-235. [ Links ]

    10. Aguilera B, Suarez-Mier MP. La importancia de la investigación del lugar de la muerte y de la entrevista familiar en casos de muerte súbita e inesperada del lactante. Cuad Med Forense. 2002;(30):33-8. [ Links ]

    11. García García FE, Pérez Martínez T, Perea Corral J, Núñez Wong-Shue J. Muerte extrahospitalaria en menores de 1 año, 1991-1993. Rev Cubana Pediatr [Internet]. 2001 [citado 31 Oct 2016];73(4):199-205. Disponible en: http://scielo.sld.cu/pdf/ped/v73n4/ped01401.pdf [ Links ]

    12. Rocca Rivarola M. Síndrome de muerte súbita del lactante [Internet]. Intramed; 2015 [citado 31 Oct 2016]. Disponible en: http://www.intramed.net/userfiles/2015/file/muertesubita.pdf [ Links ]

    13. García García FE. Síndrome de muerte súbita del lactante. Rev Cubana Pediatr [Internet]. 2008 [citado 31 Oct 2016];80(2). Disponible en: http://scielo.sld.cu/pdf/ped/v80n2/ped09208.pdf [ Links ]

    1. Ramesh S, Zalucky A, Hemmelgarn BR, Roberts DJ, Ahmed SB, Wilton SB, et al. Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis. BMC Nephrol [Internet]. 2016 [citado 18 Abr 2017];17(1):78. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC4940956/pdf/12882_2016_Article_293.pdf [ Links ]

    2. Vilches Izquierdo E, Ochoa Montes LA, González Lugo M, Ramos Marrero L, Dra. Tamayo Vicente ND, García Ones D, et al. Perfil de riesgo vascular aterosclerótico del fallecido por muerte cardíaca súbita. Rev Cubana Med [Internet]. 2013 [citado 18 Abr 2017];52(3):146-60. Disponible en: http://scielo.sld.cu/pdf/med/v52n3/med02313.pdf [ Links ]

    3. Lemery R. Sudden cardiac death: We shall never surrender. Trends Cardiovasc Med. 2016;26(8):720-21. [ Links ]

    4. Steinberg C, Laksman ZW, Krahn AD. Sudden cardiac death: A reappraisal. Trends Cardiovasc Med. 2016;26(8):709-19. [ Links ]

    5. Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI Task Force. Europace. 2014;16(11):1655-73. [ Links ]

    6. Gharacholou SM, Lopes RD, Alexander KP, Mehta RH, Stebbins AL, Pieper KS, et al. Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: Findings from the APEX-AMI trial. Arch Intern Med. 2011;171(6):559-67. [ Links ]

    7. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120(10):835-42. [ Links ]

    8. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: Lessons from the MUSTT study. J Am Coll Cardiol. 2007;50(12):1150-7. [ Links ]

    9. Rao HB, Sastry BK, Korabathina R, Raju KP. Sudden cardiac death after acute ST elevation myocardial infarction: Insight from a developing country. Heart Asia. 2012;4(1):83-89. [ Links ]

    10. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation. 1999;99(15):1978-83. [ Links ]

    11. Venkatason P, Salleh NM, Zubairi Y, Hafidz I, Ahmad WA, Han SK,et al. The bizzare phenomenon of smokers' paradox in the immediate outcome post acute myocardial infarction: an insight into the Malaysian National Cardiovascular Database-Acute Coronary Syndrome (NCVD-ACS) registry year 2006-2013. Springerplus [Internet]. 2016 [citado 18 Abr 2017];5:534. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846599/pdf/40064_2016_Article_2188.pdf [ Links ]

    12. Takagi H, Umemoto T; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Is ALICE still in Wonderland of the "smoker's paradox"? A meta-analysis of mortality following ACS. Br J Cardiol [Internet]. 2014 [citado 22 Abr 2017];21:117. Disponible en: https://bjcardio.co.uk/2014/09/is-alice-still-in -wonderland-of-the-smokers-paradox-a-meta-analysis-of-mortality-following-acs/ [ Links ]

    13. van Diepen S, Widimský P, Lopes RD, White KR, Weaver WD, Van de Werf F, et al. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI Insights. Circ Cardiovasc Qual Outcomes. 2012;5(4):437-444. [ Links ]

    14. Al-Gobari M, El Khatib C, Pillon F, Gueyffier F. â-blockers for the prevention of sudden cardiac death in heart failure patients: A meta-analysis of randomized controlled trials. BMC Cardiovasc Disord [Internet]. 2013 [citado 22 May 2017];13:52. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716800/pdf /1471-2261-13-52.pdf [ Links ]

    15. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-425. [ Links ]

    16. Jensen MT, Pereira M, Araujo C, Malmivaara A, Ferrieres J, Degano IR, et al. Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study. Eur Heart J Acute Cardiovasc Care [Internet]. 2016 [citado 22 May 2017]. Disponible en: http://journals.sagepub.com/doi/abs/10.1177/2048872616672077?url_ver=Z39.88 -2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed [ Links ]

    17. Konety SH, Koene RJ, Norby FL, Wilsdon T, Alonso A, Siscovick D, et al. Echocardiographic predictors of sudden cardiac death. The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study. Circ Cardiovasc Imaging [Internet]. 2016 [citado 26 May 2017];9:e004431. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010094/pdf/nihms803199.pdf [ Links ]

    1. Monsieurs KG, Nolan JP, Bossaert LL, Greif R, Maconochie IK, Nikolaou NI, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 1. Executive summary. Resuscitation. 2015;95:1-80. [ Links ]

    2. Dávila Radilla F, Casas Juárez J. Principales trastornos cardiacos relacionados con la muerte súbita. Rev e-sholarum. [Internet]. 2009 [citado 08 Ago 2016];11:42-53. Disponible en: http://genesis.uag.mx/escholarum/vol11/muerte.html [ Links ]

    3. García Herrero MÁ, González Cortés R, López González J, Aracil Santos FJ. La reanimación cardiopulmonar y la atención inicial a las urgencias y emergencias pediátricas. Rev Pediatr Aten Primaria Supl. 2011;13(20):197-210. [ Links ]

    4. Instituto Mexicano del Seguro Social. Manejo inicial del paro cardiorrespiratorio en pacientes mayores de 18 años [Internet]. México: Guía de Práctica Clínica, 2013 [citado 08 Ago 2016]. Disponible en: http://www.imss.gob.mx/sites/all/statics/guiasclinicas/633GRR.pdf [ Links ]

    5. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2014. [ Links ]

    6. Truong HT, Low LS, Kern KB. Current approaches to cardiopulmonary resuscitation. Curr Probl Cardiol. 2015;40:275-313. [ Links ]

    7. Balcázar-Rincón LE, Mendoza-Solís LA, Ramírez Alcántara YL. Reanimación cardiopulmonar: nivel de conocimientos entre el personal de un servicio de urgencias. Rev Esp Méd Quir. 2015;20:248-55. [ Links ]

    8. Cueto Pérez M. Conocimiento del personal de enfermería de un hospital materno-infantil sobre técnicas de reanimación cardiopulmonar [tesis de maestría en Internet]. España: Universidad de Oviedo; 2013 [citado 12 Ago 2016]. Disponible en: http://digibuo.uniovi.es/dspace/bitstream/10651/17303/1 /TFM_Monica%20Cueto%20Perez.pdf [ Links ]

    9. Travers AH, Perkins GD, Berg RA, Castren M, Considine J, Escalante R, et al. Part 3: Adult Basic Life Support and Automated External Defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015;132(16 Supl 1):S51-83. [ Links ]

    10. Machado Álvarez MC, Roque González R, Barrios Osuna I, Nodal Ortega J, Olive González JB, Quintana Pajón I. Nivel de conocimientos en reanimación cardiopulmonar cerebral en el Centro Nacional de Cirugía de mínimo acceso. Rev Cuba Anestesiol Reanim [Internet]. 2010 [citado 08 Ago 2016];9:83-94. Disponible en: http://scielo.sld.cu/pdf/scar/v9n2/ane04210.pdf [ Links ]

    11. Regalado Becerra CA, Segura Veja J, Órnelas Aguirre JM. Evaluación de conocimientos y equipamiento en los carros rojos para la reanimación cardiopulmonar en una unidad de tercer nivel de atención. Medicrit. 2008;5:63-73. [ Links ]

    12. Israelsson J, Källén P, Carlsson J. Test cases: in-hospital, scenario-based cardiopulmonary resuscitation training. Med Educ. 2009;43:1099-100. [ Links ]

    13. Chamberlain D, Smith A, Woollard M, Colquhoun M, Handley AJ, Leaves S, et al. Trials of teaching methods in basic life support (3): Comparison of simulated CPR performance after first training and at 6 months, with a note on the value of re-training. Resuscitation. 2002;53:179-87. [ Links ]

    14. Woollard M, Whitfeild R, Smith A, Colquhoun M, Newcombe RG, Vetteer N, et al. Skill acquisition and retention in automated external defibrillator (AED) use and CPR by lay responders: a prospective study. Resuscitation. 2004;60:17-28. [ Links ]

    1. Gollob MH, Blier L, Brugada R, Champagne J, Chauhan V, Connors S, et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol. 2011;27:232-45. [ Links ]

    2. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31:2715-26. [ Links ]

    3. Barriales-Villa R, Gimeno-Blanes JR, Zorio-Grima E, Ripoll-Vera T, Evangelista-Masip A, Moya-Mitjans A, et al. Protocolo de actuación en las cardiopatías familiares: síntesis de recomendaciones y algoritmos de actuación. Rev Esp Cardiol. 2016;69:300-9. [ Links ]

    4. Coronary Heart Disease Team. National Service Framework for Coronary Heart Disease - Chapter Eight: Arrhythmias and Sudden Cardiac Death. London: National Health Service; 2005. [ Links ]

    5. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-39. [ Links ]

    6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006;48:e247-346. [ Links ]

    7. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733-79. [ Links ]

    8. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011;58:1485-96. [ Links ]

    9. van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59:493-500. [ Links ]

    1. Pallares Neila L, García Junquera MJ. Guía práctica para la evaluación de la calidad en la atención de enfermería. Madrid: Olalla; 1996. [ Links ]

    2. Suárez López D, Barrera Sotolongo J. Enfermería en los servicios de urgencia y emergencia. En: León Román CA, Suárez López D, Baltar Charnicharo LR, Apao Díaz J, Pérez Ley A, Díaz Díaz LM, et al. Enfermería en Urgencias. T I. La Habana: Editorial Ciencias Médicas; 2008. p. 1-18. [ Links ]

    3. Fenton Tait MC, León Román CA, Amaro Cano MC, Durán Laporte M, Jarrosay Speck CM, Garbey Calzado J, et al. Temas de Enfermería Médico-Quirúrgica. 1ª Parte. La Habana: Editorial Ciencias Médicas; 2005. [ Links ]

    4. León Román CA. Calidad en los servicios de urgencias. En: León Román CA, Suárez López D, Baltar Charnicharo LR, Apao Díaz J, Pérez Ley A, Díaz Díaz LM, et al. Enfermería en Urgencias. T I. La Habana: Editorial Ciencias Médicas; 2008. p. 19-26. [ Links ]

    5. Dains J, Alexander E, Jordan K. Estándares para la práctica de Enfermería de Urgencia. Barcelona: Masson; 1993. [ Links ]

    6. Smeltzer SC, Bare BG, Hinkle JL, Cheever KH, eds. Brunner y Suddarth: Enfermería medicoquirúrgica. 12ª ed. Buenos Aires: Lippincott Williams & Wilkins; 2013. [ Links ]

    7. Sosa Acosta A. Urgencias médicas: Guía de primera atención. La Habana: Editorial Ciencias Médicas; 2004. [ Links ]

    8. Navarro Machado VR, Falcón Hernández A, Rodríguez Suárez G, Sosa Acosta A, Águila Trujillo L, Morejón Barroso O, et al. Manual para la instrucción del socorrista. Rodas: Damuní; 2007. [ Links ]

    9. Organización Panamericana de la Salud. Manual de diagnóstico y tratamiento en especialidades clínicas. Washington, DC: OPS; 2003. [ Links ]

    10. Barranco Ruiz F, Blasco Morilla J, Mérida Morales A, Muñoz Sánchez MA, Jareño Chaumel A, Cózar Carrasco J, et al. Principios de urgencias, emergencias y cuidados críticos. Granada: Alhulia; 1999. [ Links ]

    11. Valdivia Casanova J. Trastornos de las funciones respiratorias. En: Avilés Cruz P, ed. Texto para la especialización de enfermería en cuidados intensivos. T 3. La Habana: Pueblo y Educación; 1990. p. 462-9. [ Links ]

    12. Álvarez Sintes R, ed. Medicina General Integral. Vol. I. 2ª ed. La Habana: Editorial Ciencias Médicas; 2008. [ Links ]

    13. Iyer PW. Proceso y diagnóstico de Enfermería. Madrid: McGraw-Hill Interamericana; 1993. [ Links ]

    14. Álvarez Sáez M. Primeros auxilios y trabajos de salvamento en situaciones de desastres: Segunda parte. Kingston: Centro Latinoamericano de Medicina de Desastres (CLAMED); 2003. [ Links ]

    15. Bello Gutiérrez B, Cruz Álvarez NM, Álvarez Sáez M, Chao Rojas FL, García Gómez V, Arias González A, et al. Medicina de desastres. La Habana: Editorial Ciencias Médicas; 2004. [ Links ]

    1. Accreditation Council for Graduate Medical Education. Manual of Policies and Procedures. Chicago, IL: Accreditation Council for Graduate Medical Education; 2009. [ Links ]

    2. Gahan K, Studnek JR, Vandeventer S. King LT-D use by urban basic life support first responders as the primary airway device for out-of-hospital cardiac arrest. Resuscitation. 2011;82(12):1525-8. [ Links ]

    3. Sastre Carrera MJ, García García LM, Bordel Nieto F, López-Herce Cid J, Carrillo Álvarez A, Benítez Robredo MT, et al. Enseñanza de la reanimación cardiopulmonar básica en población general. Aten Primaria. 2004;34(8):408-13. [ Links ]

    4. Rojas L, Aizman A, Arab JP, Utili F, Andresen M. Reanimación cardiopulmonar básica: conocimiento teórico, desempeño práctico y efectividad de las maniobras en médicos generales. Rev Med Chile. 2012;140(1):73-7. [ Links ]

    1. Bajanowski T, Vege A, Byard RW, Krous HF, Arnestad M, Bachs L, et al. Sudden infant death syndrome (SIDS) - Standardised investigations and classification: recommendations. Forensic Sci Int. 2007;165(2-3):129-43. [ Links ]

    1. Ley Orgánica 15/2003 [Internet]. En: Jefatura del Estado (España). Boletín Oficial del Estado Nº 283 (26 Nov 2003). Madrid: Agencia Estatal BOE [citado 12 Jul 2016]; 2003. Disponible en: https://www.boe.es/boe/dias/2003/11/26/pdfs/A41842-41875.pdf [ Links ]

    2. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11-8. [ Links ]

    3. Oliva A, Brugada R, D'Aloja E, Boschi I, Partemi S, Brugada J, et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol. 2010;31:1-16. [ Links ]

    1. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289-300. [ Links ]

    2. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis? Circulation. 1996;94(5):983-91. [ Links ]

    3. Pilichou K, Thiene G, Bauce B, Rigato I, Lazzarini E, Migliore F, et al. Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis [Internet]. 2016 [citado 30 Oct 2016];11:33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818879/pdf/13023_2016_Article_407.pdf [ Links ]

    4. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318(3):129-33. [ Links ]

    5. Thiene G. The research venture in arrhythmogenic right ventricular cardiomyopathy: A paradigm of translational medicine. Eur Heart J. 2015;36(14):837-46. [ Links ]

    1. Jefatura del Estado. Ley Orgánica 15/2003. BOE 283/2003 [Internet]. Madrid: Publicaciones de la Administración General del Estado; 2003. p. 41842-75 [citado 30 Oct 2016]. Disponible en: https://www.boe.es/boe/dias/2003/11/26/pdfs/A41842-41875.pdf [ Links ]

    2. Basso C, Burke M, Fornes P, Gallagher PJ, De Gouveia RH, Sheppard M, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452(1):11-8. [ Links ]

    3. Oliva A, Brugada R, D'Aloja E, Boschi I, Partemi S, Brugada J, et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol. 2011;32(1):1-16. [ Links ]

    4. Ministerio de Educación, Cultura y Deporte. Real Decreto 767/2014, de 12 de septiembre, por el que se establece el título de Técnico Superior en Anatomía Patológica y Citodiagnóstico y se fijan sus enseñanzas mínimas. BOE 241/2014 [Internet]. Madrid: Publicaciones de la Administración General del Estado; 2014. p. 79051-114 [citado 30 Oct 2016]. Disponible en: https://www.seap.es/c/document_library /get_file?uuid=a20e54f8-0b08-4f9a-8bc4-ff08649c2cd2&groupId=10157 [ Links ]

    1. Chamberlain D, Cummins RO, Abramson N, Allen M, Baskett P, Becker L, et al. Pautas recomendadas para la comunicación uniforme de datos en la parada cardíaca extrahospitalaria (nueva versión abreviada). El «estilo Utstein». Med Intensiva. 1993;17:461-72. [ Links ]

    2. Appendix: Evidence-Based Worksheets 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations and 2010 American Heart Association and American Red Cross International Consensus on First Aid Science With Treatment Recommendations. Circulation. 2010;122(16 Supl. 2):606-38. [ Links ]

    3. Dirkmann D, Hanke AA, Görlinger K, Peters J. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg. 2008;106(6):1627-32. [ Links ]

    4. Cooper JA, Cooper JD, Cooper JM. Cardiopulmonary resuscitation: history, current practice, and future direction. Circulation. 2006;114(25):2839-49. [ Links ]

    5. Nichol G, Aufderheide TP, Eigel B, Neumar RW, Lurie KG, Bufalino VJ, et al. Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association. Circulation. 2010;121(5):709-29. [ Links ]

    6. Ornato JP, Becker LB, Weisfeldt ML, Wright BA. Cardiac arrest and resuscitation: An opportunity to align research prioritization and public health need. Circulation. 2010;122(18):1876-9. [ Links ]

    7. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al. Part 9: Post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Supl. 3):768-86. [ Links ]

    8. Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013;369(23):2197-206. [ Links ]

    9. Mader TJ, Nathanson BH, Soares WE, Coute RA, McNally BF. Comparative effectiveness of therapeutic hypothermia after out-of-hospital cardiac arrest: Insight from a large data registry. Ther Hypothermia Temp Manag. 2014;4(1):21-31. [ Links ]

    10. Lopez-de-Sa E. ¿Qué hacer con los supervivientes a una parada cardiaca? ¿Inducir hipotermia o basta evitar la hipertermia? Rev Esp Cardiol. 2015;68(5):369-72. [ Links ]

    11. Hörburger D, Testori C, Sterz F, Herkner H, Krizanac D, Uray T, et al. Mild therapeutic hypothermia improves outcomes compared with normothermia in cardiac-arrest patients - A retrospective chart review. Crit Care Med. 2012;40(8):2315-9. [ Links ]

    12. Reinikainen M, Oksanen T, Leppänen P, Torppa T, Niskanen M, Kurola J, et al. Mortality in out-of-hospital cardiac arrest patients has decreased in the era of therapeutic hypothermia. Acta Anaesthesiol Scand. 2012;56(1):110-5. [ Links ]

    13. Morgenegg R, Oddo M. Improving prognostic prediction of coma after cardiac arrest: New data, new clinical approach. Curr Anaesth Crit Care. 2012;2(5):249-55. [ Links ]

    14. Castrén M, Silfvast T, Rubertsson S, Niskanen M, Valsson F, Wanscher M, et al. Scandinavian clinical practice guidelines for therapeutic hypothermia and post-resuscitation care after cardiac arrest. Acta Anaesthesiol Scand. 2009;53(3):280-8. [ Links ]

    15. Nadkarni V. Cooler heads prevail… even when those with a propensity to be "hot heads" are included!. Crit Care Med. 2012;40(8):2502-3. [ Links ]

    16. Ponz de Antonio I, López de Sa E, Gemma D, González Fernández O, Caro Codón J, Blázquez Bermejo Z, et al. Influencia de la temperatura en el momento de despertar en pacientes tratados con hipotermia terapéutica tras una parada cardiaca recuperada. Rev Esp Cardiol. 2014;67(Supl. 1):16 [Resumen]. [ Links ]

    17. Malhotra S, Dhama SS, Kumar M, Jain G. Improving neurological outcome after cardiac arrest: Therapeutic hypothermia the best treatment. Anesth Essays Res. 2013;7(1):18-24. [ Links ]


    1. Bayés de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012;65(11):1039-52. [ Links ]

    2. Subirana MT, Juan-Babot JO, Puig T, Lucena J, Rico A, Salguero M, et al. Specific characteristics of sudden death in mediterranean Spanish population. Am J Cardiol. 2011;107(4):622-7. [ Links ]

    3. Nikus K, Pahlm O, Wagner G, Birnbaum Y, Cinca J, Clemmensen P, et al. Electrocardiographic classification of acute coronary syndromes: A review by a committee of the International Society for Holter and Non-Invasive Electrocardiology. J Electrocardiol. 2010;43(2):91-103. [ Links ]

    4. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-52. [ Links ]

    5. Carvajal MS, Ramos L, Robalino MD, Rentería A, Rojas J, Valdiviezo H, et al. Diseño metodológico de las cuentas satélite de servicios de salud. Instituto Nacional de Estadística y Censos, y Ministerio de Salud Pública (INEC-MSP). Quito: INEC; 2016. [ Links ]

    1. Sobrido M, González-Guitián C. La variabilidad de firmas de los artículos científicos. Galicia Clínica. 2011;72:165-7. [ Links ]

    2. Cañedo Andalia R, Nodarse Rodríguez M, Peña Rodríguez KM. ORCID: en busca de un identificador único permanente y universal para científicos y académicos. Rev Cubana Inform en Ciencias de la Salud. 2015;26:71-7. [ Links ]

    3. Sobrido Prieto M, Gutiérrez Couto U, González Guitián C. De la normalización de la firma científica a la identificación digital del autor. Index Enferm (Gran). 2016;25:56-9. [ Links ]

    4. Digital Object Identifier. Key Facts on Digital Object identifier System [Internet]. 2009 [citado 23 Enero 2017]. Disponible en: http://www.doi.org/factsheets/DOIKeyFacts.html [ Links ]

    5. Open Researcher and Contributor (ORCID). ORCID [Internet]. 2012 [citado 23 Enero 2017]. Disponible en: http://orcid.org/about/ [ Links ]

    1. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;59:2015-22. [ Links ]

    2. Myerburg RJ, Juntilla MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043-52. [ Links ]

    3. Bayés-Genís A, Viñolas X, Guindo J, Fiol M, Bayés de Luna A. Electrocardiographic and clinical precursors of ventricular fibrillation: chain of events. J Cardiovasc Electrophysiol. 1995;6:410-7. [ Links ]

    4. Moss AJ, Goldenberg I. Prevention of sudden cardiac death: need for a plaque stabilizer. Am Heart J. 2010;159:15-6. [ Links ]

    5. Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm. 2009;6:836-47. [ Links ]

    6. Ministerio de Salud Pública. Anuario Estadístico de Salud 2014. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2015. [ Links ]

    7. Atkins DL. Public access defibrillation: where does it work? Circulation. 2009;120:461-3. [ Links ]

    8. Ministerio de Salud Pública. Anuario Estadístico de Salud 2011. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2012. [ Links ]

    9. Ochoa Montes LA, Miguélez Nodarse R, Vilches Izquierdo E, Pernas Sánchez Y. El desafío mundial de la muerte súbita cardíaca en el nuevo milenio. Resumen de un estudio cubano. CorSalud [Internet]. 2012 [citado 10 Dic 2016];4:278-86. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n4a12/ms.html [ Links ]

    10. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. En: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald´s heart disease: A Textbook on Cardiovascular Medicine. 10ma ed. Philadelphia: Saunders Elsevier; 2007:933-73. [ Links ]

    11. Singh-Manoux A, Nabi H, Shipley M, Guéguen A, Sabia S, Dugravot A, et al. The role of conventional risk factors in explaining social inequalities in coronary heart disease: the relative and absolute approaches to risk. Epidemiology. 2008;19:599-605. [ Links ]

    12. Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart. 2009;95:221-7. [ Links ]

    13. Piloto Hernández L, Palma López ME, Rodríguez Álvarez L, Carmona Brito J. Principales causas de muerte en pacientes hipertensos. Rev Cubana Med [Internet]. 2015 [citado 14 Dic 2016];54:14-26. Disponible en: http://scielo.sld.cu/pdf/med/v54n1/med03115.pdf [ Links ]

    14. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-72. [ Links ]

    15. Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, Tedrow UB, et al. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol. 2012;5:1091-7. [ Links ]

    16. Kannel WB, Thomas HE. Sudden coronary death: The Framingham Study. Ann NY Acad Sci. 1982;382:3-21. [ Links ]

    17. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271-5. [ Links ]

    18. Llanes Echevarría JR, Pérez López H, Rodríguez Nande, Solís Cordero M, Batista Castellanos M, Céspedes Arias G, et al. Influencia de algunos factores de riesgo cardiovasculares sobre los eventos clínicos adversos más frecuentes, en pacientes revascularizados con circulación extracorpórea. Rev Cubana Cir [Internet]. 2011; 50(4). [citado 14 Dic 2016]. Disponible en: http://www.bvs.sld.cu/revistas/cir/vol50_4_11/cir06411.htm [ Links ]

    19. Quiles J, Miralles-Vicedo B. Estrategias de prevención secundaria del síndrome coronario agudo. Rev Esp Cardiol. 2014;67:844-8. [ Links ]

    20. Campobasso CP, Dell´Erba AS, Addante A, Zotti F, Marzullo A, Colonna MF. Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers. Am J Forensic Med Pathol. 2008;29:154-61. [ Links ]

    21. Barrabés JA, Bardají A, Jiménez-Candil J, del Nogal Sáez F, Bodí V, Basterra N, et al. Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES. Rev Esp Cardiol. 2015;68:98-106. [ Links ]

    22. Ayuso Baptista F, Jiménez Moral G, Fonseca del Pozo FJ, Ruiz Madruga M, Garijo Pérez A, Jiménez Corona J, et al. Nuevos horizontes frente a la muerte súbita cardíaca: la desfibrilación externa semiautomática. Emergencias. 2003;15:36-48. [ Links ]

    23. Ochoa Montes LA, González Lugo M, Vilches Izquierdo E, Erazo Enríquez N, Quispe Santos JF, Morales Landis J, et al. Expresión clínica del síndrome de muerte súbita cardíaca. Rev Cubana Med [Internet]. 2011 [citado 10 Dic 2016];50:16-28. Disponible en: http://scielo.sld.cu/pdf/med/v50n1/med02110.pdf [ Links ]

    24. Pons F, Lupón J, Urrutia A, González B, Crespo E, Díez C, et al. Mortalidad y causas de muerte en pacientes con insuficiencia cardiaca: experiencia de una unidad especializada multidisciplinaria. Rev Esp Cardiol. 2010;63:303-14. [ Links ]

    25. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med. 2003;348:2626-33. [ Links ]

    26. Coll Muñoz Y, Ruíz Mendoza J, Navarro JJ, de la Cruz Avilés L, Valladares Carvajal F. Factores relacionados con la mortalidad intrahospitalaria en el infarto agudo del miocardio. Rev Finlay [Internet]. 2012 [citado 11 Dic 2016];2:167-77. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/133/1314 [ Links ]

    27. Pocock S, Bueno H, Licour M, Medina J, Zhang L, Annemans L, et al. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study. Eur Heart J Acute Cardiovasc Care. 2015;4:509-17. [ Links ]

    28. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol [Internet]. 2015 [citado 10 Dic 2016];68:1125.e1-e64. Disponible en: http://www.revespcardiol.org/es/pdf/90445376/S300/ [ Links ]

    29. Bayés de Luna A, Fiol M. The surface electrocardiography in ischemic heart disease. Malden, MA: Blackwell-Futura; 2008. [ Links ]

    30. Loma-Osorio P, Aboal J, Sanz M, Caballero Á, Vila M, Lorente V, et al. Características clínicas, pronóstico vital y funcional de los pacientes supervivientes a una muerte súbita extrahospitalaria ingresados en cinco unidades de cuidados intensivos cardiológicos. Rev Esp Cardiol. 2013;66:623-8. [ Links ]

    31. Neumar RW, Barnhart JM, Berg RA, Chan PS, Geocadin RG, Luepker RV, et al. Implementation strategies for improving survival after out-of-hospital cardiac arrest in the United States: Consensus recommendations from the 2009 American Heart Association Cardiac Arrest Survival Summit. Circulation. 2011;123:2898-910. [ Links ]

    32. Bayés de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012;65:1039-52. [ Links ]

    33. Falcón Vilaú L, Fernández-Britto Rodríguez JE, Castillo Herrera JA. La lesión aterosclerótica coronaria en la muerte súbita: aplicación del sistema aterométrico. Rev Cubana Invest Bioméd [Internet]. 2000 [citado 15 Dic 2016];19:144-50. Disponible en: http://scielo.sld.cu/pdf/ibi/v19n2/ibi06200.pdf [ Links ]

    34. Chen HY, Gore JM, Lapane KL, Yarzebski J, Person SD, Gurwitz JH, et al. A 35_Year Perspective (1975 to 2009) into the long-term prognosis and hospital management of patients discharged from the hospital after a first acute myocardial infarction. Am J Cardiol. 2015;116:24-9. [ Links ]

    35. Abu-Assi E, López-López A, González-Salvado V, Redondo-Diéguez A, Peña-Gil C, Bouzas-Cruz N, et al. El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año. Rev Esp Cardiol. 2016;69:11-8. [ Links ]

    36. Littnerova S, Kala P, Jarkovsky J, Kubkova L, Prymusova K, Kubena P, et al. GRACE Score among six risk scoring systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) demonstrated the best predictive value for prediction of long-term mortality in patients with ST-elevation myocardial infarction. PLoS One [Internet]. 2015 [citado 10 Dic 2016];10:e0123215. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC4404322/pdf/pone.0123215.pdf [ Links ]

    1. González R, Raffo M, Vera M, Alarcón E, Saldías R, Gyhra A, et al. Mediastinitis postquirúrgica en cirugía cardíaca. Rev Chil Cir. 2005;57:203-8. [ Links ]

    2. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;10:606-8. [ Links ]

    3. Nieto Cabrera M. Diseño y validación de un modelo predictivo de mediastinitis en cirugía cardiaca [Tesis]. Madrid: Universidad Complutense de Madrid [Internet]; 2014 [citado 28 Feb 2017]. Disponible en: http://eprints.ucm.es/29771/1/T35996.pdf [ Links ]

    4. Careaga Reyna G, Campos Ortega R. Tratamiento de la mediastinitis y otras complicaciones de la esternotomía en cirugía cardiaca. Cir Gen. 2010;32:217-20. [ Links ]

    5. Barthelemy A. Post-sternotomy mediastinitis. En: Mathieu D, ed. Handbook on Hyperbaric Medicine. Dordrecht: Springer; 2006. p. 567-76. [ Links ]

    6. Tiveron MG, Fiorelli AI, Mota EM, Mejia OA, Brandão CM, Dallan LA, et al. Preoperative risk factors for mediastinitis after cardiac surgery: analysis of 2768 patients. Rev Bras Cir Cardiovasc. 2012;27:203-10. [ Links ]

    7. Morisaki A, Hosono M, Murakami T, Sakaguchi M, Suehiro Y, Nishimura S, et al. Effect of negative pressure wound therapy followed by tissue flaps for deep sternal wound infection after cardiovascular surgery: propensity score matching analysis. Interact Cardiovasc Thorac Surg. 2016;23:397-402. [ Links ]

    8. Fernández-Palacios Martínez J. Tratamiento quirúrgico plástico de las mediastinitis post esternotomía media tras cirugía cardíaca con circulación extracorpórea en nuestro medio: La utilización unilateral del colgajo de pectoral mayor frente a otros métodos empleados [Tesis]. Gran Canaria: Universidad de Las Palmas de Gran Canaria [Internet]; 2008 [citado 28 Feb 2017]. Disponible en: https://acceda.ulpgc.es:8443/bitstream/10553/2120/1/3209.pdf [ Links ]

    9. Soto Pernudi S, Quirós Molina P, Chamorro Castro R, Garita Jiménez E, Robelo Pentzke B, Salazar Vargas C. Infección de esternotomía media después de cirugía cardiovascular: Experiencia en el Hospital R.A. Calderón Guardia. Rev Costarric Cardiol. 2010;12:11-6. [ Links ]

    10. Baillot R, Cloutier D. Progress and milestones in the treatment of deep sternal wound infections. En: Picichè M, ed. Dawn and evolution of cardiac procedures. Milán: Springer; 2013. p. 273-84. [ Links ]

    11. Machín Rodríguez JC. Factores predictores de mediastinitis aguda en cirugía cardiovascular, protocolo de prevención y algoritmos diagnóstico y terapéutico [Tesis]. Santiago de Cuba: Universidad de Ciencias Médicas [Internet]; 2011 [citado 28 Feb 2017]. Disponible en: http://tesis.repo.sld.cu/632/1/TESIS_Dr_MACHIN.pdf [ Links ]

    12. Bermúdez Yera GJ, Chaljub Bravo E, López de la Cruz Y, Lagomasino Hidalgo AL, Navas Contino M, Quintero Fleites Y, et al. Plastia esternal con dermis y músculo pectoral por pérdida total del esternón debido a osteomielitis. CorSalud [Internet]. 2014 [citado 28 Feb 2017];6:346-51. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/124/294 [ Links ]

    13. Servicio Andaluz de Salud. Resultados y calidad del sistema sanitario público de Andalucía [Internet]. Sevilla: Escuela Andaluza de Salud Pública; 2012 [citado 10 Mar 2017]. Disponible en: http://www.calidadsaludandalucia.es/docs /resultados_y_calidad_del_sistema_sanitario_publico_de_andalucia_2012.pdf [ Links ]

    14. Careaga Reyna G, Aguirre Baca GG, Medina Concebida LE, Borrayo Sánchez G, Prado Villegas G, Argüero Sánchez R. Factores de riesgo para mediastinitis y dehiscencia esternal después de cirugía cardíaca. Rev Esp Cardiol. 2006;59:130-5. [ Links ]

    15. Gutiérrez-Urbon JM, Pereira-Rodríguez MJ, Cuenca-Castillo JJ. Estudio de casos y controles de los factores de riesgo de mediastinitis en cirugía de revascularización miocárdica. Cir Cardiov. 2013;20:13-7. [ Links ]

    16. Yu AW, Rippel RA, Smock E, Jarral OA. In patients with post-sternotomy mediastinitis is vacuum-assisted closure superior to conventional therapy?. Interact Cardiovasc Thorac Surg. 2013;17:861-5. [ Links ]

    17. Dohi S, Inaba H, Tanbara K, Yamamoto T, Kikuchi K, Shimada A, et al. Vacuum-assisted closure with a portable system for treatment of poststernotomy mediastinitis. Gen Thorac Cardiovasc Surg. 2010;58:415-9. [ Links ]

    18. Zor MH, Acipayam M, Bayram H, Oktar L, Erdogan M, Darcin OT. Single-stage repair of the anterior chest wall following sternal destruction complicated by mediastinitis. Surg Today. 2014;44:1476-82. [ Links ]

    19. Fulquet-Carreras E. Mediastinistis postoperatoria en cirugía cardíaca. Cir Cardiov. 2013;20:10-2. [ Links ]

    20. Takahara S, Sai S, Kagatani T, Konishi A. Ef?cacy and haemodynamic effects of vacuum-assisted closure for post-sternotomy mediastinitis in children. Interact Cardiovasc Thorac Surg. 2014;19:627-31. [ Links ]

    21. Tanaka T, Panthee N, Itoda Y, Yamauchi N, Fukayama M, Ono M. Negative pressure wound therapy induces early wound healing by increased and accelerated expression of vascular endothelial growth factor receptors. Eur J Plast Surg. 2016;39:247-56. [ Links ]

    22. Salica A, Weltert L, Scaffa L, Guerrieri Wolf L, Nardella S, Bellisario A, et al. Negative pressure wound treatment improves Acute Physiology and Chronic Health Evaluation II score in mediastinitis allowing a successful elective pectoralis muscle flap closure: Six-year experience of a single protocol. J Thorac Cardiovasc Surg. 2014;148:2397-403. [ Links ]

    23. Molina JE, Nelson EC, Smith RR. Treatment of postoperative sternal dehiscence with mediastinitis: Twenty-four-year use of a single method. J Thorac Cardiovasc Surg. 2006;132:782-7. [ Links ]

    24. Kubota H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, et al. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132. [ Links ]

    25. Vos RJ, Yilmaz A, Sonker U, Kelder JC, Kloppenburg GT. Vacuum-assisted closure of post-sternotomy mediastinitis as compared to open packing. Interact Cardiovasc Thorac Surg. 2012;14:17-21. [ Links ]

    26. Vos RJ, van Putte BP, Sonker U, Kloppenburg GT. Primary closure using Redon drains for the treatment of post-sternotomy mediastinitis. Interact Cardiovasc Thorac Surg. 2014;18:33-7. [ Links ]

    27. Risnes I, Abdelnoor M, Veel T, Svennevig JL, Lundblad R, Rynning SE. Mediastinitis after coronary artery bypass grafting: the effect of vacuum-assisted closure versus traditional closed drainage on survival and re-infection rate. Int Wound J. 2014;11:177-82. [ Links ]

    1. Estadella C, Vázquez S, Oliveras A. Rigidez arterial y riesgo cardiovascular. Hipertens Riesgo Vasc. 2010;27:203-10. [ Links ]

    2. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness en clinical practice. QJM. 2002;95:67-74. [ Links ]

    3. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond). 2002;103:371-7. [ Links ]

    4. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;23:554-66. [ Links ]

    5. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203-6. [ Links ]

    6. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003;21:463-72. [ Links ]

    7. Palma JL. Métodos no invasivos para la evaluación de las propiedades físicas de las grandes arterias en la hipertensión arterial. Nefrología. 2002;22:16-20. [ Links ]

    8. Laurent S, Cockcroft J, Van Borrel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-605. [ Links ]

    9. Bia D, Zócalo Y. Rigidez arterial: evaluación no invasiva en la práctica clínica. Importancia clínica y análisis de las bases metodológicas de los equipos disponibles para su evaluación. Rev Urug Cardiol. 2014;29:39-59. [ Links ]

    10. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664-70. [ Links ]

    11. Ikonomidis I, Makavos G, Lekakis J. Arterial stiffness and coronary artery disease. Curr Opin Cardiol. 2015;30:422-31. [ Links ]

    12. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-27. [ Links ]

    13. Boutouyrie P, Vermersch S, Laurent S, Briet M. Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity. Clin Exp Pharmacol Physiol. 2008;35:530-3. [ Links ]

    14. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994;140:669-82. [ Links ]

    15. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-9. [ Links ]

    16. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-41. [ Links ]

    17. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123:551-65. [ Links ]

    18. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505-11. [ Links ]

    19. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987-92. [ Links ]

    20. Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension. 2012;60:518-22. [ Links ]

    21. Hoffmann A, Isler R. Appréciation de l´aptitude à la pratique sportive sous l´angle cardiaque. Forum Med Suisse. 2007;7:889-94. [ Links ]

    22. Serratosa Fernández L. Adaptaciones Cardiovasculares del Deportista [Internet]. 2do Congreso Virtual de Cardiología; 2001 [citado 13 Abril 2017]. Disponible en: http://www.fac.org.ar/scvc/llave/exercise/serrato1 /serratoe.htm [ Links ]

    23. Carmona Puerta R, Ramos Martín R, Rabassa López-Calleja MA, Monzón León J, Pérez González L, Castro Torres Y, et al. Dispersión de la onda P incrementada en futbolistas de alto rendimiento y su relación con el tiempo de práctica deportiva. CorSalud [Internet]. 2013 [citado 13 Mar 2017];5:155-60. Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n2a13/dispersionp.html [ Links ]

    24. Géoffroy Agbélélé C, Prohías Martínez JA, Castro Arca ÁM, Mérida Álvarez O, García Hernández RA. Adaptaciones morfofuncionales evaluadas por ecocardiograma en deportistas masculinos de élite en triatlón. CorSalud [Internet]. 2014 [citado 13 Mar 2017];6:167-73. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n2a14/triatlon.html [ Links ]

    25. Otsuki T, Maeda S, Iemitsu M, Saito Y, Tanimura Y, Ajisaka R, et al. Relationship between arterial stiffness and athletic training programs in young adult men. Am J Hypertens. 2007;20:967-73. [ Links ]

    26. Collier SR, Kanaley JA, Carhart R, Frechette V, Tobin MM, Hall AK, et al. Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives. J Hum Hypertens. 2008;22:678-86. [ Links ]

    27. Aldama A, Viera A, Mena V, Porto F, Rial N. Ejercicio físico y elasticidad arterial en sujetos normales mayores de 55 años. Rev Cubana Invest Bioméd [Internet]. 2005 [citado 16 Mar 2017];24:21-31. Disponible en: http://scielo.sld.cu/pdf/ibi/v24n1/ibi03105.pdf [ Links ]

    28. Bertovic DA, Waddell TK, Gatzka CD, Cameron JD, Dart AM, Kingwell BA. Muscular strength training is associated with low arterial compliance and high pulse pressure. Hypertension. 1999;33:1385-91. [ Links ]

    29. Tinoco-Cabral CE, Fernandes-Guerra FE, Zugno LM, Tinoco-Cabral SA, Dantas-Leite L, Fernandes Filho J, et al. El entrenamiento muscular no aumenta la rigidez arterial en humanos adultos y mejora el tono corporal. Rev Salud Pública (Bogotá). 2013;15:601-13. [ Links ]

    30. Radtke T, Schmidt-Trucksäss A, Brugger N, Schäfer D, Saner H, Wilhelm M. Ultra-endurance sports have no negative impact on indices of arterial stiffness. Eur J Appl Physiol. 2014;114:49-57. [ Links ]

    31. Florescu M, Stoicescu C, Magda S, Petcu I, Radu M, Palombo C, et al. "Supranormal" cardiac function in athletes related to better arterial and endothelial function. Echocardiography. 2010;27:659-67. [ Links ]

    32. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098. [ Links ]

    33. Carrazana-Escalona R, Sánchez-Hechavarría ME, Ricardo-Ferro BT. Algoritmo para la detección de puntos clínicos de interés de la onda de pulso arterial [Internet]. Convención Internacional de Ciencias Técnicas. Universidad de Oriente; 2016 [citado 19 Mar 2016]. Disponible en:https://www.researchgate.net/profile/Miguel_Sanchez-Hechavarria/publication/305222298_Algorithm_for_the detection_of clinical_points_of_interest_of_the_arterial_pulse_wave/links/58235e7208ae61258e3ca94c.pdf?origin=publication_list [ Links ]

    34. de Loño Capote J. La práctica del ejercicio en la infancia y en la adolescencia: factor prioritario para la salud física y mental. En: Asín Cardiel E, García Touchard A, eds. Implicaciones cardiovasculares del ejercicio, el deporte y la obesidad. Madrid: Fundación Ramón Areces; 2013. p. 275-80. [ Links ]

    35. Carlos Bagnara I. Adaptaciones cardiovasculares al ejercicio físico: Una revisión de la literatura. EFDeportes.com [Internet]. 2010 [citado 19 Mar 2017];15. Disponible en: http://www.efdeportes.com/efd148/adaptaciones-cardiovasculares-al-ejercicio-fisico.htm [ Links ]

    36. González Juanatey JR. Fisiología del ejercicio y su repercusión cardiovascular. En: Asín Cardiel E, García Touchard A, eds. Implicaciones cardiovasculares del ejercicio, el deporte y la obesidad. Madrid: Madrid: Fundación Ramón Areces; 2013. p. 15-32. [ Links ]

    37. Brillante DG, O´Sullivan AJ, Howes LG. Arterial stiffness indices in healthy volunteers using non-invasive digital photoplethysmography. Blood Press. 2008;17:116-23. [ Links ]

    38. Guyton A, Hall J. Tratado de Fisiología Médica. 12ma ed. Barcelona: Elsevier; 2011. p.157-76. [ Links ]

    1. Shemie SD, Hornby L, Baker A, Teitelbaum J, Torrance S, Young K, et al. International guideline development for the determination of death. Intensive Care Med. 2014;40:788-97. [ Links ]

    2. Nolan JP, Hazinski MF, Aickin R, Bhanji F, Billi JE, Callaway CW, et al. Part 1: Executive summary. 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation [Internet]. 2015 [citado 21 Feb 2017];95:e1-e31. Disponible en: http://www.resuscitationjournal.com/article/S0300-9572(15)00360-3/pdf [ Links ]

    3. Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, et al. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J. 2006;152:223-30. [ Links ]

    4. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983-90. [ Links ]

    5. Zegers M, de Bruijne MC, de Keizer B, Merten H, Groenewegen PP, van der Wal G, et al. The incidence, root-causes, and outcomes of adverse events in surgical units: Implication for potential prevention strategies. Patient Saf Surgery [Internet]. 2011 [citado 22 Feb 2017];5:13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127749/pdf/1754-9493-5-13.pdf [ Links ]

    6. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-67. [ Links ]

    7. Martos-Benítez FD, Gutiérrez-Noyola A, Echevarría-Víctores A. Postoperative complications and clinical outcomes among patients undergoing thoracic and gastrointestinal cancer surgery: A prospective cohort study. Rev Bras Ter Intensiva. 2016;28:40-8. [ Links ]

    8. Martos Benítez FD, Gutiérrez Noyola A. Complicaciones cardiovasculares postoperatorias en cirugía mayor oncológica. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2016 [citado 24 Feb 2017];22:62-69. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/633/pdf_41 [ Links ]

    9. Geske JB, Smith SB, Morgenthaler TI, Mankad SV. Care of patients with acute pulmonary emboli: a clinical review with cardiovascular focus. Expert Rev Cardiovasc Ther. 2012;10:235-50. [ Links ]

    10. Schellhaass A, Walther A, Konstantinides S, Böttiger BW. The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int. 2010;107:589-95. [ Links ]

    11. Prandoni P, Lensing AW, Prins MH, Ciammaichella M, Perlati M, Mumoli N, et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med. 2016;375:1524-31. [ Links ]

    12. Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O´Neil BJ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011;57:700-6. [ Links ]

    13. Martos Benítez FD, Echevarría Víctores A, Echevarría Soulary JC, Gutiérrez Noyola A, Candales Arafet LA, Pupo San Juan YY. Repercusión de las complicaciones mayores posoperatorias en pacientes operados de tórax. Rev Cubana Cir [Internet]. 2014 [citado 27 Feb 2017];53:366-77. Disponible en: http://scielo.sld.cu/pdf/cir/v53n4/cir05414.pdf [ Links ]

    14. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033-69. [ Links ]

    15. Maestre A, Sánchez R, Rosa V, Aujesky D, Lorenzo A, Barillari G, et al. Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry. Eur J Intern Med. 2010;21:377-82. [ Links ]

    16. Bach AG, Taute BM, Baasai N, Wienke A, Meyer HJ, Schramm D, et al. 30-day mortality in acute pulmonary embolism: Prognostic value of clinical scores and anamnestic features. PLoS ONE [Internet]. 2016 [citado 24 Feb 2017];11:e0148728. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC4750907/pdf/pone.0148728.pdf [ Links ]

    17. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8:2450-7. [ Links ]

    18. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Supl):e195S-e226S. [ Links ]

    19. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Supl):e227S-e277S. [ Links ]

    20. Eikelboom JW, Kearon C, Guyatt G, Sessler DI, Yusuf S, Cook D, et al. Perioperative aspirin for prevention of venous thromboembolism. The PeriOperative ISchemia Evaluation-2 Trial and a pooled analysis of the randomized trials. Anesthesiology. 2016;125:1121-9. [ Links ]

    21. Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: A review. JAMA Cardiol. 2016;1:718-30. [ Links ]

    22. Martos Benítez FD, Alonso Rodríguez L, Linares Roque AL, Soto García A, Alonso Rodríguez R, García Mesa L. Betabloqueadores perioperatorios en cirugía no cardiaca: recomendaciones basadas en la evidencia. Rev Cubana Anestesiol Reanim [Internet]. 2014 [citado 24 Feb 2017];13:31-53. Disponible en: http://scielo.sld.cu/pdf/scar/v13n1/scar05114.pdf [ Links ]

    23. Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: A cohort study. Ann Intern Med. 2011;154:523-8. [ Links ]

    24. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation. 2009;119:2936-44. [ Links ]

    25. Kaul P, Federspiel JJ, Dai X, Stearns SC, Smith SC, Yeung M, et al. Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes. JAMA. 2014;312:1999-2007. [ Links ]

    26. Ghadimi K, Thompson A. Update on perioperative care of the cardiac patient for noncardiac surgery. Curr Opin Anaesthesiol. 2015;28:342-8. [ Links ]

    27. Kristensen SD, Knuuti J, Saraste A, Anker S, Bø tker HE, De Hert S, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2014;31:517-73. [ Links ]

    28. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive Summary: Heart disease and stroke statistics _ 2010 Update: A report from the American Heart Association. Circulation. 2010;121:948-54. [ Links ]

    29. Hummel A, Empe K, Dörr M, Felix SB. De novo acute heart failure and acutely decompensated chronic heart failure. Dtsch Arztebl Int. 2015;112:298-310. [ Links ]

    30. Auffret V, Leurent G, Gilard M, Hacot JP, Filippi E, Delaunay R, et al. Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention. Int J Cardiol. 2016;221:433-42. [ Links ]

    31. Marik P, Bellomo R. A rational approach to fluid therapy in sepsis. Br J Anaesth. 2016;116:339-49. [ Links ]

    32. Shen JZ, Young MJ. Corticosteroids, heart failure, and hypertension: A role for immune cells? Endocrinology. 2012;153:5692-700. [ Links ]

    33. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics _ 2015 Update: A report from the American Heart Association. Circulation. 2015;131:e29-e322. [ Links ]

    34. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics _ 2016 Update: A report from the American Heart Association. Circulation. 2016;133:e38-360. [ Links ]

    35. Monteleone PP, Lin CM. In-hospital cardiac arrest. Emerg Med Clin North Am. 2012;30:25-34. [ Links ]

    36. Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012;367:1912-20. [ Links ]

    37. Chan PS, Nallamothu BK, Krumholz HM, Spertus JA, Li Y, Hammill BG, et al. Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med. 2013;368:1019-26. [ Links ]

    38. Kronick SL, Kurz MC, Lin S, Edelson DP, Berg RA, Belli JE, et al. Part 4: Systems of Care and Continuous Quality Improvement: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Supl 2):S397-S413. [ Links ]

    39. Syue YJ, Huang JB, Cheng FJ, Kung CT, Li CJ. The prognosis of cardiac origin and noncardiac origin in-hospital cardiac arrest occurring during night shifts. Biomed Res Int [Internet]. 2016 [citado 24 Feb 2017];2016:4626027. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059516/pdf/BMRI2016 -4626027.pdf [ Links ]

    1. Steg PG, Bhatt DL, Wilson PW, D´Agostino R, Ohman EM, Röther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA.2007;297:1197-206. [ Links ]

    2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Supl S):S5-67. [ Links ]

    3. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989;3:273-7. [ Links ]

    4. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13-8. [ Links ]

    5. Kröger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A, et al. Prevalence of peripheral arterial disease - Results of the Heinz Nixdorf recall study. Eur J Epidemiol. 2006;21:279-85. [ Links ]

    6. Riambaua V, Piño C. Claudicación intermitente. Revisión de una enfermedad de prevalencia creciente (I). Clínica, etiología, epidemiología, historia natural y diagnóstico. Med Clin. 1998;110:191-7. [ Links ]

    7. Johner F, Thalhammer C, Jacomella V, Husmann M, Amann-Vesti B. Differences in cardiovascular risk factors between patients with acute limb ischemia and intermittent claudication. Angiology. 2014;65:497-500. [ Links ]

    8. Kempezinski RF. The chronically ischemic leg: An overview. En: Rutherford RB, ed. Vascular Surgery, 5ª ed. Philadelphia: WB Saunders; 2000. p. 917-27. [ Links ]

    9. Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders. Helv Chir Acta. 1954;21:499-533. [ Links ]

    10. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg. 1997;26:517-38. [ Links ]

    11. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6. [ Links ]

    12. Shadman R, Criqui MH, Bundens WP, Fronek A, Denenberg JO, Gamst AC, et al. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol. 2004;44:618-23. [ Links ]

    13. Ridker PM, Stampfer MJ, Rifai N. Novel risk factor for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481-5. [ Links ]

    14. Howard DP, Banerjee A, Fairhead JF, Hands L, Silver LE, Rothwell PM, et al. Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: Implications for prevention. Circulation. 2015;132:1805-15. [ Links ]

    15. Criqui MH. Peripheral arterial disease - Epidemiological aspects. Vasc Med. 2001;6(Supl 3):3-7. [ Links ]

    16. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384-92. [ Links ]

    17. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421-31. [ Links ]

    18. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008;13:15-24. [ Links ]

    19. Dumville JC, Lee AJ, Smith FB, Fowkes FG. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract. 2004;54:826-31. [ Links ]

    20. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296. [ Links ]

    21. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24. [ Links ]

    22. Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev [Internet]. 2014 [citado 28 Feb 2017];7:CD000990. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002 /14651858.CD000990.pub3/pdf [ Links ]

    23. WHO Expert Committee. Rehabilitation after cardiovascular diseases, with special emphasis on developing countries. WHO Technical Report Series 831. Genova: World Health Organization; 1993. [ Links ]

    24. Lauret GJ, Fokkenrood HJ, Bendermacher BL, Scheltinga MR, Teijink JA. Physical activity monitoring in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2014;47:656-63. [ Links ]

    25. Hiatt WR, Cox L, Greenwalt M, Griffin A, Schechter C. Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials. Vasc Med. 2005;10:207-13. [ Links ]

    26. Frans FA, Zagers MB, Jens S, Bipat S, Reekers JA, Koelemay MJ. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication. J Vasc Surg. 2013;57:720-7.e1. [ Links ]

    27. Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009;50:89-94. [ Links ]

    28. Nicolai SP, Viechtbauer W, Kruidenier LM, Candel MJ, Prins MH, Teijink JA. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg. 2009;50:322-9. [ Links ]

    29. Ekroth R, Dahllöf AG, Gundevall B, Holm J, Scherstén T. Physical training of patients with intermittent claudication: Indications, methods, and results. Surgery. 1978;84:640-3. [ Links ]

    30. Andreozzi GM, Kalodiki E, L Gašpar L, Martini R, Minar E, Angelides N, et al. Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology. Int Angiol. 2014;33:329-47. [ Links ]

    31. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas. Rev Esp Cardiol [Internet]. 2012 [citado 11 Mar 2017];65:172.e1-e57. Disponible en: http://www.revespcardiol.org/es/guia -practica-clinica-esc-sobre/articulo/90093018/ [ Links ]

    32. Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation. 2011;123:2344-52. [ Links ]

    33. Ades PA, Savage PD, Brawner CA, Lyon CE, Ehrman JK, Bunn JY, et al. Aerobic capacity in patients entering cardiac rehabilitation. Circulation. 2006;113:2706-12. [ Links ]

    34. Piepoli MF, Corrà U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21:664-81. [ Links ]

    35. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomized trial. Eur J Vasc Surg. 1990;4:135-40. [ Links ]

    36. Regensteiner JG, Hiatt WR. Exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev. 1995;23:1-24. [ Links ]

    37. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602-9. [ Links ]

    38. Lyu X, Li S, Peng S, Cai H, Liu G, Ran X. Intensive walking exercise for lower extremity peripheral arterial disease: A systematic review and meta-analysis. J Diabetes. 2016;8:363-77. [ Links ]

    39. Fokkenrood HJ, Bendermacher BL, Lauret GJ, Willigendael EM, Prins MH, Teijink JA. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev [Internet]. 2013 [citado 10 Mar 2017];8:CD005263. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002 /14651858.CD005263.pub3/epdf/standard [ Links ]

    40. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging. 2008;28:32-7. [ Links ]

    41. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081-93. [ Links ]

    42. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, et al. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1094-105. [ Links ]

    43. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111:369-76. [ Links ]

    44. Schairer JR, Keteyian SJ, Ehrman JK, Brawner CA, Berkebile ND. Leisure time physical activity of patients in maintenance cardiac rehabilitation. J Cardiopulm Rehabil. 2003;23:260-5. [ Links ]

    45. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007;115:2358-68. [ Links ]

    1. Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127:2031-7. [ Links ]

    2. Olsson C, Thelin S, Ståhle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006; 114:2611-8. [ Links ]

    3. Di Eusanio M, Trimarchi S, Patel HJ, Hutchison S, Suzuki T, Peterson MD, et al. Clinical presentation, management, and short-term outcome of patients with type A acute dissection complicated by mesenteric malperfusion: observations from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg. 2013;145:385-90.e1. [ Links ]

    4. Braverman AC, Thompson RW, Sánchez LA. Enfermedades de la aorta. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, Eds. Braunwald Tratado de Cardiología: Texto de medicina cardiovascular. 9ª ed. Barcelona: Elsevier España; 2013. p. 1324-54. [ Links ]

    5. Layton KF, Kallmes DF, Cloft HJ, Lindell EP, Cox VS. Bovine aortic arch variant in humans: clarification of a common misnomer. Am J Neuroradiol. 2006;27:1541-2. [ Links ]

    6. Joliat GR, Dubuis C, Déglise S. Complicated thoraco-abdominal aortic dissection presenting with lower limb ischemia in a patient with bovine arch and arteria lusoria. Eur Rev Med Pharmacol Sci. 2017;21:310-2. [ Links ]

    7. Idhrees M, Cherian VT, Menon S, Mathew T, Dharan BS, Jayakumar K. Bovine aortic arch with supravalvular aortic stenosis. Indian Heart J. 2016;68(Supl 2):S83-4. [ Links ]

    1. García Reyes J. Reanimación cerebrocardiopulmonar prolongada exitosa en un paciente con muerte súbita: un reporte de caso. Rev Colomb Anestesiol. 2014;42:229-33. [ Links ]

    2. Pérez A, González J. Muerte súbita en deportistas: Importancia del reconocimiento de las miocardiopatías. Rev Insuf Cardiaca. 2009;4:130-5. [ Links ]

    3. Carter-Monroe N, Virmani R. Tendencias actuales en la clasificación de la muerte súbita cardiaca según los datos de autopsias: una revisión de los estudios sobre la etiología de la muerte súbita cardiaca. Rev Esp Cardiol. 2011;64:10-2. [ Links ]

    4. Gutiérrez Y, Castellanos R, Ferrer I, Cabrera Y, Ávila I, Hernández A. Muerte súbita cardiovascular. Rev Finlay [Internet]. 2015 [citado 15 Mar 2017];5:198-203. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/343/1429 [ Links ]

    5. Ochoa LA, González M, Vilches E, Fernández-Britto JE, Araujo RE. Muerte súbita cardiovascular en poblaciones de riesgo. CorSalud [Internet]. 2014 [citado 15 Mar 2017];6:71-8. Disponible en: http://www.corsalud.sld.cu/suplementos/2014/v6s1a14/pob-riesgo.html [ Links ]

    6. Castellà J, Medallo J, Marrón T. Aspectos medicolegales de la muerte súbita cardiaca. Rev Esp Cardiol. 2013;13(Supl. A):30-7. [ Links ]

    7. Ochoa LA, Miguélez R, Vilches E, Pernas Y. El desafió mundial de la muerte súbita cardíaca en el nuevo milenio. Resumen de un estudio cubano. CorSalud [Internet]. 2012 [citado 19 Mar 2017];4:278-86. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n4a12/ms.html [ Links ]

    8. Muratore C, Belziti C, Gant J, Di Toro D, Mulassi A, Corte M, et al. Incidencia y variables asociadas con la muerte súbita en una población general. Subanálisis del estudio PRISMA. Rev Argent Cardiol. 2006;74:441-6. [ Links ]

    9. Ochoa LA, Yong CA, Calderín RO, González M, Miguélez R, Vilches E, et al. Factores de riesgo del síndrome metabólico en la muerte súbita cardíaca. Rev Cubana Med [Internet]. 2011 [citado 19 Mar 2017];50:426-40. Disponible en: http://scielo.sld.cu/pdf/med/v50n4/med09411.pdf [ Links ]

    10. de Asmundis C, Brugada P. Epidemiologia de la muerte súbita cardiaca. Rev Esp Cardiol. 2013;13(Supl. A):2-6. [ Links ]

    11. Brugada J. La muerte súbita cardiaca. La necesidad de una estrategia integral para combatirla. Rev Esp Cardiol. 2013;13(Supl. A):1. [ Links ]

    12. Loma-Osorio P, Aboal J, Sanz M, Caballero Á, Vila M, Lorente V, et al. Características clínicas, pronóstico vital y funcional de los pacientes supervivientes a una muerte súbita extrahospitalaria ingresados en cinco unidades de cuidados intensivos cardiológicos. Rev Esp Cardiol. 2013;66:623-8. [ Links ]

    13. Palacios-Rubio J, Núñez-Gil I. Protocolo clínico diagnóstico de muerte súbita. Medicine. 2013;11:2658-61. [ Links ]

    14. Vilches E, Ochoa LA, González M, Ramos L, Tamayo ND, García D, et al. Impacto de la hipertensión arterial esencial y la cardiopatía isquémica en víctimas de muerte cardíaca súbita. Rev Cubana Salud Pública [Internet]. 2016 [citado 23 Mar 2017];42:432-41. Disponible en: http://scielo.sld.cu/pdf/rcsp/v42n3/spu10316.pdf [ Links ]

    15. Vigo-Ramos J. Muerte súbita y emergencias cardiovasculares: problemática actual. Rev Perú Med Exp Salud Pública. 2008;25:233-6. [ Links ]

    16. León CA. Predicción de la muerte súbita cardíaca post infarto. ¿Tenemos otros métodos para predecir la muerte súbita cardíaca post infarto agudo de miocardio, además de la fracción de eyección? Insuf Card. 2011;6:144-50. [ Links ]

    17. Barbería E, Gotsens M, Xifró A, Castellà J, Rodríguez-Sanz M, Medallo J. Estudio retrospectivo de la muerte súbita cardiovascular extrahospitalaria de adultos de mediana edad en la ciudad de Barcelona. Rev Esp Cardiol. 2013;66:226-7. [ Links ]

    18. Ramos JL, Muratore C, Pachón JC, Rodríguez Á, González A, Asenjo R, et al. Prevención primaria y secundaria de muerte súbita en el ICD Registry Latin America. Arch Cardiol Mex. 2008;78:400-6. [ Links ]

    19.Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. Guía ESC 2015 sobre el tratamiento de pacientes con arritmias ventriculares y prevención de la muerte súbita cardiaca. Rev Esp Cardiol. 2016;69:176.e1-e77. [ Links ]

    1. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76. [ Links ]

    2. Mont L, Pérez-Villacastin J. Fibrilación y flutter auricular: avances en fisiopatología y tratamiento. Barcelona: Marge Books; 2007. [ Links ]

    3. Camm J, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012. Rev Esp Cardiol. 2013;66:54.e1-24. [ Links ]

    4. Gómez-Doblas JJ, Muñiz J, Alonso Martin JJ, Rodríguez-Roca G, Lobos JM, Awamleh P, et al. Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE. Rev Esp Cardiol. 2014;67:259-69. [ Links ]

    5. Mendes F, Atié J, Gracia MI, Almeida Gripp E, Sousa AS, Feijó LA, et al. Atrial fibrillation in decompensated heart failure: associated factors and In-Hospital Outcome. Arq Bras Cardiol. 2014;103:315-22. [ Links ]

    6. Puentes Madera IC. Epidemiología de las enfermedades cerebrovasculares de origen extracraneal. Rev Cubana Angiol Cir Vasc [Internet]. 2014 [citado 10 Oct 2016];15. Disponible en: http://www.bvs.sld.cu/revistas/ang/vol15_2_14/ang02214.htm [ Links ]

    7. Jiménez Cotes E, Meyer Martínez W. ¿Es el fin de la anticoagulación con la oclusión percutánea de la orejuela izquierda en fibrilación auricular? Méd UIS. 2014;27:69-76. [ Links ]

    8. Gudiño AF, Chediak C. Epidemiología, patogénesis y genética de la fibrilación auricular. Medwave [Internet]. 2012 [citado 12 Oct 2016];12:e5337. Disponible en: https://www.medwave.cl/link.cgi/Medwave/Revisiones /RevisionClinica/5337 [ Links ]

    9. Martínez Ortega RM, Tuya Pendás LC, Martínez Ortega M, Pérez Abreu A, Cánovas AM. El coeficiente de correlación de los rangos de Spearman. Rev Haban Cienc Méd [Internet]. 2009 [citado 12 Oct 2016];8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2009000200017&lng=es [ Links ]

    10. Jiménez Paneque RE, Vázquez García J, Fariñas Seijas H. Construcción y validación de un índice de gravedad para pacientes hospitalizados en áreas clínicas. Gac Sanit. 1997;11:122-30. [ Links ]

    11. Ochoa Sangrador C. Evaluación de la importancia de los resultados de estudios clínicos. Importancia clínica frente a significación estadística. Evid Pediatr [Internet]. 2010 [citado 15 Oct 2016];6:40. Disponible en: https://dialnet.unirioja.es/descarga/articulo/3245643.pdf [ Links ]

    12. Ledesma R, Molina Ibáñez G, Valero Mora P. Análisis de consistencia interna mediante Alfa de Cronbach: un programa basado en gráficos dinámicos. Psico-USF. 2002;7:143-152. [ Links ]

    13. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida. Rev Esp Cardiol. 2006;59:1329.e1-64. [ Links ]

    14. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-70. [ Links ]

    15. Urrutia de Diego A. Fibrilación auricular en el anciano. Rev Esp Geriatr Gerontol. 2008;43:106-12. [ Links ]

    16. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci E. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213-20. [ Links ]

    17. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J, et al. Investigators of the PREV-ICTUS study. Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS study. Stroke. 2007;38:1167-73. [ Links ]

    18. Elosua R, Arquer A, Mont L, Sambola A, Molina L, García-Morán E, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol. 2006;108:332-7. [ Links ]

    19. Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW, et al. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2015;131:1648-55. [ Links ]

    20. Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, et al. The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J. 2005;32:163-7. [ Links ]

    21. Dilaveris P, Stefanadis C. P wave dispersion: A valuable non-invasive marker of vulnerability to atrial fibrillation [Internet]. Proceedings of the 2nd ISHNE Atrial Fibrillation Worldwide Internet Symposium; 2007 April 1-30. London: St. Jude Medical; 2007. Disponible en: http://af-symposium.grupoakros.com.ar/2007/lectures /ing_dilaveris_polychronis.pdf [ Links ]

    22. Agarwal YK, Aronow WS, Levy JA. Association of interatrial block with development of atrial fibrillation. Am J Cardiol. 2003;91:882. [ Links ]

    23. Köse S, Kiliç A, Iyisoy A, Kurþaklioðlu H, Lenk MK. P wave duration and P dispersion in healthy children. Turk J Pediatr. 2003;45:133-5. [ Links ]

    24. Tsao HM, Yu WC, Cheng HC, Wu MH, Tai CT, Lin WS, et al. Pulmonary vein dilatation in patients with atrial fibrillation: detection by magnetic resonance imaging. J Cardiovasc Electrophysiol. 2001;12:809-13. [ Links ]

    25. Farré J, Wellens HJ. Philippe Coumel: a founding father of modern arrhythmology. Europace. 2004;6:464-5. [ Links ]

    26. Aldhoon B, Melenovský V, Peichl P, Kautzner J. New insights into mechanisms of atrial fibrillation. Physiol Res. 2010;59:1-12. [ Links ]

    27. Weinsaft JW, Kochav JD, Kim J, Gurevich S, Volo SC, Afroz A, et al. P wave area for quantitative electrocardiographic assessment of left atrial remodeling. PLoS One [Internet]. 2014 [citado 15 Oct 2016];9:e99178. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24901435/ [ Links ]

    28. Van Beeumen K, Houben R, Tavernier R, Ketels S, Duytschaever M. Changes in P-wave area and P-wave duration after circumferential pulmonary vein isolation. Europace. 2010;12:798-804. [ Links ]

    29. Martín García A, Jiménez-Candil J, Hernández J, Martín García A, Martín Herrero F, Martín Luengo C. Morfología de la onda P y recurrencia tras cardioversión de fibrilación auricular aislada. Rev Esp Cardiol. 2012;65:289-90. [ Links ]

    30. Robitaille GA, Phillips JH. An analysis of the P wave in patients with transient benign atrial fibrillation. Dis Chest. 1967;52:806-12. [ Links ]

    31. Jahangir A, Murarka S. Progression of paroxysmal to persistent atrial fibrillation: Factors promoting the HATCH Score. J Am Coll Cardiol. 2010;55:732-4. [ Links ]

    32. Llic LM, Goldenberg EM. CHADS2 score predicts time interval free of atrial fibrillation in patients with symptomatic paroxysmal atrial fibrillation. Int J Cardiol. 2010;145:576-7. [ Links ]

    33. Pérez-Ortega I, Moniche-Álvarez F, Jiménez-Hernández MD, González-Marcos JR. Ictus cardioembólico por fibrilación auricular y nuevos criterios de anticoagulación: un reto terapéutico. Rev Neurol. 2012;55:74-80. [ Links ]

    1. Richter S, Brugada P. Bidirectional ventricular tachycardia. J Am Coll Cardiol. 2009;54:1189. [ Links ]

    2. Issa ZF, Miller JM, Zipes DP. Ventricular arrhythmias in inherited channelopathies. En: Issa ZF, Miller JM, Zipes DP, eds. Clinical Arrhythmology and Electrophysiology: A Companion to Braunwald´s Heart Disease. 2ª ed. Philadelphia: Elsevier Saunders; 2012. p. 645-84. [ Links ]

    3. Baher AA, Uy M, Xie F, Garfinkel A, Qu Z, Weiss JN. Bidirectional ventricular tachycardia: ping pong in the His-Purkinje system. Heart Rhythm. 2011;8:599-605. [ Links ]

    4. Backx PH. Serving up the ping-pong mechanisms for bidirectional ventricular tachycardia. Heart Rhythm. 2011;8:606-7. [ Links ]

    1. Durrer D, van Dam RT, Freud GE, Janse MJ, Meijler FL, Arzbaecher RC. Total excitation of the isolated human heart. Circulation. 1970;41(6):899-912. [ Links ]

    2. Cassidy DM, Vassallo JA, Marchlinski FE, Buxton AE, Untereker WJ, Josephson ME. Endocardial mapping in humans in sinus rhythm with normal left ventricles: Activation patterns and characteristics of electrograms. Circulation. 1984;70(1):37-42. [ Links ]

    3. Locati ET, Bagliani G, Padeletti L. Normal ventricular repolarization and QT interval: Ionic background, modifiers, and measurements. Card Electrophysiol Clin. 2017;9(3):487-513. [ Links ]

    4. Patel C, Burke JF, Patel H, Gupta P, Kowey PR, Antzelevitch C, et al. Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: A century of controversy. Circ Arrhythm Electrophysiol. 2009;2(1):80-8. [ Links ]

    5. Wiener I, Mindich B, Pitchon R, Pichard A, Kupersmith J, Estioko M, et al. Epicardial activation in patients with coronary artery disease: Effects of regional contraction abnormalities. Circulation. 1982;65(1):154-60. [ Links ]

    6. Rodríguez Jiménez AE, Cruz Inerarity H, Valdés Arias B, Quintana Cañizares G, Toledo Rodríguez E. Duración del QRS como predictor de baja fracción de eyección en el infarto miocárdico con elevación del ST. CorSalud [Internet]. 2018 [citado 14 Ene 2018];10(1):13-20. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/191/622 [ Links ]

    7. López Ramírez M, Nafeh Abi-rezk M, Moya Liriano H, Gómez Sardiñas JA, Tamargo Barbeito TO, Valdés Álvarez J. Duración del QRS y su relación con la mortalidad postoperatoria de la cirugía de revascularización miocárdica. CorSalud [Internet]. 2018 [citado 14 Ene 2018];10(1):4-12. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/206/621 [ Links ]

    8. Donoiu I, Costinel Târtea G, Chávez-González E. Is there a utility for QRS dispersion in clinical practice? J Mind Med Sci [Internet]. 2017 [citado 14 Ene 2018];4(2):132-41. Disponible en: https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1080&context=jmms [ Links ]

    9. Chávez-González E, Moreno-Martínez FL. QRS dispersion is better than QRS duration for predicting response to cardiac resynchronization therapy. Hellenic J Cardiol. 2016;57(5):366-7. [ Links ]

    11. Tsagalou EP, Anastasiou-Nana MI, Karagounis LA, Alexopoulos GP, Batziou C, Toumanidis S, et al. Dispersion of QT and QRS in patients with severe congestive heart failure: Relation to cardiac and sudden death mortality. Hellenic J Cardiol. 2002;43(6):209-15. [ Links ]

    12. Chávez-González E, Rodríguez Jiménez AE, Moreno-Martínez FL. Duración y dispersión del QRS para predecir arritmias ventriculares en las fases iniciales del infarto agudo de miocardio. Med Intensiva. 2017;41(6):347-55. [ Links ]

    13. Take Y, Morita H. Fragmented QRS: What is the meaning? Indian Pacing Electrophysiol. 2012;12(5):213-25. [ Links ]

    1. Abboud S, Berenfield O, Sadeh D. Simulation of high-resolution QRS complex using a ventricular model with a fractal conduction system. Effects of ischemia on high-frequency QRS potentials. Circ Res. 1991;68(6):1751-60. [ Links ]

    2. Gasparini M, Leclercq C, Yu CM, Auricchio A, Steinberg JS, Lamp B, et al. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study. Am Heart J. 2014;167(2):203-9. [ Links ]

    3. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J. 2002;143(6):1085-91. [ Links ]

    4. Triola B, Olson MB, Reis SE, Rautaharju P, Merz CN, Kelsey SF, et al. Electrocardiographic predictors of cardiovascular outcome in women. The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol. 2005;46(1):51-6. [ Links ]

    5. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol. 2005;96(8):1082-8. [ Links ]

    6. Bongioanni S, Bianchi F, Migliardi A, Gnavi R, Pron PG, Casetta M, et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol. 2007;100(3):503-6. [ Links ]

    7. Kurl S, Makikallio TH, Rautaharju P, Kiviniemi V, Laukkanen JA. Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men. Circulation. 2012;125(21):2588-94. [ Links ]

    8. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2014. [ Links ]

    9. Park DW, Seung KB, Kim YH, Lee JY, Kim WJ, Kang SJ, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2010;56(2):117-24. [ Links ]

    10. Rodríguez Silva H, Galego Pimentel D, Negrín Villavicencio JA. Grupos multidisciplinarios. Impacto de los resultados obtenidos en la asistencia, docencia e investigaciones. La Habana: Boletín Científico [Internet]; 2009 [citado 18 Abr 2017]. Disponible en: http://files.sld.cu/boletincnscs/files/2009/07/respub2009dr -rodriguezsilva.pdf [ Links ]

    11. Vázquez FJ, Juffé A, Pita S, Tarrio R, Cuenca J, Herrera JM, et al. Valor de 6 escalas de riesgo para predecir mortalidad en la cirugía coronaria sin circulación extracorpórea. An Cir Card Cir Vasc. 2005;11(3):129-35. [ Links ]

    12. Kumbhani DJ, Sharma GV, Khuri SF, Kirdar JA. Fascicular conduction disturbances after coronary artery bypass surgery: a review with a meta-analysis of their long-term significance. J Card Surg. 2006;21(4):428-34. [ Links ]

    13. Acil T, Türköz R, Acil M, Sezgin AT, Baltali M, Gülcan O, et al. Value of prolonged QRS duration as a predictor of low cardiac output syndrome in patients with impaired left ventricular systolic function who undergo isolated coronary artery bypass grafting. Am J Cardiol. 2006;98(10):1357-62. [ Links ]

    14. Riera M, Herrero J, Ibáñez J, Campillo C, Amézaga R, Sáez de Ibarra JI, et al. Supervivencia a medio plazo de los pacientes operados en cirugía cardiaca mayor. Rev Esp Cardiol. 2011;64(6):463-9. [ Links ]

    15. Vidal-Pérez R, Otero-Raviña F, Gómez Vázquez JL, Santos Rodríguez JA, De Frutos De Marcos C, González-Juanatey JR. Cardiopatía isquémica en la mujer. Datos del estudio CIBAR. Rev Esp Cardiol. 2012;65(11):1056-8. [ Links ]

    16. Haddad N, Bittar E, de Marchi AF, Kantorowitz CS, Ayoub AC, Fonseca ML, et al. Hospital costs of coronary artery bypass grafting on elective coronary patients. Arq Bras Cardiol. 2007;88(4):418-23. [ Links ]

    17. Navia D, Vrancic M, Piccinini F, Benzadón M, Thierer J, Dorsa A, et al. Cirugía coronaria sin circulación extracorpórea con puentes arteriales múltiples en pacientes diabéticos: Resultados tempranos y alejados. Rev Argent Cardiol. 2013;81(6):505-12. [ Links ]

    18. Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, et al. Extent of coronary and myocardial disease and benefit from surgical revascularization in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2014;64(6):553-61. [ Links ]

    19. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation. 1996,94(9 Supl):II87-92. [ Links ]

    20. Clark AL, Goode K, Cleland JG. The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure. Eur J Heart Fail. 2008;10(7):696-702. [ Links ]

    21. Yan GH, Wang M, Yiu KH, Lau CP, Zhi G, Lee SW, et al. Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Heart Rhythm. 2012;9(6):928-35. [ Links ]

    22. Arribas Leal JM, Pascual-Figal DA, Ahumada Vidal M, Marín Ortuño F, Gutiérrez García F, García-Puente del Corral J, et al. Duración del QRS y deterioro hemodinámico precoz tras cirugía de revascularización coronaria. Rev Esp Cardiol. 2009;62(6):652-9. [ Links ]

    23. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, et al. Congestive heart failure and QRS duration: Establishing prognosis study. Chest. 2002;122(2):528-34. [ Links ]

    24. Nishiwaki N, Kawano Y, Sakai M, Furukawa K. Experience of perioperative myocardial infarction with graft patency following coronary artery bypass graft surgery. Nihon Geka Hokan. 1990;59(2):153-60. [ Links ]

    25. Siregar S, Groenwold RH, de Mol BA, Speekenbrink RG, Versteegh MI, Brandon Bravo Bruinsma GJ, et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up? Eur J Cardiothorac Surg. 2013;44(5):875-83. [ Links ]

    26. Verma S, Farkouh ME, Yanagawa B, Fitchett DH, Ahsan MR, Ruel M, et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta-analysis of randomized controlled trials. Lancet Diabetes Endocrinol. 2013;1(4):317-28 [ Links ]

    27. Biffi M, Bertini M, Boriani G, Martignani C, Branzi A. Heart failure after myocardial revascularization: Risk markers. Int J Cardiol. 2005;105(1):11-4. [ Links ]

    1. Brignole M, Auricchio A, Barón-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. Guía de práctica clínica de la ESC 2013 sobre estimulación cardiaca y terapia de resincronización cardiaca. Rev Esp Cardiol. 2014;67(1):58.e1-e60. [ Links ]

    2. Baldasseroni S, Gentile A, Gorini M, Marchionni N, Marini M, Masotti G, et al. Intraventricular conduction defects in patients with congestive heart failure: Left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J. 2003;4(9):607-13. [ Links ]

    3. Khan NK, Goode KM, Cleland JG, Rigby AS, Freemantle N, Eastaugh J, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007;9(5):491-501. [ Links ]

    4. Joseph J, Claggett BC, Anand IS, Fleg JL, Huynh T, Desai AS, et al. QRS duration is a predictor of adverse outcomes in heart failure with preserved ejection fraction. JACC: Heart Fail. 2016;4(6):477-86. [ Links ]

    5. Park HS, Kim H, Park JH, Han S, Yoo BS, Shin MS, et al. QRS prolongation in the prediction of clinical cardiac events in patients with acute heart failure: Analysis of data from the Korean Acute Heart Failure Registry. Cardiology. 2013;125(2):96-103. [ Links ]

    6. Zipes DP, Jalife J, Eds. Cardiac Electrophysiology: From Cell to Bedside. 6th Ed. Philadelphia: Elsevier-Saunders; 2014. [ Links ]

    7. Shah M, Maludum O, Bhalla V, De Venecia TA, Patil S, Curet K, et al. QRS duration and left ventricular ejection fraction (LVEF) in non-ST segment elevation myocardial infarction (NSTEMI). Int J Cardiol. 2016;221:524-8. [ Links ]

    8. Steg G, James SK, Atar D, Badano LP, Blomstrom Lundqvist C, Borger MA, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2013;66(1):53.e1-e46. [ Links ]

    9. Cabrerizo García JL, Zalba Etayo B, Pérez Calvo JI. Valor pronóstico del filtrado glomerular en el síndrome coronario agudo: ¿Índice de Cockcroft o ecuación MDRD? Med Clin (Barc). 2010;134(14):624-9. [ Links ]

    10. Gadaleta FL, Llois SC, Sinisi VA, Quiles J, Avanzas P, Kaski JC. Prolongación del intervalo QT corregido: Nuevo predictor de riesgo cardiovascular en el síndrome coronario agudo sin elevación del ST. Rev Esp Cardiol. 2008;61(6):572-8. [ Links ]

    11. Chávez González E, Alonso Herrera A, Carmona Puerta R, Pérez Cabrera D, Ramos Ramírez RR, Gómez Paima W, et al. Dispersión del QRS como índice de disincronía en el bloqueo de rama izquierda y de sincronía tras la terapia de resincronización cardíaca, una variable de respuesta exitosa. CorSalud [Internet]. 2015 [citado 14 Ene 2017];7(2):106-16. Disponible en: http://www.corsalud.sld.cu/sumario/2015 /v7n2a15/dispersionqrs.html [ Links ]

    12. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol. 1998;32(2):476-82. [ Links ]

    13. Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW, et al. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2010;106(5):630-4. [ Links ]

    14. Horwich T, Lee SJ, Saxon L. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol. 2003;92(7):804-9. [ Links ]

    15. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry. Heart. 2009;95(3):216-20. [ Links ]

    16. Zou CH, Zhang J, Zhang YH, Wei BQ, Wu XF, Zhou Q, et al. Frequency and predictors of normalization of left ventricular ejection fraction in recent-onset nonischemic cardiomyopathy. Am J Cardiol. 2014;113(10):1705-10. [ Links ]

    17. Bedetti G, Gargani L, Sicari R, Gianfaldoni ML, Molinaro S, Picano E. Comparison of prognostic value of echographic [corrected] risk score with the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute Coronary Events (GRACE) risk scores in acute coronary syndrome. Am J Cardiol. 2010;106(12):1709-16. [ Links ]

    18. De Winter O, Van de Veire N, Van Heuverswijn F, Van Pottelberge G, Gillebert TC, De Sutter J. Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction. Eur J Heart Fail. 2006;8(3):275-7. [ Links ]

    19. Jiménez-Candil J, Cruz González I, Martín F, Pabón P, León V, Hernández J, et al. Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome. Int J Cardiol. 2008;126(2):196-203. [ Links ]

    20. Nwakile C, Purushottam B, Bhalla V, Ukpong D, Shah M, Yun J, et al. Significance of QRS duration in non-ST elevation myocardial infarction. Int J Cardiol. 2015;187:146-7. [ Links ]

    21. Poole JE, Singh JP, Birgersdotter-Green U. QRS duration or QRS morphology: What really matters in cardiac resynchronization therapy? J Am Coll Cardiol. 2016;67(9):1104-17. [ Links ]

    22. Nwakile C, Purushottam B, Yun J, Bhalla V, Morris DL, Figueredo VM. QRS duration predicts 30 day mortality following ST elevation myocardial infarction. Int J Cardiol Heart Vasc. 2014;5:42-4. [ Links ]

    1. Kanbay M, Afsar B, Goldsmith D, Covic A. Sudden death in hemodialysis: An Update. Blood Purif. 2010;30(2):135-45. [ Links ]

    2. Bright R. Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine. Guy's Hosp Rep [Internet]. 1836 [citado 22 Ago 2017];1(2):338-379. Disponible en: https://babel.hathitrust.org/cgi/pt?id=iau.31858046169490;view=1up;seq=390 [ Links ]

    3. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12(5):1079-84. [ Links ]

    4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995;5(12):2024-31. [ Links ]

    5. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis. 1999;34(1):125-34. [ Links ]

    6. Truong QA, Ptaszek LM, Charipar EM, Taylor C, Fontes JD, Kriegel M, et al. Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial. J Hypertens. 2010;28(9):1959-67. [ Links ]

    7. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81(3):815-20. [ Links ]

    8. Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, et al. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study. Clin Exp Hypertens. 2010;32(3):145-53. [ Links ]

    9. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25(2):417-23. [ Links ]

    10. Smilde TD, Asselbergs FW, Hillege HL, Voors AA, Kors JA, Gansevoort RT, et al. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy. Am J Hypertens. 2005;18(3):342-7. [ Links ]

    11. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol. 1998;31(2):383-90. [ Links ]

    12. Kim SJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Kim HR, et al. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients. PLoS ONE [Internet]. 2012 [citado 22 Ago 2017];7(4):e35534. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328457/pdf/pone.0035534.pdf [ Links ]

    13. Costa F de A, Rivera IR, Vasconcelos ML, Costa AF, Póvoa RM, Bombig MT, et al. Electrocardiography in the diagnosis of ventricular hypertrophy in patients with chronic renal disease. Arq Bras Cardiol. 2009;93(4):353-9. [ Links ]

    14. Cordeiro AC, Moraes AA, Cerutti V, França F, Quiroga B, Amodeo C, et al. Clinical determinants and prognostic significance of the electrocardiographic strain pattern in chronic kidney disease patients. J Am Soc Hypertens. 2014;8(5):312-20. [ Links ]

    15. Covic AC, Buimistriuc LD, Green D, Stefan A, Badarau S, Kalra PA. The prognostic value of electrocardiographic estimation of left ventricular hypertrophy in dialysis patients. Ann Noninvasive Electrocardiol. 2013;18(2):188-98. [ Links ]

    16. Kligfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock EW, et al. Recommendations for the standardization and interpretation of the electrocardiogram. Part I: The electrocardiogram and its technology: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation. 2007;115(10):1306-24. [ Links ]

    17. Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al. AHA/ACCF/HRS Recommendations for the standardization and interpretation of the electrocardiogram. Part V: Electrocardiogram changes associated with cardiac chamber hypertrophy: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol. 2009;53(11):992-1002. [ Links ]

    18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. [ Links ]

    19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55(4):613-8. [ Links ]

    20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57(6):450-8. [ Links ]

    21. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114(5):345-52. [ Links ]

    22. Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens. 2001;14(8 Pt 1):775-82. [ Links ]

    23. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19(7):1550-8. [ Links ]

    24. Candebat Fernández OA, Rodríguez Bell Z, Rodríguez Bell V, Torres Candebat F, Callejas Candebat S. Tratamiento hemodialítico y evolución de los ancianos con insuficiencia renal crónica. MEDISAN [Internet]. 2009 [citado 30 Ago 2017];13(5). Disponible en: http://scielo.sld.cu/pdf/san/v13n5/san02509.pdf [ Links ]

    25. Astan R, Akpinar I, Karan A, Kacmaz F, Sokmen E, Baysal E, et al. The effect of hemodialysis on electrocardiographic parameters. Ann Noninvasive Electrocardiol. 2015;20(3):253-7. [ Links ]

    26. Dalas M, Vázquez A, Fernández Y, Guerra G. Comportamiento de factores pronósticos de morbilidad y mortalidad en una Unidad de Hemodiálisis. Rev Cubana Med [Internet]. 2008 [citado 22 Ago 2017];47(3). Disponible en: http://scielo.sld.cu/pdf/med/v47n3/med01308.pdf [ Links ]

    27. Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail. 2008;30(7):701-9. [ Links ]

    28. Anuario Cuba Nefro-Red 2014. Situación de la Enfermedad Renal Crónica en Cuba 2014. 3er Año [Internet]. 2015 [citado 30 Ago 2017]. Disponible en: http://files.sld.cu/nefrologia/files/2015/09/anuario-nefrologia-2014 -pagina-web-especialidad.pdf [ Links ]

    29. Bozbas H, Atar I, Yildirir A, Ozgul A, Uyar M, Ozdemir N, et al. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Ren Fail. 2007;29(3):331-9. [ Links ]

    30. Kaze FF, Kengne AP, Djalloh AM, Ashuntantang G, Halle MP, Menanga AP, et al. Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance hemodialysis. Pan Afr Med J [Internet]. 2014 [citado 22 Ago 2017];17:3. Disponible en: http://www.panafrican-med-journal.com/content /article/17/3/pdf/3.pdf [ Links ]

    31. Quiroga B, Villaverde M, Abad S, Vega A, Reque J, López-Gómez J M. Diastolic dysfunction and high levels of new cardiac biomarkers as risk factors for cardiovascular events and mortality in hemodialysis patients. Blood Purif. 2013;36(2):98-106. [ Links ]

    32. Genovesi S, Rossi E, Nava M, Riva H, de Franceschi S, Fabbrini P, et al. A case series of chronic haemodialysis patients: Mortality, sudden death, and QT interval. Europace. 2013;15(7):1025-33. [ Links ]

    33. Valentim B, Pereira A, Coelho P, Pereira T. Study of ventricular electrical systole in patients with end-stage kidney disease on hemodialysis. Arq Bras Cardiol. 2013;100(3):261-8. [ Links ]

    34. Mohi-ud-din K, Bali HK, Banerjee S, Sakhuja V, Jha V. Silent myocardial ischemia and high-grade ventricular arrhythmias in patients on maintenance hemodialysis. Ren Fail. 2005;27(2):171-5. [ Links ]

    35. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67(1):217-26. [ Links ]

    36. Gorsane I, Mahfoudhi M, Younsi F, Helal I, Abdallah TB. Prevalence and risk factors of hypertension in hemodialysis. Open J Nephrol [Internet]. 2015 [citado 22 Ago 2017];5:54-60. Disponible en: http://file.scirp.org/pdf/OJNeph_2015061615315861.pdf [ Links ]

    37. Ministerio de Salud Pública. Anuario Estadístico de Salud 2014. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2015. [ Links ]

    38. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol. 2009;4(2):394-400. [ Links ]

    39. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant. 2004;19(7):1829-34. [ Links ]

    40. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol. 2009;4(Supl 1):S79-91. [ Links ]

    41. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12(12):2759-67. [ Links ]

    42. Taddei S, Nami R, Bruno RM, Quatrini I, Nuti R. Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev. 2011;16(6):615-20. [ Links ]

    43. Bignotto LH, Kallás ME, Djouki RJ, Sassaki MM, Voss GO, Soto CL, et al. Electrocardiographic findings in chronic hemodialysis patients. J Bras Nefrol. 2012;34(3):235-42. [ Links ]

    44. Agarwal R, Light RP. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:528-36. [ Links ]

    45. Bayés de Luna A. Electrocardiografía clínica. 7ª ed. Barcelona: Wiley-Blackwell; 2012. p. 127-63. [ Links ]

    46. Kannel WB, Levy D, Cupples LA. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J Cardiovasc Pharmacol. 1987;10(Supl 6):S135-40. [ Links ]

    47. Buchner S, Debl K, Haimerl J, Djavidani B, Poschenrieder F, Feuerbach S, et al. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson [Internet]. 2009 [citado 30 Ago 2017];11:18. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696426/pdf/1532-429X-11-18.pdf [ Links ]

    48. Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension. 2004;44(2):175-9. [ Links ]

    1. Marrugat J, Elosua R, Gil M. Epidemiología de la muerte súbita cardíaca en España. Rev Esp Cardiol. 1999;52(9):717-25. [ Links ]

    2. Vigo-Ramos J. Muerte súbita y emergencias cardiovasculares: problemática actual. Rev Perú Med Exp Salud Pública. 2008;25(2):233-6. [ Links ]

    3. Myerburg RJ, Castellanos A. Colapso cardiovascular, paro cardíaco y muerte cardíaca súbita. En: Kasper DL, Fauci AS, Hauser SL, eds. Harrison Principios de Medicina Interna. 19ª ed. México DF: McGraw-Hill Interamericana; 2016. p. 1764-70. [ Links ]

    4. Ochoa Montes LA, González Lugo M, Vilches Izquierdo E, Erazo Enríquez N, Quispe Santos JF, Juan Morales L, et al. Expresión clínica del síndrome de muerte súbita cardíaca. Rev Cubana Med. 2011;50(1):16-28. [ Links ]

    5. Ochoa Montes LA. Muerte súbita cardíaca en comunidades de Arroyo Naranjo en el período 2000-2010 [Tesis doctoral]. La Habana: Universidad de Ciencias Médicas; 2012 [citado 31 Oct 2016]. Disponible en: http://tesis.repo.sld.cu/639/1/Luis_Alberto_Ochoa_Montes.pdf [ Links ]

    6. Myerburg RJ, Castellanos A. Parada cardíaca y muerte súbita cardíaca. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, ed. Braunwald Tratado de Cardiología: Texto de medicina cardiovascular. 9na ed. Barcelona: Elsevier; 2013. p. 853-93. [ Links ]

    7. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, et al. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. Circulation. 2009;119(11):1484-91. [ Links ]

    8. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008; 300(12):1423-31. [ Links ]

    9. Kannel WB, Thomas HE. Sudden coronary death: The Framingham Study. Ann N Y Acad Sci. 1982;382:3-21. [ Links ]

    10. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107(16):2096-101. [ Links ]

    11. Manderbacka K, Elovainio M. La complejidad de la asociación entre posición socioeconómica e infarto agudo de miocardio. Rev Esp Cardiol. 2010;63(9):1015-8. [ Links ]

    12. Ochoa Montes LA, González Lugo M, Tamayo Vicente ND, Romero del Sol JM, Correa Azahares DP, Miguélez Nodarse R, et al. El ámbito de la parada cardíaca como determinante en el pronóstico de aparición de la muerte súbita cardíaca. Rev Electrón PortalesMédicos.com [Internet]. 2008 [citado 18 Abr 2017];III(20):349. Disponible en: https://www.portalesmedicos.com/publicaciones/articles/1309/1/El-ambito -de-la-Parada-Cardiaca-como-determinante-en-el-Pronostico-de-aparicion-de-la-Muerte-Subita-Cardiaca.html [ Links ]

    13. Ochoa Montes LA, González Lugo M, Tamayo Vicente ND, Romero del Sol JM, Correa Azahares DP, Miguélez Nodarse R, et al. Arritmias finales en la muerte súbita cardíaca. Rev Electrón PortalesMédicos.com [Internet]. 2008;III(19):337. Disponible en: http://www.portalesmedicos.com/publicaciones/articles/1293/1/Arritmias-Finales-en-la-Muerte-Subita-Cardiaca.html [ Links ]

    14. Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública [Internet]. 2015 [citado 18 Abr 2017];41(2):298-323. Disponible en: http://scielo.sld.cu/pdf/rcsp/v41n2/spu10215.pdf [ Links ]

    15. Weisfeldt ML, Everson-Stewart S, Sitlani C, Rea T, Aufderheide TP, Atkins DL, et al. Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med. 2011;364(4):313-21. [ Links ]

    16. Ayuso Baptista F, Fonseca del Pozo FJ, Ruiz Madruga M, Jiménez Corona J, Jiménez Moral G, Martín Rioboó E. Actualización en soporte vital básico optimizado y desfibrilación externa automática. Semergen. 2002;28(11):624-30. [ Links ]

    17. Goldenberg I, Jonas M, Tenenbaum A, Boyko V, Matetzky S, Shotan A, et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003;163(19):2301-5. [ Links ]

    18. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 1999;100(9):944-50. [ Links ]

    19. Lown B. Colapso cardiovascular y muerte cardíaca súbita. En: Braunwald E, editor. Tratado de Cardiología. La Habana: Científico Técnica; 1985. p. 859-903. [ Links ]

    20. Arntz HR, Willich SN, Schreiber C, Brüggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J. 2000 Feb;21(4):315-20. [ Links ]

    21. Tavora F, Crowder C, Kutys R, Burke A. Discrepancies in initial death certificate diagnoses in sudden unexpected out-of-hospital deaths: the role of cardiovascular autopsy. Cardiovasc Pathol. 2008;17(3):178-82. [ Links ]

    22. Morentin B, Audicana C. Estudio poblacional de la muerte súbita cardiovascular extrahospitalaria: incidencia y causas de muerte en adultos de edad mediana. Rev Esp Cardiol. 2011;64(1):28-34. [ Links ]

    1. O'Donnell CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol. 2008;61(3):299-310. [ Links ]

    2. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health profesionals. Circulation 1991;83(1):356-62. [ Links ]

    3. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. [ Links ]

    4. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481-92. [ Links ]

    5. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson P, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139(2 Pt 1):272-81. [ Links ]

    6. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, et al. Factores de riesgo cardiovascular en España en la primera década del siglo XXI: Análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Rev Esp Cardiol. 2011;64(4):295-304. [ Links ]

    7. Sans S, Fitzgerald AP, Royo D, Conroy R, Graham I. Calibración de la tabla SCORE de riesgo cardiovascular para España. Rev Esp Cardiol. 2007;60(5):476-85. [ Links ]

    8. Álvarez Cosmea A, Díaz González L, López Fernández V, Prieto Díaz MA, Suárez García S. Comparación de los modelos SCORE y Framingham en el cálculo de alto riesgo cardiovascular para una muestra de varones de 45 y 65 años de Asturias. Rev Esp Salud Pública. 2005;79(4):465-73. [ Links ]

    9. Mazón-Ramos P, Bertomeu-Martínez V, Palma-Gámiz JL, Quiles-Granado J, Guindo-Soldevilla J, González-Juanatey JR. Tratamiento global del riesgo cardiovascular en el paciente hipertenso. Rev Esp Cardiol. 2007;60(Supl 1):79-91. [ Links ]

    10. Gil-Guillén V, Orozco-Beltrán D, Maiques-Galán A, Aznar-Vicente J, Navarro J, Cea-Calvo L, et al. Concordancia de las escalas REGICOR y SCORE para la identificación del riesgo cardiovascular alto en la población española. Rev Esp Cardiol. 2007;60(10):1042-50. [ Links ]

    11. Organización Mundial de la Salud. Prevención de las enfermedades cardiovasculares: Guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra: Ediciones OMS; 2008. [ Links ]

    12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289(19):2560-72. [ Links ]

    13. Castillo Arocha I, Armas Rojas NB, Dueñas Herrera A, González Greck OR, Arocha Mariño C, Castillo Guzmán A. Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/apolipoproteína A1. Rev Cubana Invest Bioméd [Internet]. 2010 [citado 30 Jun 2017];29(4):479-88. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 -03002010000400008 [ Links ]

    14. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682-6. [ Links ]

    15. Zapico E, Ordóñez J. Nuevas recomendaciones del National Cholesterol Education Program (NCEP). Consecuencias en el laboratorio clínico. Clin Invest Arterioscl. 2002;14(5):272-6. [ Links ]

    16. Almaguer López M, Herrera Valdés R, Pérez-Oliva Díaz J. Epidemia global de enfermedades vasculares crónicas: Un nuevo paradigma y desafío. Rev Haban Cienc Méd [Internet]. 2007 [citado 30 Jun 2017];6(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2007000300007&lng=es [ Links ]

    17. Lobos Bejarano JM, Brotons Cuixart C. Factores de riesgo cardiovascular y atención primaria: evaluación e intervención. Aten Primaria. 2011;43(12):668-77. [ Links ]

    18. Rodríguez-Sánchez E, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Mora-Simón S, Pérez-Arechaederra D, et al. Prevalencia de enfermedades cardiovasculares y de factores de riesgo cardiovascular en mayores de 65 años de un área urbana: estudio DERIVA. Aten Primaria. 2013;45(7):349-57. [ Links ]

    19. Dueñas Herrera A, Armas Rojas NB, de la Noval García R, Turcios Tristá SE, Milián Hernández A, Cabalé Vilariño MB. Riesgo cardiovascular total en los trabajadores del Hotel "Meliá Cohíba". Rev Cubana Endocrinol [Internet]. 2008 [citado 30 Jun 2017];19(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000100003&lng=es [ Links ]

    20. Gabriel Sánchez R, Novella Arribas B, Alonso Arroyo M, Vega Quiroga S, López García I, Suárez Fernández C, et al. El proyecto EPICARDIAN: Un estudio de cohortes sobre enfermedades y factores de riesgo cardiovascular en ancianos españoles: Consideraciones metodológicas y principales hallazgos demográficos. Rev Esp Salud Pública. 2004;78(2):243-55. [ Links ]

    21. Suárez C, Gabriel R. Epidemiología de la hipertensión arterial en España. Cardiovasc Risk Factors. 2000;9(4):239-246. [ Links ]

    22. Vasan RS, Larson MG, Leip EP, Kannel WB, Levi D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358(9294):1682-6. [ Links ]

    23. Banegas Banegas JR. Epidemiología de la hipertensión arterial en España. Situación actual y perspectivas. Hipertensión. 2005;22(9):353-62. [ Links ]

    24. Nigro D, Vergottini JC, Kuschnir E, Bendersky M, Campo I, de Roiter HG, et al. Epidemiología de la hipertensión arterial en la ciudad de Córdoba, Argentina. Rev Fed Arg Cardiol. 1999;28(1):69-75. [ Links ]

    1. Tam SK, Gu W, Mahdavi V, Nadal-Ginard B. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann N Y Acad Sci. 1995;752:72-9. [ Links ]

    2. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998;83(1):1-14. [ Links ]

    3. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336(16);1131-41. [ Links ]

    4. Nadal-Ginard B. Inducción de nuevos cardiomiocitos en el corazón adulto: futuro de la regeneración miocárdica como alternativa al trasplante. Rev Esp Cardiol. 2001;54(5):543-50. [ Links ]

    5. Anversa P, Torella D, Kajstura B, Nadal-Ginard B, Leri A. Myocardial regeneration. Eur Heart J. 2002;4(Supl. G):G67-G71. [ Links ]

    6. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone morrow-derived myogenic progenitors. Science. 1998;279(5356):1528-30. [ Links ]

    7. Orlic D, Bodine DM. Pluripotent hematopoietic stem cells of low and high density can repopulate W/Wv mice. Exp Hematol. 1992;20(11):1291-5. [ Links ]

    8. Orlic D, Fischer R, Nishikawa S, Nienhuis AW, Bodine DM. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood. 1993;82(3):762-70. [ Links ]

    9. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-5. [ Links ]

    10. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5-15. [ Links ]

    11. Chachques JC, Hidalgo J, Cattadori B, Duarte F, Shafy A, Argyriadis P, et al. Cardiomioplastia Celular: Un nuevo enfoque terapéutico para la Disfunción ventricular. Cardiología Intercontinental. 2001;10(1):11-5. [ Links ]

    12. Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119(6):1169-75. [ Links ]

    13. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106(15):1913-8. [ Links ]

    14. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107(18):2294-302. [ Links ]

    1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett DG, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807-16. [ Links ]

    2. Bayés de Luna A, López-Sandón J, Attie F, Alegría Ezquerra E. Cardiología clínica. Barcelona: Masson SA; 2003. p. 12. [ Links ]

    3. Elliott PM. Classification of cardiomyopathies: Evolution or revolution. J Am Coll Cardiol. 2013;62(22):2073-4. [ Links ]

    4. Richardson P, MacKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841-2. [ Links ]

    5. Thiene G, Corrado D, Basso C. Cardiomyopathies: Is it time for a molecular classification? Eur Heart J. 2004;25(20):1772-5. [ Links ]

    6. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace, 2011;13(8):1077-109. [ Links ]

    7. Chopra N, Knollmann BC. Genetics of sudden cardiac death syndromes. Curr Opin Cardiol. 2011;26(3):196-203. [ Links ]

    8. Bayés de Luna A. Clinical arrhythmology. Oxford: Wiley-Blackwell; 2011. [ Links ]

    9. Celiker A, Ozkutlu S, Dilber E, Karagöz T. Rhythm abnormalities in children with isolated ventricular noncompaction. Pacing Clin Electrophysiol. 2005;28(11):1198-202. [ Links ]

    10. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62(22):2046-72. [ Links ]

    11. Bayés de Luna A. Clinical electrocardiography. A textbook. 4ª ed. Oxford: Wiley-Blackwell; 2012. p. 453-4, 458-60. [ Links ]

    12. Yin L. Non-compact cardiomyopathy or ventricular non-compact syndrome? J Cardiovasc Ultrasound. 2014;22(4):165-72. [ Links ]

    13. Brescia ST, Rossano JW, Pignatelli R, Jefferies JL, Price JF, Decker JA, et al. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation. 2013;127(22):2202-8. [ Links ]

    14. Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E, et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J. 2005;26(2):187-92. [ Links ]

    15. Kobza R, Jenni R, Erne P, Oechslin E, Duru F. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction. Pacing Clin Electrophysiol. 2008;31(4):461-7. [ Links ]

    16. Ikeda U, Minamisawa M, Koyama J. Isolated left ventricular non-compaction cardiomyopathy in adults. J Cardiol. 2015;65(2):91-7. [ Links ]

    17. Thiene G, Corrado D, Basso C. Revisiting definition and classification of cardiomyopathies in the era of molecular medicine. Eur Heart J. 2008;29(2):144-6. [ Links ]

    18. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: More questions than answers? J Am Coll Cardiol. 2014;63(23):2584-6. [ Links ]

    19. Pasotti M. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: More questions than answers? J Am Coll Cardiol. 2014;63(23):2584. [ Links ]

    20. Arbustini E, Narula N, Tavazzi L, Serio A, Grasso M, Favalli V, et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol. 2014;64(3):304-18. [ Links ]

    21. Arbustini E, Weidemann F, Hall JL. Left ventricular noncompaction: A distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol. 2014;64(17):1840-50. [ Links ]

    22. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Am J Cardiol. 2009;104(7):984-9. [ Links ]

    23. Sen-Chowdhry S, McKenna WJ. Left ventricular noncompaction and cardiomyopathy: Cause, contributor, or epiphenomenon. Curr Opin Cardiol. 2008;23(3):171-5. [ Links ]

    24. Duru F, Candinas R. Noncompaction of ventricular myocardium and arrhythmias. J Cardiovasc Electrophysiol. 2000;11(4):493. [ Links ]

    25. Modi S, Krahn AD. Sudden cardiac arrest without overt heart disease. Circulation. 2011;123(25):2994-3008. [ Links ]

    26. Stollberger C, Gerger D, Jirak P, Wegner C, Finsterer J. Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction. Ann Noninvasive Electrocardiol. 2014;19(6):567-73. [ Links ]

    27. Viskin S, Rogowski O. Asymptomatic Brugada syndrome: A cardiac ticking time-bomb? Europace. 2007;9(9):707-10. [ Links ]

    28. Dorantes M, Pham Trung C. Estimulación eléctrica programada del corazón en el síndrome de Brugada. Parte II: Variaciones sobre un mismo tema. CorSalud [Internet]. 2015 [citado 30 Sep 2017];7(3):202-13. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/59/96 [ Links ]

    29. Dorantes M, Pham Trung C. Estimulación eléctrica programada del corazón en el síndrome de Brugada. Parte I: Una visión actual. CorSalud [Internet]. 2015 [citado 30 Sep 2017];7(1):46-51. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/11/11 [ Links ]

    30. Josephson ME. Electrophysiology at a crossroads. Heart Rhythm. 2007;4(5):658-61. [ Links ]

    31. Josephson ME. Electrophysiology at a crossroads: A revisit. Heart Rhythm. 2016;13(12):2317-22. [ Links ]

    32. Buxton AE. Programmed ventricular stimulation: not dead. Circulation. 2014;129(8):831-3. [ Links ]

    33. Martini B, Martini N, Dorantes Sánchez M, Márquez MF, Zhang L, Fontaine G, et al. Pistas de una enfermedad orgánica subyacente en el síndrome de Brugada. Arch Cardiol Mex. 2017;87(1):49-60. [ Links ]

    34. Tester DJ, Ackerman MJ. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation. 2011;123(9):1021-37. [ Links ]

    35. Celiker A, Kafali G, Doðan R. Cardioverter defibrillator implantation in a child with isolated noncompaction of the ventricular myocardium and ventricular fibrillation. Pacing Clin Electrophysiol. 2004;27(1):104-8. [ Links ]

    36. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomiopathy. Lancet. 2015;386(9995):813-25. [ Links ]

    37. Van Malderen S, Wijchers S, Akca F, Caliskan K, Szili-Torok T. Mismatch between the origin of premature ventricular complexes and the noncompacted myocardium in patients with noncompaction cardiomyopathy patients: involvement of the conduction system? Ann Noninvasive Electrocardiol [Internet]. 2017 [citado 30 Sep 2017];22(2):e12394. Disponible en: https://doi.org/10.1111/anec.12394 [ Links ]

    38. Caliskan K, Ujvari B, Bauernfeind T, Theuns DA, Van Domburg RT, Akca F, et al. The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias. J Cardiovasc Electrophysiol. 2012;23(9):938-44. [ Links ]

    39. Caliskan K, Szili-Torok T, Theuns DA, Kardos A, Geleijnse ML, Balk AH, et al. Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22(8):898-904. [ Links ]

    40. Muser D, Liang JJ, Witschey WR, Pathak RK, Castro S, Magnani S, et al. Ventricular arrhythmias associated with left ventricular noncompaction: Electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2017;14(2):166-75. [ Links ]

    41. Viskin S. The QT interval: too long, too short or just right. Heart Rhythm. 2009;6(5):711-5. [ Links ]

    42. Anttonen O, Junttila MJ, Maury P, Schimpf R, Wolpert C, Borggrefe M, et al. Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm. 2009;6(2):267-71. [ Links ]

    43. Jerez AM, Echevarría S, Guevara G, Aleaga E. Miocardiopatía por ventrículo no compactado. Acerca de su evolución histórica, definiciones y generalidades del tema. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2015 [citado 30 Sep 2017];21(2):117-22. Disponible en: http://www.revcardiologia.sld.cu/index.php /revcardiologia/article/view/586/pdf_11 [ Links ]

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29. [ Links ]

    2. Ministerio de Salud Pública. Anuario Estadístico de Salud 2016. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2017. [ Links ]

    3. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71. [ Links ]

    4. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911-39. [ Links ]

    5. Lal H, Kolaja KL, Force T. Cancer genetics and the cardiotoxicity of the therapeutics. J Am Coll Cardiol. 2013;61(3):267-74. [ Links ]

    6. Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: A clinical update. Cardiol Res Pract [Internet]. 2011 [citado 15 Oct 2017];2011:317659. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC3051159/pdf/CRP2011-317659.pdf [ Links ]

    7. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991-4008. [ Links ]

    8. Ruiz Mori E, Ayala Bustamante L, Burgos Bustamante J. Insuficiencia cardíaca por quimioterapia. Rev Soc Peruana Med Interna. 2016;29(2):59-64. [ Links ]

    9. Perrino C, Schiattarella GG, Magliulo F, Ilardi F, Carotenuto G, Gargiulo G, et al. Cardiac side effects of chemotherapy: State of art and strategies for a correct management. Curr Vasc Pharmacol. 2014;12(1):106-16. [ Links ]

    10. Bloom M, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, et al. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. Circ Heart Fail [Internet]. 2016 [citado 15 Oct 2017];9(1):e002661. Disponible en: http://circheartfailure.ahajournals.org /content/9/1/e002661.long [ Links ]

    11. Wise J. Adult survivors of childhood cancer are at high risk of cardiac abnormalities, study finds. BMJ [Internet]. 2016 [citado 15 Oct 2017];352:h7026. Disponible en: https://search.proquest.com/openview /d6b604e490d36b922a0723b4d3bcebe8/1.pdf?pq-origsite=gscholar&cbl=2043523 [ Links ]

    12. Velásquez CA, González M, Berrouet MC, Jaramillo N. Cardiotoxicidad inducida por la quimioterapia desde las bases moleculares hasta la perspectiva clínica. Rev Colomb Cardiol. 2016;23(2):104-11. [ Links ]

    13. Meza-Cejudo S. Cardiotoxicidad por quimioterapia; implicaciones anestésicas. Rev Mex Anestesiol. 2017;40(Supl 1):S18-S20. [ Links ]

    14. Prado A. Miocardiopatía producida por antineoplásicos. Un nuevo desafío para los cardiólogos. Rev Fed Arg Cardiol. 2016;45(4):164-7. [ Links ]

    15. Jiménez-Cotes EA, Meyer-Martínez WS, Gallego-González D. Biomarcadores en la detección temprana de cardiotoxicidad inducida por quimioterapia; estado actual. Arch Med (Manizales). 2015;15(1):126-37. [ Links ]

    16. López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P, et al. Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones. Rev Esp Cardiol. 2017;70(6):474-86. [ Links ]

    17. Navarro-Ulloa OD, Barranco-Camargo LA, Jurado-López SP, Zabala-Carballo CI, Giraldo-Peniche LE. Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas. Rev Colomb Cardiol [Internet]. 2018 [citado 02 Ene 2018];25(1):80.e1-7. Disponible en: http://www.elsevier.es/es-revista-revista-colombiana-cardiologia -203-articulo-muerte-subita-debida-cardiotoxicidad-aguda-S0120563317301353 [ Links ]

    18. Klaassen CD, editor. Casarett and Doull's Toxicology: The basic science of poisons. 8ª ed. New York: McGraw-Hill Education; 2013. [ Links ]

    19. Ritter J, Flower R, Henderson G, Rang H. Rang & Dale's Pharmacology. Edinburgh: Churchill Livingstone; 2015. 20. Martins KF, Messias AD, LeiteI FL, Duek E. Preparation and characterization of paclitaxel-loaded PLDLA microspheres. Materials Research. 2014;17(3):650-6. [ Links ]

    20. Martins KF, Messias AD, LeiteI FL, Duek E. Preparation and characterization of paclitaxel-loaded PLDLA microspheres. Materials Research. 2014;17(3):650-6. [ Links ]

    21. Lax J, Piñeiro D, Falconi M, Agüero R, Barugel M, Bermann A, et al. Consenso de diagnóstico, prevención y tratamiento de la cardiotoxicidad por tratamiento médico del cáncer. Rev Argent Cardiol [Internet]. 2013. [citado 02 Ene 2018];81(Supl. 5):1-64. Disponible en: https://www.sac.org.ar/wp-content/uploads/2014/04 /Consenso-Cardiotoxicidad.pdf [ Links ]

    22. Schlitt A, Jordan K, Vordermark D, Schwamborn J, Langer T, Thomssen C. Cardiotoxicity and oncological treatments. Dtsch Arztebl Int. 2014;111(10):161-8. [ Links ]

    23. López-Velarde Peña T, López-Velarde Badager P. Prevención y tratamiento de cardiotoxicidad en pacientes con cáncer. An Med (Mex). 2014;59(1):54-60. [ Links ]

    24. Reborido N, Parma G, Noria S, Schiavone A, Bonelli A, Lluberas R. Strain bidimensional para detección precoz de disfunción sistólica del ventrículo izquierdo inducida por agentes quimioterápicos. Rev Urug Cardiol. 2016;31(2):266-76. [ Links ]

    25. Espinola Zavaleta N, Lupi Herrera E. El papel del ecocardiograma en la valoración de la cardiotoxicidad por quimioterapia. An Med (Mex). 2015;60(3):199-205. [ Links ]

    26. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893-911. [ Links ]

    1. Tseng ZH, Gerstenfeld EP. Outflow Tract Ventricular Tachyarrhythmias: Mechanisms, Clinical Features, and Management. En: Zipes DP, Jalife J. Cardiac Electrophysiology: From Cell to Bedside. 6ta Ed. New York: Elsevier; 2014. p. 815-25. [ Links ]

    2. Issa ZF, Miller JM, Zipes DP. Adenosine-Sensitive Outflow Tract Ventricular Tachycardia. En: Issa ZF, Miller JM, Zipes DP. Clinical Arrhythmology and Electrophysiology. A Companion to Braunwald's Heart Disease. 2da Ed. Boston: Elsevier; 2015. p. 562-86. [ Links ]

    3. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. Guía ESC 2015 sobre el tratamiento de pacientes con arritmias ventriculares y prevención de la muerte súbita cardiaca. Rev Esp Cardiol. 2016;69(2):176.e1-e77. [ Links ]

    4. Iwai S, Cantillon DJ, Kim RJ, Markowitz SM, Mittal S, Stein KM, et al. Right and left ventricular outflow tract tachycardias: Evidence for a common electrophysiologic mechanism. J Cardiovasc Electrophysiol. 2006;17(10):1052-8. [ Links ]

    5. Yamada T, McElderry HT, Okada T, Murakami Y, Doppalapudi H, Yoshida N, et al. Idiopathic left ventricular arrhythmias originating adjacent to the left aortic sinus of valsalva: Electrophysiological rationale for the surface electrocardiogram. J Cardiovasc Electrophysiol. 2010;21(2):170-6. [ Links ]

    6. Kumagai K, Fukuda K, Wakayama Y, Sugai Y, Hirose M, Yamaguchi N, et al. Electrocardiographic characteristics of the variants of idiopathic left ventricular outflow tract ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 2008;19(5):495-501. [ Links ]

    7. Asirvatham SJ. Correlative anatomy for the invasive electrophysiologist: Outflow tract and supravalvar arrhythmia. J Cardiovasc Electrophysiol. 2009;20(8):955-68. [ Links ]

    8. Anderson RH. Clinical anatomy of the aortic root. Heart. 2000;84(6):670-3. [ Links ]

    9. Lerman BB, Stein K, Engelstein ED, Battleman DS, Lippman N, Bei D, et al. Mechanism of repetitive monomorphic ventricular tachycardia. Circulation. 1995;92(3):421-9. [ Links ]

    10. Kim RJ, Iwai S, Markowitz SM, Shah BK, Stein KM, Lerman BB. Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias. J Am CollCardiol. 2007;49(20):2035-43. [ Links ]

    11. Marchlinski FE, Deely MP, Zado ES. Sex-specific triggers for right ventricular outflow tract tachycardia. Am Heart J. 2000;139(6):1009-13. [ Links ]

    12. Hayashi H, Fujiki A, Tani M, Usui M, Mizumaki K, Shimono M, et al. Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. Am J Cardiol. 1999;84(1):99-101. [ Links ]

    13. Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E, et al. The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm. 2011;8(7):1046-9. [ Links ]

    14. Yokokawa M, Good E, Crawford T, Jongnarangsin K, Chugh A, Pelosi F, et al. Ventricular tachycardia originating from the aortic sinus cusp in patients with idiopathic dilated cardiomyopathy. Heart Rhythm. 2011;8(3):357-60. [ Links ]

    15. Tanner H, Hindricks G, Schirdewahn P, Kobza R, Dorszewski A, Piorkowski C, et al. Outflow tract tachycardia with R/S transition in lead V3: Six different anatomic approaches for successful ablation. J Am CollCardiol. 2005;45(3):418-23. [ Links ]

    16. Yamada T, Murakami Y, Yoshida N, Okada T, Shimizu T, Toyama J, et al. Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp. J Am CollCardiol. 2007;50(9):884-91. [ Links ]

    17. Betensky BP, Park RE, Marchlinski FE, Hutchinson MD, Garcia FC, Dixit S, et al. The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. J Am CollCardiol. 2011;57(22):2255-62. [ Links ]

    18. Yoshida N, Inden Y, Uchikawa T, Kamiya H, Kitamura K, Shimano M, et al. Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias. Heart Rhythm. 2011;8(3):349-56. [ Links ]

    19. Ouyang F, Mathew S, Wu S, Kamioka M, Metzner A, Xue Y, et al. Ventricular arrhythmias arising from the left ventricular outflow tract below the aortic sinus cusps: Mapping and catheter ablation via transseptal approach and electrocardiographic characteristics. Circ Arrhythm Electrophysiol. 2014;7(3):445-55. [ Links ]

    20. Bala R, Garcia FC, Hutchinson MD, Gerstenfeld EP, Dhruvakumar S, Dixit S, et al. Electrocardiographic and electrophysiologic features of ventricular arrhythmias originating from the right/left coronary cusp commissure. Heart Rhythm. 2010;7(3):312-22. [ Links ]

    21. Callans DJ. Catheter ablation of idiopathic ventricular tachycardia arising from the aortic root. J Cardiovasc Electrophysiol.2009;20(8):969-72. [ Links ]

    22. Sasaki T, Hachiya H, Hirao K, Higuchi K, Hayashi T, Furukawa T, et al. Utility of distinctive local electrogram pattern and aortographic anatomical position in catheter manipulation at coronary cusps. J Cardiovasc Electrophysiol. 2011;22(5):521-9. [ Links ]

    23. Yamada T, McElderry HT, Doppalapudi H, Murakami Y, Yoshida Y, Yoshida N, et al. Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation. J Am CollCardiol. 2008;52(2):139-47. [ Links ]

    24. Tabatabaei N, Asirvatham SJ. Supravalvular arrhythmia: Identifying and ablating the substrate. Cir c Arrhythm Electrophysiol. 2009;2(3):316-26. [ Links ]

    25. Uribe W, Astudillo V, Medina E, Marín J, González E, Aristizábal J, et al. Taquicardia ventricular proveniente de las cúspides coronarias, características electrocardiográficas, electrofisiológicas y resultados de ablación con radiofrecuencia: validación de un algoritmo diagnóstico. Rev Iberoam Arritmol. 2010;1(2):134-46. [ Links ]

    26. Natale A, Raviele A, Al-Ahmad A, Alfieri O, Aliot E, Almendral J, et al. Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21(3):339-79. [ Links ]

    1. Muñoz JS, Linares G, Peña IA. Trombosis del stent. Antes y después de los stents farmacológicos. En: Sousa A GMR, Abizaid A, Martínez Ríos M, Berrocal D, Sousa JE, eds. Intervenciones cardiovasculares SOLACI. 2ªed. Colombia; 2009. p. 453-67. [ Links ]

    2. Morice MC, Serruys PW, Sousa JE, Fajadet J, BanHayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773-80. [ Links ]

    3. de la Torre Hernández JM, Windecker S. Trombosis muy tardía con nuevos stentsfarmacoactivos, ¿ha dejado de ser un asunto relevante? Rev Esp Cardiol. 2012;65(7):595-8. [ Links ]

    4. Holmes DR, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56(17):1357-65. [ Links ]

    5. García Tejada J, Albarrán González-Trevilla A. Stents y trombosis. Med Clin. 2008;130(5):175-6. [ Links ]

    6. Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stent. Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation. 2007;115(17):2352-7. [ Links ]

    7. Takano M, Yamamoto M, Mizuno K. Two cases of coronary stent thrombosis very late after bare-metal stenting. JACC Cardiovasc Interv. 2009;2(12):1286-7. [ Links ]

    8. Soto G, Sepúlveda P, Donoso H, Puentes A, Bellet A, Albisa G, et al. Trombosis "extremadamente" tardía de stent. Rev Chil Cardiol. 2012;31(3):263-6. [ Links ]

    9. Cuesta J, Rivero F, Bastante T, Benedicto A, Alfonso F. Ruptured "non-culprit" in-stent neoatherosclerosis during ST-segment elevation acute myocardial infarction. Euro Intervention. 2016;12(10):1222. [ Links ]

    10. Filgueiras Frías CE, Bestard Bicet R, Laria Menchaca S, López Ferrero L, Pérez del Todo JM, Villanueva Ponte LH. Trombosis muy tardía de stent convencional. Una sorpresa desagradable. Rev Cubana Cardiol Cir Cardiovasc. 2011;17(2):180-5. [ Links ]

    1. McManus B. Tumores cardíacos primarios. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, eds. Braunwald. Tratado de Cardiología: Texto de medicina cardiovascular. 9ª ed. Barcelona: Elsevier España SL; 2013. p. 1660-72. [ Links ]

    2. Melero MJ, Piñeiro Ibáñez DJ. Tumores cardíacos. En: Rozman C, Cardellach López F, eds. Farreras-Rozman. Medicina Interna. 18ª Ed. Barcelona: Elsevier España; 2016. p. 574-6. [ Links ]

    3. Hernández-Bringas O, Ortiz-Hidalgo C. Características histopatológicas e inmunohistoquímicas de los mixomas cardiacos. Arch Cardiol Mex. 2013;83(3):199-208. [ Links ]

    4. Rottier Salguero R, Vega Ulate GA. Tumor primario del corazón más común: Mixoma cardíaco. Rev Med Cos Cen. 2012;69(604):481-7. [ Links ]

    5. Muñoz Serret D, García E, Páez J, Hernández E. Mixoma gigante de aurícula derecha. Presentación de un caso. Cir Cardiov. 2013;20(4):203-5. [ Links ]

    7. Manzur F, Barbosa C, Puello A. Mixoma auricular izquierdo asociado a insuficiencia severa de válvula mitral en paciente de género femenino de 31 años de edad: Reporte de caso. Rev Colomb Cardiol.2011;18(6):345-9. [ Links ]

    8. Fuertes A. Cardiomegalia radiológica. En: Laso Guzmán FJ, ed. Diagnóstico diferencial en medicina interna. 3ª Ed. Barcelona: Elsevier España; 2013. p. 145-52. [ Links ]

    9. Navarro OD, Fernández LJ. Estenosis mitral por mixoma auricular izquierdo. Rev Colomb Cardiol. 2016;23(4):304.e1-e4. [ Links ]

    10. Moreno-Ariño M, Ortiz-Santamaria V, Deudero Infante A, Ayats Delgado M, Novell Teixidó F. Un simulador clásico de vasculitis sistémica. Reumatol Clin. 2016;12(2):103-6. [ Links ]

    11. Vico Besó L, Zúñiga Cedó E. Tromboembolismo pulmonar secundario a mixoma de aurícula derecha. Semergen. 2013;39(7):e54-e56. [ Links ]

    12. Failo M, Rosende A, Fallabrino L. Accidente cerebrovascular y mixoma auricular. Rev CONAREC. 2011;27(110):219-21. [ Links ]

    13. Sabater N, Alforja S, Rey A, Giralt J. Diagnóstico tardío de obstrucción de arteria oftálmica por mixoma atrial. Arch Soc Esp Oftalmol. 2013;88(8):313-5. [ Links ]

    14. Antolín A, Franco A, Albero MD, Giménez MJ, Margarit C, Ibáñez A, et al. Fracaso renal agudo secundario a mixoma cardíaco. Nefrología. 1997;XVII(2):174-7. [ Links ]

    15. Al-Fakhouri A, Janjua M, DeGregori M. Acute myocardial infarction caused by left atrialmyxoma: Role of intracoronary catheter aspiration. Rev Port Cardiol. 2017;36(1):63.e1-63. [ Links ]

    16. Imbalzano E, Di Bella G, Casale M, Boretti I, Manganaro R, Lamari A, et al. Angina pectoris: First manifestation of a left atrial myxoma. Int J Cardiol. 2014;172(1):e165-6. [ Links ]

    17. Bermúdez Yera GJ, Medrano Plana Y, Bermúdez Yera R, Lagomasino Hidalgo A, López de la Cruz Y, González Borges LA, et al. Tratamiento quirúrgico urgente en paciente con mixoma auricular izquierdo pediculado. CorSalud [Internet]. 2009 [citado 22 Ago 2010];1(4).Disponible en: http://www.corsalud.sld.cu/sumario/2009/v1n4a09/mixoma.htm [ Links ]

    18. Bermúdez Yera R, Lagomasino Hidalgo A, Bermúdez Yera GJ, Medrano Plana Y, González Díaz A, Monteagudo Lima L, et al. Mixoma biauricular: Presentación del primer caso operado en el Cardiocentro Ernesto Che Guevara. CorSalud [Internet]. 2010 [citado 22 Ago 2017];2(2):164-9. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n2a10/mixoma.htm [ Links ]

    19. García-Quintana A, Martín-Lorenzo P, Suárez de Lezo J, Díaz-Escofet M, Llorens R, Medina A. Mixoma auricular izquierdo infectado. Rev Esp Cardiol. 2005;58(11):1358-60. [ Links ]

    20. Castellanos Rojas R, Ferrer Herrera I, Martínez Pinto PD, Carreras Calvo F, Perozo Panicello R, Segura Pujal LA. Mixoma ventricular izquierdo en paciente con síndrome de inmunodeficiencia humana. AMC [Internet]. 2016 [citado 22Ago2017];20(3):309-14. Disponible en: http://scieloprueba.sld.cu/pdf/amc/v20n3 /amc110306.pdf [ Links ]

    1. Lecube A, Monereo S, Rubio MÁ, Martínez-de-Icaya P, Martí A, Salvador J, et al. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016. Endocrinol Diabetes Nutr. 2017;64(Suppl 1):15-22. [ Links ]

    2. Madeira FB, Silva AA, Veloso HF, Goldani MZ, Kac G, Cardoso VC, et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS One [Internet]. 2013 [citado 15 Jul 2017];8(13):e60673. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610876/pdf/pone.0060673.pdf [ Links ]

    3. Jiménez Acosta SM, Rodríguez Suárez A, Díaz Sánchez ME. La obesidad en Cuba. Una mirada a su evolución en diferentes grupos poblacionales. Rev Cubana Aliment Nutr [Internet]. 2013 [citado 15 Jul 2017];23(2):297-308. Disponible en: http://www.revalnutricion.sld.cu/index.php/rcan/article/view/299/289 [ Links ]

    4. De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016;22(2):681-703. [ Links ]

    1. SciELO. SciELO _ Un modelo para publicación electrónica en países en desarrollo [Internet]. Disponible en: http://www.scielo.org/php/level.php?lang=es&component=44&item=1 [ Links ]

    2. SciELO Cuba. Criterios, política y procedimientos para la admisión y permanencia de revistas científicas en la colección de SciELO Cuba [Internet]. Disponible en: http://scielo.sld.cu/criteria/SciELO_Cuba_NUEVOS_CRITERIOS_Es.html [ Links ]

    3. El Director. La UCB se consolida como la institución con mayor presencia en la red SciELO. Punto Cero. 2013;18(27):6-8. Disponible en: www.redalyc.org/pdf/4218/421839654001.pdf [ Links ]

    1. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: An updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166(22):2437-45. [ Links ]

    2. Capasso JM, Li P, Guideri G, Malhotra A, Cortese R, Anversa P. Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats. Circ Res. 1992;71(2):346-56. [ Links ]

    3. Schoppet M, Maisch B. Alcohol and the heart. Herz. 2001;26(5):345-52. [ Links ]

    4. Delbridge LM, Connell PJ, Harris PJ, Morgan TO. Ethanol effects on cardiomyocyte contractility. Clin Sci (Lond). 2000;98(4):401-7. [ Links ]

    5. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001;344(8):549-55. [ Links ]

    6. Fernández-Solá J, Nicolas JM, Oriola J, Sacanella E, Estruch R, Rubin E, et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med. 2002;137(5 Part 1):321-6. [ Links ]

    7. Djoussé L, Gaziano JM. Alcohol consumption and heart failure: A systematic review. Curr Atheroscler Rep. 2008;10(2):117-20. [ Links ]

    8. Iacovoni A, de Maria R, Gavazzi A. Alcoholic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2010;11(12):884-92. [ Links ]

    9. Klein AL, Burstow DJ, Tajik AJ, Zachariak PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 1994;69(3):212-24. [ Links ]

    10. Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011;31(4):534-40. [ Links ]

    11. Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, et al. Systolic and diastolic dysfunction in cirrhosis: A tissue-Doppler and speckle tracking echocardiography study. Liver Int. 2013;33(8):1158-65. [ Links ]

    12. Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int. 2014;8(4):588-94. [ Links ]

    13. Ruíz-del-Árbol L, Achécar L, Serradilla R, Rodríguez-Gandía MÁ, Rivero M, Garrido E, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology. 2013;58(5):1732-41. [ Links ]

    14. Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34(36):2804-11. [ Links ]

    15. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis. 2008;28(1):59-69. [ Links ]

    16. Henriksen JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52(10):1511-7. [ Links ]

    17. Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Gonçalves F, Bettencourt P. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int. 2010;30(7):1059-66. [ Links ]

    1. Valenzuela A, Morgado N. Breve historia de la relación entre el colesterol y las enfermedades cardiovasculares. Rev Chil Nutr. 2006;33(2):130-4. [ Links ]

    2. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25(10):567-79. [ Links ]

    3. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769-818. [ Links ]

    4. Ministerio de Salud Pública. Anuario Estadístico de Salud 2011. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2012. [ Links ]

    5. Llerena-Rojas LR, Peix-González A, Valiente-Mustelier J. Técnicas de imagen no invasivas en la valoración y la prevención de la enfermedad coronaria. Rev Esp Cardiol Supl. 2011;11(E):36-44. [ Links ]

    6. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55(15):1600-7. [ Links ]

    7. Lahoz C, Mostaza JM. La aterosclerosis como enfermedad sistémica. Rev Esp Cardiol. 2007;60(2):184-95. [ Links ]

    8. Velasco del Castillo S, Aguilar Torres R, Paré Bardera JC. Actualización en técnicas de imagen cardiaca: ecocardiografía, resonancia magnética en cardiología y tomografía computarizada con multidetectores. Rev Esp Cardiol. 2009;62(Supl1):129-50. [ Links ]

    9. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168(12):1333-9. [ Links ]

    10. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365(3):213-21. [ Links ]

    11. Chain S, Luciardi HL, Feldman G, Valberdi A. El espesor íntima-media carotídeo, un marcador de ateroesclerosis subclínica y riesgo cardiovascular. Importancia de su valoración y dificultades en su interpretación. Rev Fed Arg Cardiol. 2005;34(3):392-402. [ Links ]

    12. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: A new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20(2):159-69. [ Links ]

    13. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997;28(6):1189-94. [ Links ]

    14. Mack WJ, Selzer RH, Hodis HN, Erickson JK, Liu CR, Liu CH, et al. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke. 1993;24(12):1779-83. [ Links ]

    15. Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R, et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2000;18(2):197-201. [ Links ]

    16. Nafeh M, Hernández R, Carballo N, Villar A, Guevara L, Chaos N, et al. Resultados de la revascularización coronaria en el Cardiocentro del Hospital «Hermanos Ameijeiras», en un período de 20 años. Rev Cubana Cir [Internet]. 2011 [citado 15 Oct 2017];50(1):54-72. Disponible en: http://scielo.sld.cu/pdf/cir/v50n1/cir05111.pdf [ Links ]

    17. Iscan HZ, Kandemir O, Gol MK, Saritas A, Tasdemir O. Coronary reoperations without the use of cardiopulmonary bypass. Cardiovasc Surg. 2003;11(2):155-8. [ Links ]

    18. Gómez Doblas JJ, Jiménez Navarro M, Rodríguez Bailón I, Alonso Briales JH, Hernández García JM, Montiel Trujillo A, et al. Coronariografía preoperatoria en pacientes valvulares. Análisis de probabilidad de lesión coronaria. Rev Esp Cardiol. 1998;51(9):756-61. [ Links ]

    19. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440-92. [ Links ]

    20. Coskun U, Yildiz A, Esen OB, Baskurt M, Cakar MA, Kilickesmez KO, et al. Relationship between carotid intima-media thickness and coronary angiographic findings: A prospective study. Cardiovasc Ultrasound [Internet]. 2009 [citado 10 Oct 2017];7:59. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC2809045/ [ Links ]

    22. Torrents A, Esplugas E, Jara F, Mauri J. ¿Ha variado desde 1980 la indicación de coronariografía preoperatoria en pacientes valvulares? Estudio prospectivo de 300 nuevos casos consecutivos. Rev Esp Cardiol. 1988;41(10):586-9. [ Links ]

    23. Muñoz San José JC, de la Fuente Galán L, Garcimartin Cerrón I, de la Torre Carpenter M, Bermejo García J, Alonso Martín J, et al. Coronariografía preoperatoria en pacientes valvulares. Criterios de indicación en una determinada población. Rev Esp Cardiol. 1997;50(7):467-73. [ Links ]

    24. Fournier JA, Sánchez-González A, Cortacero JA, Martínez A. Estudio angiográfico prospectivo de la enfermedad arterial coronaria en pacientes con patología valvular crónica severa. Rev Esp Cardiol. 1988;41(8):462-6. [ Links ]

    25. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37(1):87-92. [ Links ]

    26. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient _ Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98(2A):2H-15H. [ Links ]

    27. García Fernández R, García Pérez-Velazco J, Concepción Milián A, Curbelo Cuevas MA, García Barreto D. Diagnóstico incruento de la aterosclerosis por ultrasonido. Estructura vascular grosor íntima-media de la pared arterial. Rev Cubana Med [Internet]. 2003 [citado 15 Oct 2017];42(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232003000300008 [ Links ]

    28. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11(1):21-7. [ Links ]

    1. León Regal ML, Benet Rodríguez M, Brito Pérez de Corcho Y, González Otero LH, de Armas García JO, Miranda Alvarado L. La hiperreactividad cardiovascular y su asociación con factores de riesgo cardiovasculares. Rev Finlay [Internet]. 2015 [citado 26 Sep 2017];5(4):228-41. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/377/1445 [ Links ]

    2. Ministerio de Salud Pública. Anuario Estadístico de Salud 2015. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2016. [ Links ]

    3. World Heart Federation. The Mexico Declaration: Improving circulatory health for all people [Internet]. WHF [citado 15 Oct 2017]. Disponible en: https://www.world-heart-federation.org/wp-content/uploads/2017/07/The -Mexico-Declaration-Circulatory-Health-for-All-People.pdf [ Links ]

    4. Llapur Milián R, González Sánchez R. La enfermedad cardiovascular aterosclerótica desde la niñez a la adultez. Rev Cubana Pediatr [Internet]. 2017 [Citado 10 Oct 2017];89(3):271-7. Disponible en: http://scielo.sld.cu/pdf/ped/v89n3/ped01317.pdf [ Links ]

    5. González Sánchez R, Llapur Milián R, Jiménez Hernández JM, Llapur González A, Fernández Morales D. Percepción de riesgo de hipertensión arterial infantil en familiares de niños y adolescentes. Rev Cubana Pediatr [Internet]. 2011 [citado 10 Oct 2017];83(1):65-73. Disponible en: http://scielo.sld.cu/pdf/ped/v83n1/ped07111.pdf [ Links ]

    6. Beck CC, Lopes AS, Pitanga FJ. Anthropometric indexes of overweight and obesity as predictors of lipid changes in adolescents. Rev Paul Pediatr. 2011;29(1):46-53. [ Links ]

    7. Ferrer Arrocha M, Fernández-Britto Rodríguez JE, Piñeiro Lamas R, Carballo Martínez R, Sevilla Martínez D. Obesidad e hipertensión arterial: señales ateroscleróticas tempranas en los escolares. Rev Cubana Pediatr [Internet]. 2010 [citado 10 Oct 2017];82(4):20-30. Disponible en: http://scielo.sld.cu/pdf/ped/v82n4/ped03410.pdf [ Links ]

    8. Naranjo Domínguez AA, Padrón González AA, Arman Alessandini GE, Aroche Aportela R, Cabinda A. Señales aterogénicas tempranas en un área de salud del municipio Consolación del Sur. CorSalud [Internet]. 2014 [citado 22 Sep 2017];6(4):314-20. Disponible en: http://www.revcorsalud.sld.cu/index.php /cors/article/view/119/289 [ Links ]

    9. Esquivel Lauzurique M, Rubén Quesada M, González Fernández C, Rodríguez Chávez L, Tamayo Pérez V. Curvas de crecimiento de la circunferencia de la cintura en niños y adolescentes habaneros. Rev Cubana Pediatr [Internet]. 2011 [citado 30 Sep 2017];83(1):44-55. Disponible en: http://scielo.sld.cu/pdf/ped/v83n1/ped05111.pdf [ Links ]

    10. McDowell MA, Fryar CD, Hirsch R, Ogden CL. Anthropometric reference data for children and adults: U.S. population, 1999-2002. Adv Data. 2005;(361):1-5. [ Links ]

    11. Castro Pacheco BL, Machado Lubián MC, Ibargollen Negrín L, Santacruz Domínguez M, Ruíz Tellechea Y, Razón Behar R, et al. Manual de procedimientos para la atención de grupos priorizados (niños/as y adolescentes) dirigido a Médicos de la Familia. La Habana: Ministerio de Salud Pública; 2011. [ Links ]

    12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. [ Links ]

    13. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. [ Links ]

    14. O'Donnell CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol. 2008;61(3):299-310. [ Links ]

    15. Song SH. Early-onset type 2 diabetes: High lifetime risk for cardiovascular disease. Lancet Diabetes Endocrinol. 2016;4(2):87-8. [ Links ]

    16. Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: A cross-sectional study. Lancet Diabetes Endocrinol. 2016;4(2):115-24. [ Links ]

    17. Rodríguez Domínguez L, Fernández-Britto Rodríguez JE, Díaz Sánchez ME, Ruiz Álvarez V, Hernández Hernández H, Herrera Gómez V, et al. Sobrepeso y dislipidemias en adolescentes. Rev Cubana Pediatr [Internet]. 2014 [citado 5 Oct 2017];86(4):433-44. Disponible en: http://scielo.sld.cu/pdf/ped/v86n4/ped04414.pdf [ Links ]

    18. Pérez Torre M, Cuartas S. Diabetes tipo 2 y síndrome metabólico, utilidad del índice triglicéridos/HDL colesterol en Pediatría. Rev Cubana Pediatr [Internet]. 2016 [citado 22 Sep 2017];88(3):335-47. Disponible en: http://scielo.sld.cu/pdf/ped/v88n3/ped0703316.pdf [ Links ]

    19. Irecta Najera CA, Álvarez Gordillo GC. Mecanismos moleculares de la obesidad y el rol de las adipocinas en las enfermedades metabólicas. Rev Cubana Invest Bioméd [Internet]. 2016 [citado 22 Sep 2017];35(2):174-83. Disponible en: http://scielo.sld.cu/pdf/ibi/v35n2/ibi06216.pdf [ Links ]

    20. Vicente Sánchez B. Obesidad infantil, resistencia a la insulina y síndrome metabólico. Rev Finlay [Internet]. 2016 [citado 28 Sep 2017];6(3):191-2. Disponible en: http://scielo.sld.cu/pdf/rf/v6n3/rf01306.pdf [ Links ]

    21. Centro de Investigación Biomédica en Red - Fisiopatología de la Obesidad y Nutrición. La guía de consenso europea sobre hipertensión en niños y adolescentes recomienda el control de la presión arterial a partir de los tres años. CIBEROBN [Internet]. 2016 [citado 28 Sep 2017]. Disponible en: http://www.ciberobn.es/noticias/la-guia-de-consenso-europea-sobre-hipertension-en-ninos-y-adolescentes-recomienda-el-control -delapresion-arterial-a-partir-de-los-tres-anos [ Links ]

    22. Ramiro-González MD, Sanz-Barbero B, Royo-Bordonada MA. Exceso de peso infantil en España 2006-2012. Determinantes y error de percepción parental. Rev Esp Cardiol. 2017;70(8):656-63. [ Links ]

    23. Fariñas Rodríguez L, Vázquez Sánchez V, Fuentes-Smith LE, Martínez Fuentes A. Índice de conicidad en una muestra de niños cubanos, herramienta para estudios poblacionales. Rev Cubana Genet Comunit. 2012;6(2):31-7. [ Links ]

    24. Miguel Soca PE, Peña González M. Síndrome metabólico, hipertensión arterial y adiposidad. MEDISAN [Internet]. 2017 [citado 30 Sep 2017];21(2):138-40. Disponible en: http://scielo.sld.cu/pdf/san/v21n2/san01212.pdf [ Links ]

    25. Corella del Toro I, Miguel-Soca PE, Aguilera Fuentes PL, Suárez Peña E. Factores de riesgo asociados al síndrome metabólico en niños y adolescentes con obesidad. Rev Cubana Pediatr [Internet]. 2016 [citado 30 Sep 2017];88(1):8-20. Disponible en: http://scielo.sld.cu/pdf/ped/v88n1/ped03116.pdf [ Links ]

    26. Álvarez Estrabao OA, Leyva Leyva D, Bermúdez Suárez AR. La hipertensión arterial en niños y adolescentes. CCM [Internet]. 2010 [citado 30 Sep 2017];14(3). Disponible en: http://www.cocmed.sld.cu/no143/pdf/no143rev02.pdf [ Links ]

    27. Araujo Herrera O. Síndrome metabólico en la infancia, un enfoque para la atención primaria. Rev Cubana Pediatr [Internet]. 2015 [citado 11 Oct 2017];87(1):82-91. Disponible en: http://scielo.sld.cu/pdf/ped/v87n1/ped10115.pdf [ Links ]

    28. Díaz-Perera Fernández G, Alemañy Díaz-Perera C, Bacallao Gallestey J, Ramírez Ramírez H, Ferrer Arrocha M, Alemañy Pérez E. Factores contextuales de las señales ateroscleróticas tempranas en adolescentes. Rev Haban Cienc Méd [Internet]. 2015 [citado 11 Oct 2017];14(6):760-73. Disponible en: http://scielo.sld.cu/pdf/rhcm/v14n6/rhcm06615.pdf [ Links ]

    29. Hernández Gárciga FF, Pría Barros MC, Pérez Lemus F. Riesgo aterogénico en una población rural de La Habana a partir de algunos factores tradicionales. Tercer trimestre 2004. Rev Haban Cienc Méd [Internet]. 2007 [citado 15 Oct 2017];6(3). Disponible en: http://scieloprueba.sld.cu/pdf/rhcm/v6n3/rhcm08307.pdf [ Links ]

    30. Hernández Gárciga FF. Identificación de familias aterovulnerables en la atención primaria de salud. Rev Cub Salud Pública [Internet]. 2017 [citado 15 Oct 2017];43(4). Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/1010/935 [ Links ]

    1. Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: The concept of allergic angina. Br J Clin Pract. 1991;45(2):121-8. [ Links ]

    2. Kounis NG, Zavras GM. Allergic angina and allergic myocardial infarction. Circulation. 1996;94(7):1789. [ Links ]

    3. Pfister CW, Plice SG. Acute myocardial infarction during a prolonged allergic reaction to penicillin. Am Heart J. 1950;40(6):945-7. [ Links ]

    4. Pampín F, Rial Prado MJ, Vázquez Vigo R, González Guzmán LA. Síndrome coronario agudo por hipersensibilidad: Síndrome de Kounis. Galicia Clin. 2014;75(1):31-2. [ Links ]

    5. Kounis NG, Soufras GD. Coronary stent thrombosis: Beware of an allergic reaction and of Kounis syndrome. Indian Heart J.2014;66(2):153-5. [ Links ]

    6. Bastante T, Rivero F, Cuesta J, Benedicto A, Restrepo J, Alfonso F. Nonatherosclerotic causes of acute coronary syndrome: Recognition and management. Curr Cardiol Rep. 2014;16(11):543. [ Links ]

    7. Çeliker M, Tuncer M, Sekeralmaz A. A case with repeated recurrent acute coronary syndrome due to pseudoephedrine use: Kounis syndrome. Case Rep Med [Internet]. 2014 [citado 31 Oct 2017];2014:742905. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243469/pdf/CRIM2014-742905.pdf [ Links ]

    8. Biteker M. Current understanding of Kounis syndrome. Expert Rev Clin Immunol. 2010;6(5):777-88. [ Links ]

    9. Cha YS, Kim H, Bang MH, Kim OH, Kim HI, Cha K, et al. Evaluation of myocardial injury through serum troponin I and echocardiography in anaphylaxis. Am J Emerg Med.2016;34(2):140-4. [ Links ]

    10. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Event and Reports (RADAR) Project. J Am Coll Cardiol. 2006;47(1):175-81. [ Links ]

    11. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: A study over a 3-year period comprising 940.000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy. 2004;34(2):285-90. [ Links ]

    12. Latour-Pérez J, Cabello JB. Significado clínico del síndrome coronario agudo con elevación transitoria del segmento ST. Med Intensiva. 2011;35(5):267-9. [ Links ]

    13. Cevik C, Nugent K, Shome GP, Kounis NG. Treatment of Kounis syndrome. Int J Cardiol. 2010;143(3):223-6. [ Links ]

    14. Gómez Canosa MS, Castro Orjales MJ, Rodríguez Fariñas FJ, García Jiménez A, Gutiérrez Cortés JM. Tratamiento del síndrome de Kounis. Med Intensiva. 2011;35(8):519-20. [ Links ]

    15. Cardona Dahl V, Cabañes Higuero N, Fernández Rivas MM, Freijó Martín C, Guardia Martínez P, de la Hoz Caballer B, et al. Guía de actuación en anafilaxia. Med Clin (Barc). 2011;136(8):349-55. [ Links ]

    16. Doðan V, Mert GÖ, Biteker FS, Mert KU, Biteker M. Treatment of Kounis syndrome. Int J Cardiol. 2015;181:133-4. [ Links ]

    17. Domínguez Franco AJ, Gómez Doblas JJ, García Pinilla JM, Hernández García JM, Jiménez Navarro M, Alonso Briales JH, et al. Treatment of refractory vasoespastic angina with corticosteroids. A case report. Int J Cardiol. 2007;118(2):e51-3. [ Links ]

    18. Takagi S, Goto Y, Hirose E, Terashima M, Sakuragi S, Suzuki S, et al. Successful treatment of refractory vasospastic angina with corticosteroids: Coronary arterial hyperactivity caused by local inflammation? Circ J. 2004;68(1):17-22. [ Links ]

    19. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-80.e1-42. [ Links ]

    20. Villamil-Munévar PA, Sánchez-Solanilla LF. Síndrome de Kounis o angina alérgica. Rev Colomb Cardiol. 2017;24(4):382-7. [ Links ]

    21. Santos Monzón Y, Pérez González JA, Mata Cuevas A, Rivero Nóbrega Y, Roque Corzo JJ. Un caso de síndrome de Kounis en Sagua La Grande. CorSalud [Internet]. 2014 [citado 31 Oct 2017];6(2):201-4. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/170/391 [ Links ]

    22. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol. 2015;68(12):1125.e1-e64. [ Links ]

    23. Felices-Abad F, Latour-Pérez J, Fuset-Cabanes MP, Ruano-Marco M, Cuñat-de la Hoz J, del Nogal-Sáez F, et al. Indicadores de calidad en el síndrome coronario agudo para el análisis del proceso asistencial pre e intrahospitalario. Med Intensiva. 2010;34(6):397-417. [ Links ]

    24. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(22):2271-306. [ Links ]

    1. Peix González A. La cardiología nuclear en Cuba. Nucleus [Internet]. 2014 [Citado 10 Nov 2017];(56):21-6. Disponible en: http://scielo.sld.cu/pdf/nuc/n56/nuc035614.pdf [ Links ]

    2. Mendoza Rodríguez V. Valor de la tomografía de 64 cortes en el diagnóstico de la cardiopatía isquémica en Cuba. La Habana: Editorial Universitaria; 2012. [ Links ]

    3. Ministerio de Salud Pública. Anuario Estadístico de Salud 2015. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2016. [ Links ]

    4. Ministerio de Salud Pública. Anuario Estadístico de Salud 2010. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2011. [ Links ]

    5. Ministerio de Salud Pública. Anuario Estadístico de Salud 2011. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2012. [ Links ]

    6. Ministerio de Salud Pública. Anuario Estadístico de Salud 2012. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2013. [ Links ]

    7. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2014. [ Links ]

    8. Ministerio de Salud Pública. Anuario Estadístico de Salud 2014. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2015. [ Links ]

    9. Peña Quián Y. Factores aterogénicos que justifican la tomografía sincronizada de perfusión miocárdica en diabéticos tipo 2 sin clínica cardiovascular. La Habana: Editorial Universitaria; 2011. [ Links ]

    10. Peix A, Batista E, Cabrera LO, Padrón K, Rodríguez L, Sainz B, et al. Gated-SPECT myocardial perfusion imaging for evaluation of patients with acute chest pain and a normal or non-diagnostic electrocardiogram. Eur Heart J Suppl. 2011;13(A):A8. [ Links ]

    11. Peix A, Cabrera LO, Heres F, Rodríguez L, Valdés A, Valiente J, et al. Interrelationship between myocardial perfusion imaging, coronary calcium score, and endothelial function in asymptomatic diabetics and controls. J Nucl Cardiol. 2011;18(3):398-406. [ Links ]

    12. Peix González A, García Barreto D. Direcciones actuales en la detección de viabilidad miocárdica en cardiología nuclear. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 1999 [citado 10 Nov 2017];13(1):53-60. Disponible en: http://bvs.sld.cu/revistas/car/vol13_1_99/car09199.pdf [ Links ]

    13. Álvarez-Gómez JA, Rivas-Estany E, Stusser Beltranena R, Hernández Cañero A, Barrera Sarduy D, Hernández González R, et al. Precondicionamiento isquémico inducido por el ejercicio en pacientes con enfermedad coronaria. Rev Cubana Med [Internet]. 2003 [citado 30 Sep 2017];42(1):52-7. Disponible en: http://scielo.sld.cu/pdf/med/v42n1/med07103.pdf [ Links ]

    14. Peix González A, López Díaz A, Ponce Vicente F, Maltas Pineda AM, García Fernández R, Barrera Sarduy JD, et al. Gammagrafía miocárdica con doble isótopo (201Tl en reposo/99mTc-tetrofosmin en esfuerzo) en la detección de hipoperfusión reversible. Rev Esp Med Nucl Imagen Mol. 2000;19(1):11-6. [ Links ]

    15. Peix A, Chacón D, Ponce F, López A, Cabrera O, Maltas AM, et al. Gammagrafía de perfusión miocárdica con Tecnecio 99m-MIBI para predecir al año, la evolución de mujeres referidas para evaluación de dolor precordial. Rev Cubana Med [Internet]. 2002 [citado 30 Sep 2017];41(4):220-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232002000400007 [ Links ]

    16. Ponce Vicente F, Peix González A, López Díaz A, Filgueiras Frías CE, Castillo Fundora M, García Barreto D, et al. Empleo del dipiridamol en la gammagrafía de miocardio con tetrofosmín-Tc99m en pacientes con bloqueo completo de rama izquierda. Resultados preliminares. Rev Cubana Med [Internet]. 2002 [citado 22 Sep 2017];41(5). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034 -75232002000500002 [ Links ]

    17. Peix AT, Chacón D, Llerena L, Torres MB, García EJ, Cabrera LO. Gammagrafía de perfusión miocárdica con tecnecio 99m-MIBI en el diagnóstico de la enfermedad coronaria en mujeres. Rev Cubana Med [Internet]. 2006 [citado 22 Sep 2017];45(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232006000200004 [ Links ]

    18. Peix A, García EJ, Valiente J, Tornés F, Cabrera LO, Cabalé B, et al. Ischemia in women with angina and normal coronary angiograms. Coron Artery Dis. 2007;18(5):361-6. [ Links ]

    19. Peña Quián Y, Fernández-Britto J, Bacallao Gallestey J, Batista Cuéllar JF, Coca Pérez MA, Toirac García N, et al. Diagnóstico de isquemia miocárdica silente en diabéticos tipo 2 mediante electrocardiograma, ergometría y Gated-SPECT. Rev Cuban Invest Bioméd [Internet]. 2008 [citado 22 Sep 2017];27(3-4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002008000300004 [ Links ]

    20. Peña Y, Coca MA, Batista JF, Fernández-Britto J, Quesada R, Peña A. Utilidad de la tomografía computarizada de emisión de fotón único sincronizada con el electrocardiograma para la detección de isquemia miocárdica silente en diabéticos tipo 2. Rev Méd Chile. 2009;137(8)1023-30. [ Links ]

    21. Peix A, González A, García EJ, Valiente J, Cabrera LO, Sixto S, et al. Left ventricular dysfunction secondary to ischemia in women with angina and normal coronary angiograms. J Womens Health (Larchmt). 2009;18(2):155-61. [ Links ]

    22. Ramírez Méndez M, Castañeda Casarvilla L, Aladro Miranda IF, Moreno-Martínez FL, Osorio Gómez CM, Hernández Ortega R, et al. Gammagrafía con 99tc-MIBI para determinar la efectividad de la heberquinasa en la reperfusión de la arteria relacionada con el infarto. CorSalud [Internet]. 2010 [citado 22 Sep 2017];2(4):273-8. Disponible en: http://bvs.sld.cu/revistas/cors/pdf/2010/v2n4a10/gammagrafia.pdf [ Links ]

    23. Valdés Martín A, Sixto Fernández S, Peix González A. Gammagrafía de perfusión miocárdica en mujeres postmenopáusicas con angina y coronarias epicárdicas angiográficamente normales. CorSalud [Internet]. 2011 [citado 30 Sep 2017];3(1):4-14. Disponible en: http://www.corsalud.sld.cu/sumario/2011/v3n1a11 /gammagrafia.htm [ Links ]

    24. Peña Y, Fernández-Britto JE, Bacallao J, Batista JF, de León ML. Lipid levels as predictors of silent myocardial ischemia in a type 2 diabetic population in Havana. MEDICC Rev. 2012;14(1):18-24. [ Links ]

    25. Cabrera Rodríguez LO, Peix A, Padrón KM, Carrillo R, Fernández Y, Mena E. Alteración de la perfusión, desplazamiento del ST y arritmias en paciente con espasmo coronario sin lesiones significativas. Alasbimn J [Internet]. 2012 [citado 5 Oct 2017]. Disponible en: http://www.alasbimnjournal.net/a/95 [ Links ]

    26. Peix González A. Aplicaciones clínicas de las técnicas nucleares en el estudio del sincronismo ventricular. CorSalud [Internet]. 2012 [citado 10 Oct 2017];4(3):191-200. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n3a12/tecnicas.html [ Links ]

    27. Rochela Vázquez LM, Peix González A, Batista Cuellar JF, Romero Collado S, Oviedo Pérez L, Fernández-Britto JE, et al. Asociación de los resultados positivos del SPECT de perfusión miocárdica con 99mTc-MIBI, con la presencia de dislipidemia en pacientes = 40 años de edad. Nucleus. 2012;51(8):32-6. [ Links ]

    28. Peix A, Batista E, Cabrera LO, Rodríguez L, Padrón K, Saínz B, et al. Gated-SPECT myocardial perfusion imaging and coronary calcium score for evaluation of patients with acute chest pain and a normal or nondiagnostic electrocardiogram. Coron Artery Dis. 2012;23(7):438-44. [ Links ]

    29. Cabrera-Rodríguez LO, Peix AT, Padrón KM, Chacón D, Carrillo R, Fernández Y, et al. Prognostic value of gated SPECT after reperfusion for acute myocardial infarction. MEDICC Rev. 2013;15(2):20-5. [ Links ]

    30. Rochela Vázquez LM, Peña Quián Y, Batista Cuéllar JF, Romero Collado S, Valladares Oviedo L, Peix González A, et al. Relación entre la gammagrafía de perfusión miocárdica y el sobrepeso u obesidad, en pacientes mayores de 40 años de edad. Rev Electrón. PortalesMédicos.com [Internet]. 2014 [citado 6 Oct 2017];9(7):280. Disponible en: http://www.revista-portalesmedicos.com/revista-medica/gammagrafia-de -perfusion-miocardica-sobrepeso-obesidad/2/ [ Links ]

    31. Peix A, Karell J, Rodríguez L, Cabrera LO, Padrón K, Carrillo R, et al. Gated SPECT myocardial perfusion imaging, intraventricular synchronism, and cardiac events in heart failure. Clin Nucl Med. 2014;39(6):498-504. [ Links ]

    32. Peix A, Mesquita CT, Paez D, Pereira CC, Felix R, Gutierrez C, et al. Nuclear medicine in the management of patients with heart failure: Guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun. 2014;35(8):818-23. [ Links ]

    33. Peix González A. Experiencia del Instituto de Cardiología en la evaluación del paciente con dolor torácico agudo mediante técnicas de Cardiología Nuclear. CorSalud [Internet]. 2015 [citado 10 Oct 2017];7(1):52-9. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/4/4 [ Links ]

    34. Peix A, Macides Y, Rodríguez L, Cabrera LO, Padrón K, Heres F, et al. Stress-rest myocardial perfusion scintigraphy and adverse cardiac events in heart failure patients. MEDICC Review. 2015;17(2):33-8. [ Links ]

    35. Padrón García KM, Peix González AT, Cabrera Rodríguez LO, Reyes N, Rodríguez-Nande L, López Ferrero L, et al. Gammagrafía de perfusión miocárdica versus otras técnicas en el diagnóstico de enfermedad arterial coronaria. Rev Cuban Cardiol [Internet]. 2016 [citado 10 Oct 2017];22(1):25-34. Disponible en: http://www.medigraphic.com/pdfs/cubcar/ccc-2016/ccc161e.pdf [ Links ]

    1. Stoupel E. Space weather and timing of cardiovascular events: Clinical cosmobiology. Saarbrucken (Alemania): Lambert Academic Publishing; 2012. [ Links ]

    2. Babayev ES, Crosby NB, Obridko VN, Rycroft MJ. Potential effects of solar and geomagnetic variabilityon terrestrial biological systems. En: Maris G, Demetrescu C. Advances in solar and solar-terrestrial physics. Kerala (India): Research Signpost; 2012. p. 329-76. [ Links ]

    3. Stoupel EG, Petrauskiene J, Kalediene R, Sauliune S, Abramson E, Shochat T. Space weather and human deaths distribution: 25 years' observation (Lithuania, 1989-2013). J Basic Clin Physiol Pharmacol. 2015;26(5):433-41. [ Links ]

    4. Hoyt DV, Schatten KH. The role of the sun in climate change. New York: Oxford University Press; 1997. [ Links ]

    5. Otsuka K, Cornelissen G, Halberg F. Chronoastrobiology. En: Chronomics and Continuous Ambulatory Blood Pressure Monitoring [Internet]. Tokyo: Springer Japan; 2016 [cited 15 Sep 2017]. p. 359-403. Disponible en: http://link.springer.com/10.1007/978-4-431-54631-3_13 [ Links ]

    6. Shaposhnikov D, Revich B, Gurfinkel Y, Naumova E. The influence of meteorological and geomagnetic factors on acute myocardial infarction and brain stroke in Moscow, Russia. Int J Biometeorol. 2014;58(5):799-808. [ Links ]

    7. Ministerio de Salud Pública.Anuario Estadístico de Salud 2015. La Habana: Dirección de Registros Médicos y Estadísticas en Salud; 2016. [ Links ]

    8. Rivero A, Bolufé J, Ortiz PL, Rodríguez Y, Reyes MC. Influence of climate variability on acute myocardial infarction mortality in Havana, 2001-2012. MEDICC Rev. 2015;17(2):14-9. [ Links ]

    9. Rivero VA. Clima y mortalidad por infarto agudo de miocardio en Cuba 2000-2005 [Tesis]. La Habana: Universidad de La Habana; 2008. [ Links ]

    10. Rodríguez Taboada RE, Sierra Figueredo P, Sierra Figueredo S. Geomagnetic activity related to acute myocardial infarctions: Relationship in a reduced population and time interval. Geofis Int. 2004;43(2):265-9. [ Links ]

    11. Montero Vega V, Montero Campello MJ, Sierra Figueredo P, Sierra Figueredo S, Frómeta Jiménez de Castro E. Mortalidad por infarto agudo de miocardio y su relación con las tormentas solares y geomagnéticas en la provincia Guantánamo. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2014 [citado22 Sep2017];20(2):78-83. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/516/628 [ Links ]

    12. Oficina Nacional de Estadística e Información. Villa Clara [Internet]. Oficina Nacional de Estadísticas [citado19 Sep2017]. Disponible en: http://www.onei.cu/publicaciones/provincias_masinf/villa%20clara.htm [ Links ]

    13. National Centers for Environmental Information. Solar Indices Bulletin (monthly) [Internet]. National Geophysical Data Center, USA [citado 19 Sep 2017]. Disponible en: https://www.ngdc.noaa.gov/metaview/page?xml=NOAA/NESDIS/NGDC/STP/Solar/iso/xml/solar-indices -bulletin.xml&view=getDataView&header=none [ Links ]

    14. National Centers for Environmental Information. Geomagnetic Indices Bulletin (monthly) [Internet]. National Geophysical Data Center, USA [citado 19 Sep 2017]. Disponible en: https://www.ngdc.noaa.gov/stp/geomag/geoib.html [ Links ]

    15. Sodankyla Geophysical Observatory. Neutron Monitoring Data (daily, monthly, yearly) [Internet]. Finland: Oulu University [citado22 Sep 2017]. Disponible en: http://tvcomm.co.uk/g7izu/homepage/south-pole -neutron-monitor/ [ Links ]

    16. Stoupel E, Tamoshiunas A, Radishauskas R, Bernotiene G, Abramson E, Sulkes J, et al. Acute myocardial infarction (AMI) and intermediate coronary syndrome (ICS). Health. 2010;2(2):131-6. [ Links ]

    17. Stoupel E, Kalediene R, Petrauskiene J, Starkuviene S, Abramson E, Israelevich P, et al. Clinical cosmobiology: distribution of deaths during 180 months and cosmophysical activity. The Lithuanian study, 1990-2004. The role of cosmic rays. Medicina (Kaunas). 2007;43(10):824-31. [ Links ]

    18. Stoupel E, Kalediene R, Petrauskiene J, Starkuviene S, Abramson E, Israelevich P, et al. Twenty years study of solar, geomagnetic, cosmic ray activity links with monthly deaths number (n-850304). J Biomed Sci Eng. 2011;4(6):426-34. [ Links ]

    19. Stoupel E, Kalediene R, Petrauskiene J, Domarkiene S, Radishauskas R, Abramson E, et al. Threekinds of cosmophysical activity: links to temporal distribution of deaths and occurrence of acute myocardial infarction. Med Sci Monit. 2004;10(2):CR80-84. [ Links ]

    20. Stoupel E, Kalediene R, Petrauskiene J, Starkuviene S, Abramson E, Israelevich P, et al. Monthly deaths number and concomitant environmental physical activity: 192 months observation (1990-2005). Sun Geosph. 2007;2(2):78-83. [ Links ]

    21. Stoupel E, Hod M, Shimshoni M, Friedman S, Ovadia J. Pregnancy induced hypertension in months with different cosmic activity. Clin Exper Obst Gynec. 1990;17:7-12. [ Links ]

    22. Stoupel E, Keret R, Assa S, Kaufman H, Shimshoni M, Laron Z. Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuro Endocrinol Lett. 1983;5:365-8. [ Links ]

    23. Stoupel E, Tamoshiunas A, Radishauskas R, Bernotiene G, Abramson E, Israelevich P. Acute myocardial infarction (AMI) (n-11026) on days of zero geomagnetic activity (GMA) and the following week: differences at months of maximal and minimal solar activity (SA) in solar cycles 23 and 24. J Basic Clin Physiol Pharmacol. 2012;23(1):5-9. [ Links ]

    24. Stoupel E. Considering space weather forces interaction on human health: The equilibrium paradigm in clinical cosmobiology _ Is it equal? J Basic Clin Physiol Pharmacol. 2015;26(2):147-51. [ Links ]

    25. Ebrille E, Konecny T, Konecny D, Spacek R, Jones P, Ambroz P, et al. Correlation of geomagnetic activity with implantable cardioverter defibrillator shocks and antitachycardia pacing. Mayo Clin Proc. 2015;90(2):202-8. [ Links ]

    26. Stoupel E, Kusniec J, Golovchiner G, Abramson E, Kadmon U, Strasberg B. Association of time of occurrence of electrical heart storms with environmental physical activity. Pacing Clin Electrophysiol. 2014;37(8):1067-70. [ Links ]

    1. Ministerio de Salud Pública. Anuario Estadístico de Salud 2015. La Habana: Dirección de Registros Médicos y Estadísticas en Salud; 2016. [ Links ]

    2. Perdomo García FJ, Martínez Muñiz JO, Torralbas Reverón FE, Machín Rodríguez JC, Ávalos Carrazana G. Cirugía coronaria sin circulación extracorpórea en el Cardiocentro de Santiago de Cuba durante el trienio 2007-2009. MEDISAN [Internet]. 2011 [citado 15 Oct 2017];15(12):1705-13. Disponible en: http://scielo.sld.cu/pdf/san/v15n12/san041211.pdf [ Links ]

    3. González Jiménez JN. Cirugía cardiovascular y trasplantología. Apuntes históricos. La Habana: Editorial Ciencias Médicas; 2012. p. 2-30. [ Links ]

    4. Carvajal-Veitía W, Deturnell-Campos Y, Echevarría-García I, Martínez-Acosta M, Castillo-Rodríguez ME. Protocolo de valoración de la composición corporal para el control cineantropométrico del entrenamiento deportivo. Documento de consenso del Departamento de Cineantropometría del Instituto de Medicina del Deporte de Cuba. Rev Cubana Med Dep Cult Fís [Internet]. 2011 [citado 15 Oct 2017];5(3). Disponible en: https://es.scribd.com/document/106156571/Protocolo-de-valoracion-de-la-composicion-corporal [ Links ]

    5. Alvero-Cruz JR, Correas Gómez L, Ronconi M, Fernández Vázquez R, Porta i Manzañido J. La bioimpedancia eléctrica como método de estimación de la composición corporal, normas prácticas de utilización. Rev Andal Med Deporte. 2011;4(4):167-74. [ Links ]

    6. López Calbet JA, Dorado García C, Chavarren Cabrero J. Evaluación de la composición corporal mediante absorciometría fotónica dual de rayos X: Aplicaciones y limitaciones en el ámbito del deporte. En: Aguado Garnelo JL, Ed. Métodos de estudio de composición corporal en deportistas. Madrid: Ministerio de Educación, Cultura y Deporte; 2003. p. 55-79. [ Links ]

    7. Ellis KJ, Bell SJ, Chertow GM, Chumlea WC, Knox TA, Kotler DP, et al. Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference. Nutrition. 1999;15(11-12):874-80. [ Links ]

    8. Núñez Bourón AI, Lara Lafargue A, Morales Larramendi R. Determinación de agua y electrolitos por el método de bioimpedancia eléctrica en una población de referencia. Santiago de Cuba: CNEA; 2007. [ Links ]

    9. Centro de Cibernética aplicada a la Medicina (CECAM). Informática Médica. T2. La Habana: Editorial Ciencias Médicas; 2004. p. 629. [ Links ]

    10. De Sequera Ortíz P, Alcazar Arroyo R, Albalate Ramon M. Trastornos del potasio [Internet]. En: Lorenzo V, López Gómez JM, Eds. Nefrología al Día. Madrid: Sociedad Española de Nefrología; 2015 [citado 10 Oct 2017]. Disponible en: http://revistanefrologia.com/es-monografias-nefrologia-dia-pdf-monografia-20 [ Links ]

    11. Pascual Figal DA. Cardiología clínica. En Gómez Hospital JA, Ed. Libro-Guía del residente de Cardiología. Madrid: Acción Médica; 2007. p. 11-17. [ Links ]

    12. Mesa Díaz ME, Rizo Rodríguez R, Núñez Bourón AI, Pupo Leyte AB. Modificaciones del agua extracelular en cardiópatas isquémicos susceptibles a cirugía correctora sin circulación extracorpórea. Rev Electron Portales Méd [Internet]. 2013 [citado 15 Oct 2017];8(14):582. Disponible en: https://www.revista-portalesmedicos.com/revista-medica/agua-extracelular-cardiopatas-circulacion-extracorporea/ [ Links ]

    13. Aldama Pérez LI, Cuba Rodríguez AL, Ravelo Llanes K, Pedroso Morales I, Padrón Pazo R, Rocha Quintana M. Rehabilitación cardiovascular en pacientes con insuficiencia cardíaca crónica de etiología isquémica. Rev Cubana Invest Bioméd [Internet]. 2012 [citado 15 Oct 2017];31(4):437-46. Disponible en: http://scielo.sld.cu/pdf/ibi/v31n4/ibi04412.pdf [ Links ]

    14. Albert Cabrera MJ, Montano Luna JA, Prieto Díaz VI, Céspedes Lantigua LA. Problemas más frecuentes del sistema cardiovascular. En: Álvarez Sintes R. Medicina General Integral. Vol 4. 3ra. ed. La Habana: Editorial Ciencias Médicas; 2014. p. 1113-7. [ Links ]

    15. Marín F, Díaz-Castro O, Ruiz-Nodar JM, García de la Villa B, Sionis A, López J, et al. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos. Rev Esp Cardiol. 2014;67(2):120-6. [ Links ]

    16. Zubia Olaskoaga F. Cuidados postoperatorios en cirugía torácica. En: Montejo JC, García de Lorenzo A, Marco P, Ortiz C. Manual de Medicina Intensiva. 4ta ed. Madrid: Elsevier; 2013. [ Links ]

    17. Quintana Setién C. Hipertensión arterial. En: Vicente Peña E, Rodríguez Porto AL, Sánchez Zulueta E, Quintana López L, Riverón González JM, Ledo Grogués D, et al. Diagnóstico y tratamiento en Medicina Interna. La Habana: Editorial Ciencias Médicas; 2012. p. 79-96. [ Links ]

    18. Fernández Reverón F. Alteraciones de los equilibrios hidromineral y ácido base. La Habana: Editorial Ciencias Médicas; 2015. p. 11,32-73. [ Links ]

    19. Pardo Gómez G, García Gutiérrez A. Temas de cirugía. T1. La Habana: Editorial Ciencias Médicas; 2011. p. 1-3. [ Links ]

    1. Jones DS. CABG at 50 (or 107?) - The complex course of therapeutic innovation. N Engl J Med. 2017;376(19):1809-11. [ Links ]

    2. Rocha EAV. Fifty years of coronary artery bypass graft surgery. Braz J Cardiovasc Surg. 2017;32(4):2-3. [ Links ]

    3. Tendolkar AG. Coronary artery bypass grafting, an on-off affair. Ind J Thorac Cardiovasc Surg. 2003;19(2):92-101. [ Links ]

    4. Konstantinov IE. The last word on "a proper name for the internal mammary artery?". Ann Thorac Surg. 1999;68(4):1440-1. [ Links ]

    5. Konstantinov IE. Robert H. Goetz: The surgeon who performed the first successful clinical coronary artery bypass operation. Ann Thorac Surg. 2000;69(6):1966-72. [ Links ]

    6. Konstantinov IE. Vasilii I Kolesov: A surgeon to remember. Tex Heart Inst J. 2004;31(4):349-58. [ Links ]

    7. Tomanek RJ. Historical perspectives. En: Tomanek RJ, ed. Coronary Vasculature: Development, Structure-Function, and Adaptations. New York: Springer; 2013. p. 83-100. [ Links ]

    8. Piciché M. The history of myocardial revascularization before the advent of cardiopulmonary bypass. En: Piciché M, ed. Dawn and Evolution of Cardiac Procedures: Research Avenues in Cardiac Surgery and Interventional Cardiology. Milan: Springer-Verlag; 2013. p. 65-77. [ Links ]

    9. Wilson JM. Coronary artery bypass surgery and percutaneous coronary revascularization: Impact on morbidity and mortality in patients with coronary artery disease. En: Willerson JT, Holmes DR, eds. Coronary Artery Disease. London: Springer-Verlag; 2015. p. 683-726. [ Links ]

    10. Siderys H, Grice PF, Shumacker HB, Riberi A. Occlusion of the great cardiac vein and coronary artery ligation. Surg Gynecol Obstet. 1956;102(1):18-26. [ Links ]

    11. Hardin R, Shumacker HB, Chien SS, Bounous G. Bilateral internal mammary artery ligation and coronary artery occlusion. Surg Gynecol Obstet. 1959;108(5):518-22. [ Links ]

    12. Briggs JD, Jordan PH, Longmire WP. Experience with resection of the pancreas in the treatment of chronic relapsing pancreatitis. Ann Surg. 1956;144(4):681-95. [ Links ]

    13. Fonkalsrud EW. About William P. Longmire Jr. [Internet]. Longmire Surgical Society. University of California, Los Angeles [citado 16 Oct 2017]. Disponible en: http://surgery.ucla.edu/about-william-p-longmire-jr [ Links ]

    14. Lowenstein E, Reves JG. A history of cardiac anesthesiology. En: Eger II EI, Saidman L, Westhorpe R, eds. The Wondrous Story of Anesthesia. New York: Springer; 2014. p. 829-46. [ Links ]

    15. Kato H, Kuriki A, Kamei Y, Torii S. Free intrathoracic jejunal transfer for thoracic oesophageal reconstruction: A case report. Br J Plast Surg. 1995;48(1):11-3. [ Links ]

    16. Hoksch B, Ablassmaier B, Zieren J, Müller JM. Quality of life after gastrectomy: Longmire's reconstruction alone compared with additional pouch reconstruction. World J Surg. 2002;26(3):335-41. [ Links ]

    17. Aston JS, Longmire WP. Management of the pancreas after pancreaticoduodenectomy. Ann Surg. 1974;179(3):322-7. [ Links ]

    18. Terasaki PI. Longmire Lecture: My 50 years at the University of California, Los Angeles. World J Surg. 2000;24(7):828-33. [ Links ]

    19. Stoney WS. Bill Longmire and the Blue Baby Operation. J Am Coll Surg. 2004;198(4):653-9. [ Links ]

    20. Gott VL. And it happened during our lifetime… Ann Thorac Surg. 1993;55(5):1057-64. [ Links ]

    21. Beal JM, Longmire WP, Leake WH. Resection of the auricular appendages. Ann Surg. 1950;132(3):517-30. [ Links ]

    22. Spencer FC, Muller WH, Longmire WP. Experimental pulmonic valvulotomy under direct vision by temporarily occluding the pulmonary artery. Ann Surg. 1952;135(1):34-8. [ Links ]

    23. Vineberg A, Miller G. Internal mammary coronary anastomosis in the surgical treatment of coronary artery insufficiency. CanMed Assoc J. 1951;64(3):204-10. [ Links ]

    24. Shrager JB. The Vineberg procedure: The immediate forerunner of coronary artery bypass grafting. Ann Thorac Surg. 1994;57(5):1354-64. [ Links ]

    25. Stavrou A, Gkiousias V, Kyprianou K, Dimitrakaki IA, Challoumas D, Dimitrakakis G. Coronary endarterectomy: The current state of knowledge. Atherosclerosis. 2016;249:88-98. [ Links ]

    26. Stephenson LW. History of Cardiac Surgery. En: Cohn L, editor. Cardiac Surgery in the Adult. New York: McGraw-Hill; 2008. p. 3-28. [ Links ]

    27. Longmire WP, Barker WF. Operations on the adrenal glands. Calif Med. 1952;77(2):121-6. [ Links ]

    28. Longmire WP, Beal JM. Construction of a substitute gastric reservoir following total gastrectomy. Ann Surg. 1952;135(5):637-45. [ Links ]

    29. Longmire WP, Ravitch MM. A new method for constructing an artificial esophagus. Ann Surg. 1946;123(5):819-34. [ Links ]

    30. Mulder DG, Kattus AA, Longmire WP. The treatment of acquired aortic stenosis by valvuloplasty. J Thorac Cardiovasc Surg. 1960;40:731-43. [ Links ]

    31. Millis JM, Tompkins RK, Zinner MJ, Longmire WP Jr, Roslyn JJ. Management of bile duct strictures. An evolving strategy. Arch Surg. 1992;127(9):1077-82. [ Links ]

    32. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, et al. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg. 2005;130(5):1391-8. [ Links ]

    33. Thomas JL. The Vineberg legacy. Internal mammary artery implantation from inception to obsolescence. Tex Heart Inst J. 1999;26(2):107-13. [ Links ]

    34. Nguyen HD, Vo TA, Nguyen TT, Pham TV, Vu TT. Minimally invasive direct coronary artery bypass: Preliminary results at University Medical Center of Ho Chi Minh city. Vietnam JSciech. 2017;59(4):47-50. [ Links ]

    35. Benetti F. The history of OPCAB. JSM Cardiothorac Surg [Internet]. 2017 [citado 22 Dic 2017];2(2):1013. Disponible en: https://www.jscimedcentral.com/CardiothoracicSurgery/cardiothoracicsurgery-2-1013.pdf [ Links ]

    1. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1983;250(13):1757-65. [ Links ]

    2. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am J Cardiol. 2010;106(3):342-7. [ Links ]

    3. Hurtado J, Pinar Bermúdez E, Redondo B, Lacunza Ruiz J, Gimeno Blanes JR, García de Lara J, et al. Intervencionismo percutáneo urgente sobre el tronco coronario izquierdo no protegido. Factores predictores de mortalidad y análisis del shock cardiogénico. Rev Esp Cardiol. 2009;62(10):1118-24. [ Links ]

    4. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563-70. [ Links ]

    5. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014. Rev Esp Cardiol. 2015;68(2):144.e1-e95. [ Links ]

    6. Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, et al. Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease. J Am Coll Cardiol. 2016;68(10):999-1009. [ Links ]

    7. Pappalardo A, Mamas M, Imola F, Ramazzotti V, Manzoli A, Prati F, et al. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2011;4(6):618-26. [ Links ]

    8. El-Menyar AA, Al Suwaidi J, Holmes DR. Left main coronary artery stenosis: State-of-the-art. Curr Probl Cardiol. 2007;32(3):103-93. [ Links ]

    9. Hsueh SK, Hsieh YK, Wu CJ, Fang CY, Youssef AA, Chen CJ, et al. Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenosis: Transradial versus transfemoral approach. Chang Gung Med J. 2008;31(2):190-200. [ Links ]

    10. Cheng HY, Wang KT, Lin WH, Tsai JP, Chen YT. Percutaneous coronary intervention for left main coronary artery disease _ A single hospital experience without on-site cardiac surgery. Acta Cardiol Sin. 2015;31(4):267-79. [ Links ]

    11. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-72. [ Links ]

    12. Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J. 2008;155(2):274-83. [ Links ]


     1. Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv. 2014;7(5):453-63. [ Links ]

    2. Suzuki H. Different definition of microvascular angina. Eur J Clin Invest. 2015;45(12):1360-6. [ Links ]

    3. Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res. 2011;90(1):9-17. [ Links ]

    4. Sucato V, Evola S, Quagliana A, Novo G, Andolina G, Assennato P, et al. Comparison of coronary artery flow impairment in diabetic and hypertensive patients with stable microvascular angina. Eur Rev Med Pharmacol Sci. 2014;18(23):3687-9. [ Links ]

    5. Vavas E, Hong SE, Henry S, Rosen SE, Mieres JH. Imaging tests, provocative tests, including exercise testing in women with suspected coronary artery disease. Curr Cardiovasc Risk Rep. 2012;6(5):469-78. [ Links ]

    6. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Buechel RR, Küest SM, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011;32(12):1465-71. [ Links ]

    7. Thomson LE, Wei J, Agarwal M, Haft-Baradaran A, Shufelt C, Mehta PK, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging [Internet]. 2015 [citado 14 Feb 2018];8(4):e002481. Disponible en: http://circimaging.ahajournals.org/content/8/4/e002481.long [ Links ]

    8. Dahmani R, Ben Said R, Arous Y, Mahfoudhi H, Chourabi C, Ghommidh M, et al. Contribution of cardiac magnetic resonance imaging in the diagnosis of acute coronary syndrome with normal coronary angiography. Tunis Med. 2016;94(6):167-172. [ Links ]

    9. Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation. 2014;129(17):1723-30. [ Links ]

    10. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734-44. [ Links ]

    11. Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, et al. Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography. J Am Coll Cardiol. 2015;66(17):1918-33. [ Links ]

    12. Luo C, Long M, Hu X, Huang Z, Hu C, Gao X, et al. Thermodilution-derived coronary microvascular resistance and flow reserve in patients with cardiac syndrome X. Circ Cardiovasc Interv. 2014;7(1):43-8. [ Links ]

    13. Sedlak T, Izadnegahdar M, Humphries KH, Bairey Merz CN. Sex-specific factors in microvascular angina. Can J Cardiol. 2014;30(7):747-55. [ Links ]

    14. Agrawal S, Mehta PK, Bairey Merz CN. Cardiac Syndrome X: Update 2014. Cardiol Clin. 2014;32(3):463-78. [ Links ]

    15. Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging. 2013;6(6):660-7. [ Links ]

    16. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012;33(22):2771-82. [ Links ]

    17. Peix A, González A, García EJ, Valiente J, Cabrera LO, Sixto S, et al. Left ventricular dysfunction secondary to ischemia in women with angina and normal coronary angiograms. J Womens Health (Larchmt). 2009;18(2):155-61. [ Links ]

    18. Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J. 2015;36(45):3134-46. [ Links ]

    1. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132(15):1435-86. [ Links ]

    2. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-76. [ Links ]

    3. Benito N, Pericas JM, Gurguí M, Mestres CA, Marco F, Moreno A, et al. Health care-associated infective endocarditis: a growing entity that can be prevented. Curr Infect Dis Rep. 2014;16(11):439. [ Links ]

    4. Kashef MA, Friderici J, Hernandez-Montfort J, Atreya AR, Lindenauer P, Lagu T. Quality of care of hospitalized infective endocarditis patients: Report from a tertiary medical center. J Hosp Med. 2017 Jun;12(6):414-20. [ Links ]

    5. Chen C, Huang CH, Chen YC. Timing of surgery for fungal infective endocarditis. Heart Surg Forum. 2017 Aug 24;20(4):E129-31. [ Links ]

    6. Zhou J. Nursing care of patients with acute right-sided endocarditis induced by intravenous drug abuse. Zhonghua Hu Li Za Zhi. 1997;32(5):270-1. [ Links ]

    7. Garcés-Guerrero SL, Rojas-Lule NG, Sierra Pacheco M. Intervenciones de enfermería especializada en la prevención de endocarditis infecciosa en niños con cardiopatía congénita. Enferm Univ. 2012;9(2):14-26. [ Links ]

    8. Reyes Martínez M. Proceso enfermero a una persona con endocarditis infecciosa, aplicando los conceptos teóricos de Virginia Henderson. Rev Mex Enferm Cardiol. 2012;20(1):21-9. [ Links ]

    9. de Souza AF, Rocha AL, Castro WH, Ferreira FM, Gelape CL, Travassos DV, et al. Dental care before cardiac valve surgery: Is it important to prevent infective endocarditis? Int J Cardiol Heart Vasc. 2016;12:57-62. [ Links ]

    1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337(22):1576-83. [ Links ]

    2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101(11):1297-302. [ Links ]

    3. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102(7):748-54. [ Links ]

    4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-37. [ Links ]

    5. Moss A, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-83. [ Links ]

    6. Alzueta J, Fernández-Lozano I. Registro Español de Desfibrilador Automático Implantable. XIII Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2016). Rev Esp Cardiol. 2017;70(11):960-70. [ Links ]

    7. Eucomed. Medical Technology Statistics for Cardiac Rhythm Management products, 2012-2016 [citado 6 Jul 2018]. Disponible en: http://www.medtecheurope.org [ Links ]

    8. Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JC, Filho SG, et al. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study. Ann Noninvasive Electrocardiol. 2005;10(4):420-8. [ Links ]

    9. Narbondo F, Pouso J, Varela G, Calleriza F, Do Mato G, Reyes W. Cardiodesfibriladores implantables. Diecinueve años de experiencia en un centro de nuestro país. Rev Urug Cardiol. 2013;28(2):141-50. [ Links ]

    10. Niemeijer MN, van den Berg ME, Leening MJ, Hofman A, Franco OH, Deckers JW, et al. Declining incidence of sudden cardiac death from 1990-2010 in a general middle-aged and elderly population: The Rotterdam Study. Heart Rhythm. 2015;12(1):123-9. [ Links ]

    11. Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58(12):1254-61. [ Links ]

    12. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the Implantable Cardioverter-Defibrillator Registry. J Am Coll Cardiol. 2010;56(14):1133-9. [ Links ]

    13. Alzueta-Rodriguez J, Fernández-Pastor J, Ruiz-Salas A. Indicaciones y utilización del desfibrilador automático implantable ¿está infrautilizada esta terapia en nuestro medio? Cardiocore. 2015;50(3):115-8. [ Links ]

    14. Arribas F, López-Gil M, Salguero R, Chimero J. Algunos aspectos relacionados con la implantación del desfibrilador automático implantable. Rev Esp Cardiol Supl. 2008;8(A):51-64. [ Links ]

    15. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-50. [ Links ]

    16. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death _ Executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27(17):2099-140. [ Links ]

    17. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1-62. [ Links ]

    1. Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol. 2010;106(3):374-7. [ Links ]

    2. Dorenkamp M, Zabel M, Sticherling C. Role of coronary angiography before radiofrequency ablation in patients presenting with paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol Ther. 2007;12(2):137-44. [ Links ]

    3. Almendral J, Castellanos E, Ortiz M. Taquicardias paroxísticas supraventriculares y síndromes de preexcitación. Rev Esp Cardiol 2012;65(5):456-69. [ Links ]

    4. Schueler M, Vafaie M, Becker R, Biener M, Thomas D, Mueller M, et al. Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia. Acute Card Care. 2012;14(4):131-7. [ Links ]

    5. Ben Yedder N, Roux JF, Paredes FA. Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011;27(1):105-9. [ Links ]

    1. Gaziano TA, Gaziano JM. Repercusión global de las enfermedades cardiovasculares. En: Bonow RO, Mann DL, Zipes DP, Libby P, Braunwald E, eds. Braunwald Tratado de Cardiología: Texto de Medicina Cardiovascular. 9na ed. Barcelona: Elsevier España, SL; 2012. p. 1-20. [ Links ]

    2. Doval HC, Tajer CD. Evidencias en Cardiología. 5ª ed. Buenos Aires: Editorial GEDIC; 2008. [ Links ]

    3. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics _ 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-171. [ Links ]

    4. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1-e157. [ Links ]

    5. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(18):e426-e579. [ Links ]

    6. Ministerio de Salud Pública. Anuario Estadístico de Salud 2012. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2013. [ Links ]

    7. Braunwald E. Unstable angina: An etiologic approach to management. Circulation. 1998;98(21):2219-22. [ Links ]

    8. Williams DO, Abbott JD, Kip KE; DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation. 2011;114(20):2154-62. [ Links ]

    9. Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 2005;366(9489):914-20. [ Links ]

    10. Aragam KG, Tamhane UU, Kline-Rogers E, Li J, Fox KA, Goodman SG, et al. Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One [Internet]. 2009 [citado 18 Abr 2017];4(11):e7947. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC2776353/pdf/pone.0007947.pdf [ Links ]

    11. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835-42. [ Links ]

    12. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502. [ Links ]

    13. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360(9335):743-51. [ Links ]

    14. Michalis LK, Stroumbis CS, Pappas K, Sourla E, Niokou D, Goudevenos JA, et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). Eur Heart J. 2000;21(23):1954-9. [ Links ]

    15. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290(12):1593-9. [ Links ]

    16. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics _ 2012 update: A report from the American Heart Association. Circulation. 2012;125(1):e2-220. [ Links ]

    17. Heras M. Cardiopatía isquémica en la mujer: Presentación clínica, pruebas diagnósticas y tratamiento de los síndromes coronarios agudos. Rev Esp Cardiol. 2006;59(4):371-81. [ Links ]

    18. Alfredsson J, Stenestrand U, Wallentin L, Swahn E. Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart. 2012;93(11):1357-62. [ Links ]

    19. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation. 2011;124(19):2145-54. [ Links ]

    20. Filgueiras Frías CE, Laria Menchaca S, Cruz Pantoja M, López Pérez JE, Torres Pérez JA, López Ferrero L, et al. La coronariografía diagnostica desde la perspectiva del sexo. Rev Cuban Cardiol [Internet]. 2011 [citado 15 Oct 2017];17(1):18-26. Disponible en: http://www.bvs.sld.cu/revistas/car/vol17_1_11/car04111.pdf [ Links ]

    21. Bendersky M. Asociaciones de drogas en hipertensión arterial. Rev Fed Arg Cardiol. 2010;39(1):16-21. [ Links ]

    22. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1 - Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765-74. [ Links ]

    23. Samet JM. Los riesgos del tabaquismo activo y pasivo. Salud Pública Méx. 2002;44(Supl. 1):144-60. [ Links ]

    24. Badimón L, Vilahur G, Padró T. Lipoproteínas, plaquetas y aterotrombosis. Rev Esp Cardiol. 2009;62(10):1161-78. [ Links ]

    25. Testamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263(2 Pt 2):H321-6. [ Links ]

    26. Inzucchi SE. Diagnosis of diabetes. N Engl J Med. 2012;367(6):542-50. [ Links ]

    27. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: A new factor of the metabolic syndrome. A population-based study. Diabetes Care. 1998;21(4):649-54. [ Links ]

    28. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334(6):374-81. [ Links ]

    29. Centers for Disease Control and Prevention. National Diabetes Fact Sheet [Internet], 2011 [citado 10 Oct 2017]. Disponible en: https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf [ Links ]

    30. Dotevall A, Hasdai D, Wallentin L, Battler A, Rosengren A. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS. Diabet Med. 2005;22(11):1542-50. [ Links ]

    31. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879-87. [ Links ]

    32. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-425. [ Links ]

    1. Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald. Tratado de Cardiología. 10ma Ed. Barcelona: Elsevier; 2016. [ Links ]

    2. Ferreira-González I. Epidemiología de la enfermedad coronaria. Rev Esp Cardiol. 2014;67(2):139-144. [ Links ]

    3. Marín F, Díaz-Castro O, Ruiz-Nodar JM, García de la Villa B, Sionis A, López J, et al. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos. Rev Esp Cardiol. 2014;67(2):120-6. [ Links ]

    4. Mele EF. Avances en la reperfusión del infarto agudo de miocardio. Realidad en Latinoamérica. Rev Esp Cardiol. 2010;63(Supl. 2):12-9. [ Links ]

    5. Ministerio de Salud Pública. Anuario Estadístico de Salud 2016. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2017. [ Links ]

    6. Dionisio GF, Gómez G, Maris Macín S, Geronazzo RJ, Kevorkian R, Ferreirós E, et al. Comparación de dos registros de síndrome coronario agudo en la Argentina: STRATEG-SIA y SCAR (1999-2011). Rev Argent Cardiol. 2015;83(4):300-4. [ Links ]

    7. Posnenkova OM, Kiselev AR, Popova YV, Gridnev VI, Prokhorov MD, Dovgalevsky PY, et al. Impact of patient-related and treatment-related factors on in-hospital mortality of patients with ST-elevation myocardial infarction: Data of Russian Acute Coronary Syndrome Registry. Cor Vasa [Internet]. 2014 [citado 20 Feb 2018];56(3):e217-27. Disponible en: http://dx.doi.org/10.1016/j.crvasa.2014.03.004 [ Links ]

    8. Negi PC, Merwaha R, Panday D, Chauhan V, Guleri R. Multicenter HP ACS Registry. Indian Heart J. 2016;68(2):118-27. [ Links ]

    9. Fox KA, Anderson FA, Dabbous OH, Steg PG, López-Sendón J, Van de Werf, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007;93(2):177-82. [ Links ]

    10. Fernández-Ortiz A, Jiménez-Candil J, Bodí V, Barrabés JA. Actualización en cardiopatía isquémica. Rev Esp Cardiol. 2012;65(Supl. 1):42-9. [ Links ]

    11. Steg G, James SK, Atar D, Badano LP, Blomstrom C, Borger MA, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol [Internet]. 2013 [citado 28 Feb 2018];66(1):53.e1-e46. Disponible en: http://www.revespcardiol.org/en/guia -practica-clinica-esc-el/articulo/90180910/ [ Links ]

    12. de Winter RJ. Estrategias de tratamiento y estratificación del riesgo en los síndromes coronarios agudos: ¿cómo identificar a los pacientes que se pueden beneficiar de un abordaje invasivo temprano? Rev Esp Cardiol. 2010; 63(8):888-9. [ Links ]

    13. Cordero Sandoval QM, Ramírez Gómez JI, Moreno-Martínez FL, González Alfonso O. Valor predictivo de algunos modelos de estratificación de riesgo en pacientes con infarto agudo de miocardio con elevación del ST. CorSalud [Internet]. 2013 [citado 27 Feb 2018];5(1):57-71. Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n1a13/estratificacion.html [ Links ]

    14. Andrés E, Cordero A, Magán P, Alegría E, León M, Luengo E, et al. Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio, un estudio de seguimiento de 8 años. Rev Esp Cardiol. 2012;65(5):414-20. [ Links ]

    15. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ [Internet]. 2006 [citado 20 Feb 2018];333(7578):1091. Disponible en: http://dx.doi.org/10.1136/bmj.38985.646481.55 [ Links ]

    16. Ruesga Zamora EA, Saturno Chiu G. Cardiología. 2da. Ed. Ciudad México: El Manual Moderno; 2011. [ Links ]

    17. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108(23):2851-6. [ Links ]

    18. Martínez A, Nazzal C, Fajuri A, Barra LE, Mayerson A, Cavada G, et al. Mortalidad post infarto del miocardio en Chile: Comparación de los registros de angioplastia primaria versus trombolisis. Rev Chil Cardiol. 2010;29(1):29-36. [ Links ]

    19. Fernández Pereira C, Descalzo A, Rodríguez A. Identifican los factores predictivos de morbilidad y mortalidad en pacientes con infarto agudo de miocardio incluidos en el registro argentino de angioplastia coronaria (RadAC). Rev Arg Cardioangiol Interven. 2012;3(1):28-36. [ Links ]

    20. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011;124(6):704-11. [ Links ]

    21. González-Rosas IA, Hernández-Santamaría I, Vázquez-Martínez de Velasco A, Pérez-Salgado H, López-Gómez LM, García-Aguilar BS, et al. Complicaciones mecánicas del infarto: rotura de pared libre ventricular. Presentación de un caso. Rev Mex Cardiol. 2014;25(1):36-42. [ Links ]

    1. González López-Varcárcel B, Cabeza Mora A, López Cabañas A, Díaz Berenguer JA, Álamo Santana F, Ortún Rubio V. Evolución de los estudios de utilización de medicamentos: del consumo a la calidad de la prescripción. Cuad Econ ICE. 2004;67:161-89. [ Links ]

    2. Chivite D, Franco J, Formiga F. Insuficiencia cardíaca crónica en el paciente anciano. Rev Esp Geriatr Gerontol. 2015;50(5):237-46. [ Links ]

    3. Romero CE. ¿Tantos estuvieron tan equivocados tanto tiempo? Rev Urug Cardiol. 2015;30(1):13-6. [ Links ]

    4. Ortega López IL, Espinosa Durán R, Ibáñez Alcaraz M, Pelegrín Gamboa AL. Problemas asociados al uso de digoxina en pacientes geriátricos. Rev Cuba Farm [Internet]. 2014 [citado 27 Dic 2017];48(1):73-88. Disponible en: http://scielo.sld.cu/pdf/far/v48n1/far09114.pdf [ Links ]

    5. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-31. [ Links ]

    6. Moreno Pérez LM, Rodríguez Camiño R, Peraza Martínez E, Peraza Martínez C. Efectos de los medicamentos cardiovasculares sobre el globo ocular. CorSalud [Internet]. 2013 [citado 27 Dic 2017];5(1):72-83. Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n1a13/globocular.html [ Links ]

    7. Salech F, Palma D, Garrido P. Epidemiología del uso de medicamentos en el adulto mayor. Rev Med Clin Condes. 2016;27(5):660-70. [ Links ]

    8. Lo Presti A, Aular Y, Fernández Y, Carrillo M, Arenas E. Interacciones farmacológicas potenciales en pacientes con enfermedad cardiovascular polimedicados. Salus. 2015;19(2):13-9. [ Links ]

    9. Di Somma S, Magrini L. Tratamiento farmacológico en la insuficiencia cardiaca aguda. Rev Esp Cardiol. 2015;68(8):706-13. [ Links ]

    10. Samper Muarrak H, Pérez Muarrak D, Baró Rojas M, Sánchez Condales E, Reyes Quintana Y. Efectos del uso del carvedilol en la miocardiopatía dilatada en edad pediátrica. MediCiego [Internet]. 2015 [citado 27 Dic 2017];21(2). Disponible en: http://www.revmediciego.sld.cu/index.php/mediciego/article/view/406/769 [ Links ]

    11. Montoya JA, Arango C, Gaviria A, Mejía A, Carvajal JD, Hurtado JS, et al. Interacciones potenciales de fármacos antihipertensivos en un año de estudio de pacientes con hipertensión arterial atendidos en hospitales de 11 municipios del Departamento de Risaralda, Colombia. Gac Méd Caracas. 2013;121(2):132-41. [ Links ]

    12. Calvo Barbado DM, Delgado Martínez I, Alfonso Orta I, Alonso Carbonell L, Alonso Galván P, Broche Villareal L, et al. Formulario Nacional de Medicamentos. La Habana: Editorial Ciencias Médicas; 2014. [ Links ]

    13. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239. [ Links ]

    14. Scheuermeyer FX, Grafstein E, Stenstrom R, Christenson J, Heslop C, Heilbron B, et al. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness. Acad Emerg Med. 2013;20(3):222-30. [ Links ]

    15. Ishikawa T. Pharmacological rate control therapy for atrial fibrillation. Nihon Rinsho. 2013;71(1):72-8. [ Links ]

    16. Bonino A, Zócalo Y, Varela G, Calleriza F, Do Mato G, Reyes Caorsi W. Terapia de resincronización cardíaca: experiencia a diez años y análisis de la evolución clínica de los pacientes en un centro de nuestro país. Rev Urug Cardiol. 2014;29(2):173-180. [ Links ]

    17. Whitbeck MG, Charnigo RJ, Khairy P, Ziada K, Bailey AL, Zegarra MM, et al. Increased mortality among patients taking digoxin _ Analysis from the AFFIRM study. Eur Heart J. 2013;34(20):1481-8. [ Links ]

    18. Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: Findings from the TREAT-AF study. J Am Coll Cardiol. 2014;64(7):660-8. [ Links ]

    19. Pastori D, Farcomeni A, Poli D, Antonucci E, Angelico F, Del Ben M, et al. Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. Intern Emerg Med. 2016;11(2):199-204. [ Links ]

    20. Joundi RA, Cipriano LE, Sposato LA, Saposnik G. Stroke Outcomes Research Working Group. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc Score of 1: Systematic review and meta-analysis. Stroke. 2016;47(5):1364-7. [ Links ]

    1. Bienert IRC, de Oliveira RC, de Andrade PB, Caramori CA. Bibliometric indexes, databases and impact factors in cardiology. Rev Bras Cir Cardiovasc. 2015;30(2):254-9. [ Links ]

    2. Moed HF. New developments in the use of citation analysis in research evaluation. Arch Immunol Ther Exp (Warsz). 2009;57(1):13-8. [ Links ]

    3. Dávila M, Guzmán R, Arroyo HM, Piñeres D, de la Rosa D, Caballero-Uribe CV. Bibliometría: conceptos y utilidades para el estudio médico y la formación profesional. Salud (Barranquilla). 2009;25(2):319-330. [ Links ]

    4. Araújo JA, Arencibia R. Informetría, bibliometría y cienciometría: aspectos teórico-prácticos. ACIMED. 2002;10(4):5-6. [ Links ]

    5. Rueda-Clausen Gómez CF, Villa-Roel Gutiérrez C, Rueda-Clausen Pinzón CE. Indicadores bibliométricos: Origen, aplicación, contradicción y nuevas propuestas. MedUNAB. 2005;8(1):29-36. [ Links ]

    6. Michán L, Muñoz-Velasco I. Cienciometría para ciencias médicas: Definiciones, aplicaciones y perspectivas. Inv Ed Med. 2013;2(6):100-6. [ Links ]

    7. Jiménez-Contreras E, de Moya-Anegón F, Delgado-López-Cózar E. The evolution of research activity in Spain. The impact of the National Commission for the Evaluation of Research Activity (CNEAI). Research Policy. 2003;32(1), 123-42. [ Links ]

    8. Owen JM. The scientific article in the age of digitization. Dordrecht: Spinger; 2010. [ Links ]

    9. Málaga Sabogal L. Indicadores bibliométricos en medicina de las instituciones peruanas (2009 - 2011) [Tesis]. Lima: Universidad Nacional Mayor de San Marcos [Internet]; 2014 [citado 20 Ene 2018]. Disponible en: http://cybertesis.unmsm.edu.pe/handle/cybertesis/3773 [ Links ]

    10. Castro-Rodríguez Y, Grados-Pomarino S. Productividad científica de revistas odontológicas peruanas. Evaluación de los últimos 10 años. Educ Med. 2017;18(3):174-8. [ Links ]

    11. CorSalud. Instrucciones a los autores y normas de publicación en CorSalud: actualización de 2016. CorSalud [Internet]. 2016 [citado 12 Feb 2018];8(3):203-8. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/144/339 [ Links ]

    12. Harzing AW. The Publish or Perish Book. HTML edition [Internet]. Melbourne: Tarma Software Research; 2013 [Consultado 14 Ene 2018]. Disponible en: https://harzing.com/popbook/toc.htm [ Links ]

    13. Valdés Balbín R, Fundora-Mirabal JA, Cárdenas-de Baños L, Bencomo-Díaz D, González-Losada C, Pacheco-Mendoza J, et al. Revista Habanera de Ciencias Médicas: una mirada desde la cienciometría. Rev Haban Cienc Méd [Internet]. 2017 [citado 20 Oct 2017];16(1). Disponible en: http://scieloprueba.sld.cu/pdf/rhcm/v16n1/rhcm06117.pdf [ Links ]

    14. Corrales-Reyes IE, Fornaris-Cedeno Y, Reyes-Pérez JJ. Análisis bibliométrico de la revista Investigación en Educación Médica. Período 2012-2016. Inv Ed Med. 2018;7(25):8-26. [ Links ]

    15. Peralta MJ, Frías M, Gregorio O. Criterios, clasificaciones y tendencias de los indicadores bibliométricos en la evaluación de la ciencia. Rev Cuba Inf Cienc Salud [Internet]. 2015 [citado 30 Mar 2017];26(3):290-309. Disponible en: http://scielo.sld.cu/pdf/ics/v26n3/rci09315.pdf [ Links ]

    16. van Eck NJ, Waltman L. VOSviewer Manual. Manual for VOSviewer version 1.6.6 [Internet]. Leiden: Leiden University [citado 13 Feb 2018]; 2017. Disponible en: http://www.vosviewer.com/documentation /Manual_VOSviewer_1.6.6.pdf [ Links ]

    17. Perianes-Rodriguez A, Waltman L, van Eck NJ. Constructing bibliometric networks: A comparison between full and fractional counting. J Informetr. 2016;10(4):1178-95. [ Links ]

    18. Dialnet [Internet]. Perfil CorSalud en Dialnet. Fundación Dialnet. Universidad de La Rioja [citado 13 Dic 2018] Disponible en: http://dialnet.unirioja.es/servlet/revista?codigo=15833 [ Links ]

    19. Imbiomed [Internet]. Perfil CorSalud en Imbiomed. Índice Mexicano de Revistas Biomédicas Latinoamericanas [citado 13 Dic 2018] Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php?method=showIndex&id_revista=267 [ Links ]

    20. Latindex [Internet]. Perfil del CorSalud en Latindex. Universidad Nacional Autónoma de México [citado 14 Dic 2018] Disponible en: http://www.latindex.unam.mx/latindex/ficha?folio=20131 [ Links ]

    21. DOAJ [Internet]. Perfil de CorSalud en DOAJ. Directory of Open Access Journals [citado 14 Dic 2018] Disponible en: http://doaj.org/search?source={%22query%22:{%22query_string%22:{%22query%22:%22CorSalud%22,%22default_operator%22:%22AND%22}}} [ Links ]

    22. EBSCO [Internet]. Perfil de CorSalud en EBSCO. EBSCO Industries [citado 15 Dic 2018] Disponible en: http://web.a.ebscohost.com/ehost/resultsadvanced?sid=a0fbb138-88e0-4a5e-8e95 -744e18f6f07b%40sessionmgr4002&vid=1&hid=4204&bquery=corsalud&bdata=JmRiPWx0aCZsYW5nPWVzJnR5cGU9MSZzaXRlPWVob3N0LWxpdmU%3d [ Links ]

    23. Moreno-Martínez FL. CorSalud, The New England Journal of Medicine y el Comité Internacional de Editores de Revistas Médicas. CorSalud [Internet]. 2016 [citado 17 Ene 2018];8(2):92-3. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/104/247 [ Links ]

    24. Torres-Salinas D, Jiménez-Contreras E. Introducción y estudio comparativo de los nuevos indicadores de citación sobre revistas científicas en Journal Citation Reports y Scopus. Prof Inf. 2010;19(2):201-7. [ Links ]

    25. Cañedo Andalia R, Cruz Font J. Tendencias, limitaciones y perspectivas en la evaluación de las publicaciones científicas y académicas mediante indicadores cienciométricos. En: Cañedo Andalia R, Rodríguez Labrada R, Fernández Valdés MM, Zayas Mujica R, Nodarse Rodríguez M, Sánchez Tarragó N, et al. Lecturas avanzadas para la alfabetización informacional en salud. Holguín: Centro Provincial de Información de Ciencias Médicas; 2011. [citado 17 Ene 2018]. Disponible en: http://www.hlg.sld.cu/sitios/CPICM/index.php?option=com_jdownloads&Itemid=87&view=viewcategory&catid=5 [ Links ]

    26. Silva Ayçaguer LC. El índice-H y Google académico: una simbiosis cienciométrica inclusiva. Rev Cub Inf Cienc Salud [Internet]. 2012 [citado 18 Feb 2018];23(2):308-22. Disponible en: http://acimed.sld.cu/index.php/acimed/article/view/384/252 [ Links ]

    27. Rolo Mantilla M, Ojeda Cabrera A, Collado Martínez R, Fuentes García S, Ferreiro García B, Martínez Vasallo H. La producción científica de la Revista Médica Electrónica durante los años 2012-2014. Rev Med Electrón [Internet]. 2015;37(4):313-22. [citado 17 Feb 2018]. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/1483/pdf_29 [ Links ]

    28. Miró O, Burrillo-Putze G, Tomás Vecina S, Pacheco A, Sánchez M. Estimación del impacto bibliométrico de EMERGENCIAS durante los últimos 10 años (1997-2006). Emergencias. 2007;19(4):187-94. [ Links ]

    29. Romero-Torres M, Acosta-Moreno LA, Tejada-Gómez MA. Ranking de revistas científicas en Latinoamérica mediante el índice h: estudio de caso Colombia. Rev Esp Doc Cient [Internet]. 2013 [citado 10 Feb 2018];36(1):e003. Disponible en: http://redc.revistas.csic.es/index.php/redc/article/view/773/861 [ Links ]

    30. Espino Hernández M, Baños Benítez A, Víctores ME, Valdés Roque Y. Análisis métrico de la producción científica de la revista "Panorama Cuba y Salud" en el período 2006-2011. Rev Cub Inf Cienc Salud [Internet]. 2013 [citado 30 Mar 2018];24(3):229-42. Disponible en: http://scielo.sld.cu/pdf/ics/v24n3/rci02313.pdf [ Links ]

    31. Corrales-Reyes IE, Acosta-Batista C, Reyes-Pérez JJ, Fornaris-Cedeño Y. Análisis bibliométrico de Medicc Review. Período 2010-2015. Educ Med [Internet]. 2017 [citado 31 Oct 2017]:[10 p.]. En Prensa. Disponible en: http://dx.doi.org/10.1016/j.edumed.2017.04.015 [ Links ]

    32. González Rodríguez R, Cardentey García J, Izquierdo Almora Y. Estudio bibliométrico de la Revista de Ciencias Médicas de Pinar del Río. 2013-2015. Rev Cienc Méd Pinar Río [Internet]. 2017 [citado 15 Feb 2018];21(1):79-86. Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/2762/pdf [ Links ]

    33. Restrepo Arango C, Urbizagástegui Alvarado R. La productividad de los autores en la ciencia de la información colombiana. Ci Inf. 2010;39(3):9-22. [ Links ]

    34. Morales Fernández T, Martínez Ramos AT, Rivas Corrías B, Diago Gómez A, Clavero Fleites L, Martínez Bernal S. Producción científica de la revista EDUMECENTRO y su visibilidad a través de Google Académico. Edumecentro [Internet]. 2017 [citado 19 Feb 2018];9(4):162-79. Disponible en: http://revedumecentro.sld.cu/index.php/edumc/article/view/1031/pdf_278 [ Links ]

    35. Alhuay-Quispe J, Pacheco-Mendoza J. Escaso uso de indicadores de productividad científica en estudios bibliométricos. Educ Med. 2018;19(2):128-30. [ Links ]

    36. Bridgewater B. Anuario 2012: Cirugía cardíaca en adultos. Las revistas de las Sociedades Nacionales presentan una selección de las investigaciones que han impulsado avances recientes en Cardiología Clínica. CorSalud [Internet]. 2013 [citado 20 Feb 2018];5(1):17-29. Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n1a13/almanac-cirugia.html [ Links ]

    37. Moreno-Martínez FL. Más preguntas que respuestas. Respuesta del Editor. CorSalud [Internet]. 2014 [citado 20 Feb 2018];6(4):362-4. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n4a14 /cartasv6n4.html#preguntas3 [ Links ]

    38. Ayala Picazo M. Estudio bibliométrico de la revista Anales Médicos (1955-2015). Parte 1, análisis de la producción científica. An Med (Mex). 2016;61(4):246-50. [ Links ]

    39. Arencibia-Arrebola DF, Betancourt-López V, González-Alfalla N, Puig-Fernández Y, Biart-La Rosa O, Fernández-Sanguinety DF, et al. Estudio bibliométrico de la producción científica de VacciMonitor (2000-2013). Vaccimonitor. 2014;23(2):41-8. [ Links ]

    40. Allen HG, Stanton TR, Di Pietro F, Moseley GL. Social media release increases dissemination of original articles in the clinical pain sciences. PLoS One [Internet]. 2013 [citado 20 Feb 2018];8(7):e68914. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714259/pdf/pone.0068914.pdf [ Links ]

    41. Alonso Arévalo J, Cordón-García JA, Maltrás Barba B. Altmetrics: medición de la influencia de los medios en el impacto social de la investigación. Cuad Doc Multimed [Internet]. 2016 [citado 8 Oct 2017];27(1):75-101. Disponible en: http://dx.doi.org/10.5209/rev_CDMU.2016.v27.n1.52870 [ Links ]

    42. López G, González O. Estudio bibliométrico de la Revista CorSalud. Biblios. 2013;52:16-26. [ Links ]

    1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137-46. [ Links ]

    2. Rodríguez-Artalejo F, Banegas Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57(2):163-70. [ Links ]

    3. Llorens P, Escoda R, Miró Ò, Herrero-Puente P, Martín-Sánchez FJ, Jacob J, et al. Características clínicas, terapéuticas y evolutivas de los pacientes con insuficiencia cardiaca aguda atendidos en servicios de urgencias españoles: Registro EAHFE (Epidemiology of Acute Heart Failure in Spanish Emergency Departments). Emergencias. 2015;27(1):11-22. [ Links ]

    4. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108(8):977-82. [ Links ]

    5. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847. [ Links ]

    6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239. [ Links ]

    7. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. [ Links ]

    8. Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014;2(2):97-112. [ Links ]

    9. Pérez-Díez C, Real-Campaña JM, Noya-Castro MC, Andrés-Paricio F, Abad-Sazatornil MR, Povar-Marco JB. Errores de medicación en un servicio de urgencias hospitalario: estudio de situación para mejorar la seguridad de los pacientes. Emergencias. 2017;29(6):412-5. [ Links ]

    10. De Andrés Lázaro AM. Acerca de los errores de medicación en los servicios de urgencias hospitalarios: pasos para la mejora en la seguridad del paciente. Emergencias. 2017;29(6):371-2. [ Links ]

    11. Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail. 2016;4(6):464-72. [ Links ]

    12. Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction - A report from the CHART-2 Study. Eur J Heart Fail. 2017;19(10):1258-69. [ Links ]

    13. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126(1):65-75. [ Links ]

    14. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50(8):768-77. [ Links ]

    15. Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J. 2014;168(5):721-30. [ Links ]

    16. Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, et al. Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: A Nationwide Cohort Study. Circ Heart Fail [Internet]. 2017 [citado 18 Abr 2018];10(6):e003875. Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.117.003875 [ Links ]

    17. Farmakis D, Simitsis P, Bistola V, Triposkiadis F, Ikonomidis I, Katsanos S, et al. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol. 2017;106(5):359-68. [ Links ]

    18. Gómez-Otero I, Ferrero-Gregori A, Varela Román A, Seijas Amigo J, Pascual-Figal DA, Delgado Jiménez J, et al. La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca. Rev Esp Cardiol. 2017;70(5):338-46. [ Links ]

    19. Guisado-Espartero ME, Salamanca-Bautista P, Aramburu-Bodas Ó, Conde-Martel A, Arias-Jiménez JL, Llàcer-Iborra P, et al. Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry. Int J Cardiol. 2018;255:124-8. [ Links ]

    20. Miró Ò, Javaloyes P, Gil V, Jacob J, Herrero-Puente P, Martín-Sánchez FJ, et al. Mortalidad tras un episodio de insuficiencia cardiaca aguda en una cohorte de pacientes con función ventricular intermedia: análisis global y en relación con el lugar de ingreso. Med Clin (Barc). 2018;151(6):223-30. [ Links ]

    21. Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39(1):26-35. [ Links ]

    22. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation. 2009;119(24):3070-7. [ Links ]

    23. Koh AS, Tay WT, Teng THK, Vedin O,Benson L, Dahlstrom U, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2017;19(12):1624-34. [ Links ]

    24. Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574-85. [ Links ]

    25. Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goetschalckx K, Pfister O, et al. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail. 2017;19(12):1586-96. [ Links ]

    26. Hamatani Y, Nagai T, Shiraishi Y, Kohsaka S, Nakai M, Nishimura K, et al. Long-term prognostic significance of plasma B-type natriuretic peptide level in patients with acute heart failure with reduced, mid-range, and preserved ejection fractions. Am J Cardiol. 2018;121(6):731-8. [ Links ]

    27. Miró Ò, Javaloyes P, Gil V, Martín-Sánchez FJ, Jacob J, Herrero P, et al. Comparative analysis of short term outcomes of patients with heart failure with mid-range ejection fraction after acute decompensation. Am J Cardiol. 2018 [En prensa]. DOI: https://doi.org/10.1016/j.amjcard.2018.09.021 [ Links ]

    28. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-87. [ Links ]

    29. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-25. [ Links ]

    30. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456-67. [ Links ]

    31. Gilbert RE, Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet. 2015;385(9982):2107-17. [ Links ]

    32. Sakata Y, Shiba N, Takahashi J, Miyata S, Nochioka K, Miura M, et al. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Eur Heart J. 2015;36(15):915-23. [ Links ]

    33. Faggiano P, D´Aloia A, Gualeni A, Gardini A, Giordano A. Mechanisms and immediate outcome of in-hospital cardiac arrest in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;87(5):655-7,A10-1. [ Links ]

    34. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-81. [ Links ]

    35. Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol. 2012;110(2):270-6. [ Links ]

    36. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338-45. [ Links ]

    37. Jacob J, Arranz M, Sancho Ramoneda M, López A, Navarro Sáez MC, Cousiño Chao JR, et al. Estudio de cohortes de pacientes tratados con ventilación no invasiva en servicios de urgencias prehospitalarios y hospitalarios de Cataluña: registro VNICat. Emergencias. 2017;29(1):33-8. [ Links ]

    38. Park JJ, Kim SH, Oh IY, Choi DJ, Park HA, Cho HJ, et al. The effect of door-to-diuretic time on clinical outcomes in patients with acute heart failure. JACC Heart Fail. 2018;6(4):286-94. [ Links ]

    39. Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(25):3042-51. [ Links ]

    40. Harjola P, Harjola VP. ¿Podemos hacer más por los pacientes con insuficiencia cardiaca aguda en la fase prehospitalaria? Emergencias. 2017;29(4):221-2. [ Links ]

    41. Miró O, Llorens P, Escalada X, Herrero P, Jacob J, Gil V, et al. Atención prehospitalaria a los pacientes con insuficiencia cardiaca aguda en España: estudio SEMICA. Emergencias. 2017;29(4):223-30. [ Links ]

    42. Aguirre Tejedo A, Miró O. Prevalencia de factores precipitantes de insuficiencia cardiaca aguda y su impacto pronóstico: una revisión sistemática. Emergencias. 2017;29(3):185-93. [ Links ]

    43. Llorens P. Necesidad de evaluar el riesgo de los pacientes con insuficiencia cardiaca aguda en los servicios de urgencias más allá del juicio clínico. Emergencias. 2018;30(2):75-6. [ Links ]

    44. García-Gutiérrez S, Quintana López JM, Antón-Ladislao A, Gallardo Rebollal MS, Rilo Miranda I, Morillas Bueno M, et al. Validación externa de la escala EAHFE-3D para la evaluación del pronóstico en insuficiencia cardiaca aguda. Emergencias. 2018;30(2):84-90. [ Links ]

    45. Rivero-Santana A, Del Pino-Sedeño T, Ramallo-Fariña Y, Vergara I, Serrano-Aguilar P. Valor de los instrumentos ISAR y TRST para predecir resultados adversos en población general geriátrica asistida en los servicios de urgencias: metanálisis. Emergencias. 2017;29(1):49-60. [ Links ]

    1. Bayliss CE, Beanlands DS, Baird RJ. The pacemaker-twiddler's syndrome: A new complication of implantable transvenous pacemakers. Can Med Assoc J. 1968;99(8):371-3. [ Links ]

    2. Veltri EP, Mower MM, Reid PR. Twiddler's syndrome: A new twist. Pacing Clin Electrophysiol. 1984;7(6 Pt 1):1004-9. [ Links ]

    3. Carnero-Varo A, Pérez-Paredes M, Ruiz-Ros JA, Giménez-Cervantes D, Martínez-Corbalán FR, Cubero-López T, et al. "Reel syndrome": A new form of Twiddler's syndrome? Circulation. 1999;100(8):e45-6. [ Links ]

    4. Munawar M, Munawar DL, Basalamah F, Pambudi J. Reel syndrome: A variant form of Twiddler's syndrome. J Arrhythmia. 2011;27(4):338-42. [ Links ]

    5. Konishi H, Tokano T, Nakazato Y, Komatsu S, Suwa S, Komatsu K, et al. Twiddler's syndrome detected by patient's complaint of implantable cardioverter-defibrillator rotation in the subcutaneous pocket. J Arrhythm. 2012;28(4):239-41. [ Links ]

    6. Patel MB, Pandya K, Shah AJ, Lojewski E, Castellani MD, Thakur R. Reel syndrome _ not a twiddler variant. J Interv Card Electrophysiol. 2008;23(3):243-6. [ Links ]

    7. Chemello D, Subramanian A, Cameron D. Twiddler syndrome with 180° rotation of an implantable cardioverter defibrillator generator resulting in malfunction of one of the shocking coils. Europace. 2009;11(10):1259. [ Links ]

    8. Ramírez P, Barrero R, González R, Frangini P, Vergara I. Síndrome de Twiddler: una causa infrecuente de disfunción de marcapaso definitivo. Rev Med Chile. 2011;139(7):917-9. [ Links ]

    9. Larrouse E, Rodríguez E, Moya A, Rodríguez O, Soler Soler J. Síndrome de Twiddler en un paciente portador de desfibrilador automático implantable: ¿una complicación evitable? Rev Esp Cardiol. 2001;54(12):1456-8. [ Links ]

    10. Ejima K, Shoda M, Manaka T, Hagiwara N. Reel syndrome. J Cardiovasc Electrophysiol. 2009;20(7):822. [ Links ]

    11. van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol. 2011;58(10):995-1000. [ Links ]

    12. Echeverri D, Barón AM, García JC, Ramírez JD. Síndrome de reel: una variante del síndrome de Twiddler. Rev Colomb Cardiol. 2015;22(3):153-5. [ Links ]

    1. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86. [ Links ]

    2. Tissières P, Gervaix A, Beghetti M, Jaeggi ET. Value and limitations of the von Reyn, Duke, and modified Duke criteria for the diagnosis of infective endocarditis in children. Pediatrics [Internet]. 2003 [citado 10 May 2018];112(6 Pt 1):e467-471. Disponible en: http://pediatrics.aappublications.org/content/pediatrics/112/6 /e467.full.pdf [ Links ]

    3. BinAbdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart. 2014;9(1):131-43. [ Links ]

    4. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325-44. [ Links ]

    5. Torres Gómez DA, Reales Agón MF, Roa Bernal JA, Alarcón J. Endocarditis bacteriana y embolismo pulmonar múltiple como complicación asociada en pacientes pediátricos. Rev Gastrohnup. 2015;17(3):S13-6. [ Links ]

    6. Ortiz-Bautista C, López J, García-Granja PE, Vilacosta I, Sevilla T, Sarriá C, et al. Endocarditis infecciosa derecha en portadores de dispositivos cardiacos: perfil clínico y pronóstico. Med Clin (Barc). 2017;149(11):477-482. [ Links ]

    7. Vallabhajosyula S, Varma MD, Vallabhajosyula S, Vallabhajosyula S. Right-sided infective endocarditis in an Indian Intensive Care Unit. J Glob Infect Dis. 2016;8(3):124-5. [ Links ]

    8. Otome O, Guy S, Tramontana A, Lane G, Karunajeewa H.A retrospective review: Significance of vegetation size in injection drug users with right-sided infective endocarditis. Heart Lung Circ. 2016;25(5):466-70. [ Links ]

    9. Di Filippo S. Prophylaxis of infective endocarditis in patients with congenital heart disease in the context of recent modified guidelines. Arch Cardiovasc Dis. 2012;105(8-9):454-60. [ Links ]

    10. Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-sided infective endocarditis and pulmonary infiltrates: An Update. Cardiol Rev. 2016;24(5):230-7. [ Links ]

    11. Marom D, Levy I, Gutwein O, Birk E, Ashkenazi S. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J. 2011;30(7):585-8. [ Links ]

    12. Johnson JA, Boyce TG, Cetta F, Steckelberg JM, Johnson JN. Infective endocarditis in the pediatric patient: A 60-year single-institution review. Mayo Clin Proc. 2012;87(7):629-35. [ Links ]

    13. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252-89. [ Links ]

    14. Bai AD, Steinberg M, Showler A, Burry L, Bhatia RS, Tomlinson GA, et al. Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: A meta-analysis. J Am Soc Echocardiogr. 2017;30(7):639-646.e8. [ Links ]

    15. Begezsán II, Bejan C, Ghibu L, Dorobãt CM, Roºu F.Infective endocarditis in non-HIV immunosuppressed patients. Rev Med Chir Soc Med Nat Iasi. 2012;116(3):687-91. [ Links ]

    16. Raza S, Hussain ST, Rajeswaran J, Ansari A, Trezzi M, Arafat A, et al. Value of surgery for infective endocarditis in dialysis patients. J Thorac Cardiovasc Surg. 2017;154(1):61-70.e6. [ Links ]

    17. Ajdakar S, Elbouderkaoui M, Rada N, Drais G, Bouskraoui M. Multiple pulmonary emboli complicating infective endocarditis in a child with congenital heart disease. Arch Pediatr. 2015;22(4):401-4. [ Links ]

    1. Antzelevitch C, Yan GX. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm. 2015;12(8):1852-66. [ Links ]

    2. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC).Eur Heart J. 2015;36(41):2793-2867. [ Links ]

    3. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15(10):1389-406. [ Links ]

    4. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105(11):1342-7. [ Links ]

    5. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108(25):3092-6. [ Links ]

    6. Naseef A, Behr ER, Batchvarov VN. Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndrome. J Saudi Heart Assoc. 2015;27(2):96-108. [ Links ]

    7. Adler A, Rosso R, Chorin E, Havakuk O, Antzelevitch C, Viskin S. Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm. 2016;13(1):299-310. [ Links ]

    8. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106(19):2514-9. [ Links ]

    9. Antzelevich C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: Report of the second consensus conference. Circulation. 2005;111(5):659-70. [ Links ]

    10. Pitzalis MV, Anaclerio M, Iacoviello M, Forleo C, Guida P, Troccoli R, et al. QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol. 2003;42(9):1632-7. [ Links ]

    11. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47(9):1828-34. [ Links ]

    12. Maury P, Sacher F, Gourraud JB, Pasquié JL, Raczka F, Bongard V, et al. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm. 2015;12(12):2469-76. [ Links ]

    13. Letsas KP, Weber R, Astheimer K, Kalusche D, Arentz T. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Europace. 2010;12(2):271-4. [ Links ]

    14. Nakano Y, Shimizu W, Ogi H, Suenari K, Oda N, Makita Y, et al. A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome. Europace. 2010;12(3):410-6. [ Links ]

    15. Okamura H, Kamakura T, Morita H, Tokioka K, Nakajima I, Wada M, et al. Risk stratification in patients with Brugada syndrome without previous cardiac arrest _ prognostic value of combined risk factors. Circ J. 2015;79(2):310-7. [ Links ]

    1. Chávez González E. Despolarización (complejo QRS) o repolarización ventricular (intervalo QT): ¿quién aporta más al diagnóstico y pronóstico en distintos escenarios clínicos? CorSalud [Internet] 2018[citado 30 Jun 2018];10(1):1-3. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/289/623 [ Links ]

    2. Chávez-González E, Moreno-Martínez FL. QRS dispersion is better than QRS duration for predicting response to cardiac resynchronization therapy. Hellenic J Cardiol. 2016;57(5):366-7. [ Links ]

    3. Chávez-González E, Alonso Herrera A, Carmona Puerta R, Pérez Cabrera D, Ramos Ramírez RR, Gómez Paima W, et al. Dispersión del QRS como índice de disincronía en el bloqueo de rama izquierda y de sincronía tras la terapia de resincronización cardíaca, una variable de respuesta exitosa. CorSalud [Internet]. 2015 [citado 4 Jul 2018];7:106-16. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors /article/view/28/73 [ Links ]

    4. Chávez-González E, Rodríguez Jiménez AE, Moreno-Martínez FL. Duración y dispersión del QRS para predecir arritmias ventriculares en las fases iniciales del infarto agudo de miocardio. Med Intensiva. 2017;41(6):347-55. [ Links ]

    5. Alemán AA, Dorantes M, Castro J, González L, Coto Y, Rodríguez MA. Arritmias ventriculares malignas en pacientes con cardiodesfibrilador implantable: signos eléctricos predictores de recidivas. CorSalud [Internet] 2014 [citado 3 Jul 2018];6(1):63-9. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view /180/410 [ Links ]

    6. Alemán AA, Dorantes M. Marcadores electrocardiográficos de arritmias ventriculares malignas. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2012 [citado 30 Jun 2018];18(2):66-71. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/198/235 [ Links ]

    7. Dorantes M. Signos eléctricos premonitorios de riesgo: ¿cuál es el mejor? Controversia no terminada, en impetuoso crecimiento. CorSalud [Internet]. 2010 [citado 9 Jul 2018];2(1):55-61. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n1a10/signos.htm [ Links ]

    8. Coronel R, Wilms-Schopman FJ, Opthof T, Janse MJ. Dispersion of repolarization and arrhythmogenesis. Heart Rhythm. 2009;6(4):537-43. [ Links ]

    9. Kentta TV, Nearing BD, Porthan K, Tikkanen JT, Viitasalo M, Nieminen MS, et al. Prediction of sudden cardiac death with automated high-throughput analysis of heterogeneity in standard resting 12-lead electrocardiograms. Heart Rhythm. 2016;13(3):713-20. [ Links ]

    10. Verrier RL, Huikuri H. Tracking interlead heterogeneity of R-and T-wave morphology to disclose latent risk for sudden cardiac death. Heart Rhythm. 2017;14(10):1466-75. [ Links ]

    11. Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: A new index for arrhythmogenicity. Clin Sci (Lond). 2003;105(6):671-6. [ Links ]

    12. Tse G, Gong M, Wong CW, Chan C, Georgopoulos S, Chan YS, et al. Total cosine R-to-T for predicting ventricular arrhythmic and mortality outcomes: A systematic review and meta-analysis. Ann Noninvasive Electrocardiol [Internet]. 2017 [citado 7 Jul 2018];23(2):e12495. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/anec.12495 [ Links ]

    13. Martini B, Martini N, Dorantes Sánchez M, Márquez MF, Zhang L, Fontaine G, et al. Pistas de una enfermedad orgánica subyacente en el síndrome de Brugada. Arch Cardiol Mex. 2017;87(1):49-60. [ Links ]

    14. Kardys I, Kors JA, van der Meer IM, Hofman A, van der Kuip DA, Witteman JC. Spatial QRS-T angle predicts cardiac death in a general population. Eur Heart J. 2003;24(14):1357-64. [ Links ]

    15. Dorantes M. Bloqueo de rama izquierda. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2013 [citado 7 Jul 2018];19(1):50-4. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/354 /325 [ Links ]

    16. Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart. 2002;88(1):47-51. [ Links ]

    17. Kirchhof P, Franz M, Bardai A, Wilde A. Giant T-U waves precede torsades de pointes in long QT syndrome: A systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. J Am Coll Cardiol. 2009;54(2):143-9. [ Links ]

    1. Dorantes Sánchez M. Despolarización y repolarización ventriculares para estratificar riesgo de arritmias ventriculares malignas y de muerte súbita. CorSalud [Internet]. 2018 [citado 19 Jul 2018];10(3):266-9. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/351/719 [ Links ]

    2. Chávez González E. Despolarización (complejo QRS) o repolarización ventricular (intervalo QT): ¿quién aporta más al diagnóstico y pronóstico en distintos escenarios clínicos? CorSalud [Internet] 2018 [citado 20 Jul 2018];10(1):1-3. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/289/623 [ Links ]

    3. Coronel R, Wilms-Schopman FJ, Opthof T, Janse MJ. Dispersion of repolarization and arrhythmogenesis. Heart Rhythm. 2009;6(4):537-43. [ Links ]

    4. Alemán AA, Dorantes M. Marcadores electrocardiográficos de arritmias ventriculares malignas. Rev Cuban Cardiol [Internet]. 2012 [citado 20 Jul 2018];18(2):66-71. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/198/235 [ Links ]

    5. Dorantes M. Signos eléctricos premonitorios de riesgo: ¿cuál es el mejor? Controversia no terminada, en impetuoso crecimiento. CorSalud [Internet]. 2010 [citado 19 Jul 2018];2(1):55-61. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n1a10/signos.htm [ Links ]

    6. Martini B, Martini N, Dorantes Sánchez M, Márquez MF, Zhang L, Fontaine G, et al. Pistas de una enfermedad orgánica subyacente en el síndrome de Brugada. Arch Cardiol Mex. 2017;87(1):49-60. [ Links ]

    7. Verrier RL, Huikuri H. Tracking interlead heterogeneity of R- and T-wave morphology to disclose latent risk for sudden cardiac death. Heart Rhythm. 2017;14(10):1466-75. [ Links ]

    8. Alemán AA, Dorantes M, Castro J, González L, Coto Y, Rodríguez MA. Arritmias ventriculares malignas en pacientes con cardiodesfibrilador implantable: signos eléctricos predictores de recidivas. CorSalud [Internet] 2014 [citado 3 Jul 2018];6(1):63-9. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view /180/410 [ Links ]

    9. Kentta TV, Nearing BD, Porthan K, Tikkanen JT, Viitasalo M, Nieminen MS, et al. Prediction of sudden cardiac death with automated high-throughput analysis of heterogeneity in standard resting 12-lead electrocardiograms. Heart Rhythm. 2016;13(3):713-20. [ Links ]

    10. Chávez-González E, Rodríguez Jiménez AE, Moreno-Martínez FL. Duración y dispersión del QRS para predecir arritmias ventriculares en las fases iniciales del infarto agudo de miocardio. Med Intensiva. 2017;41(6):347-55. [ Links ]

    11. Rodríguez González F, Chávez González E, Machín Cabrera WJ, Reyes Hernández LM, González Ferrer V. Arritmias ventriculares y nuevo síndrome coronario agudo en pacientes con infarto y dispersión del intervalo QT prolongado. CorSalud [Internet]. 2013 [citado 21 Jul 2018];5(1):101-7. Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n1a13/sca-qtlargo.html [ Links ]

    12. Rodríguez F, Chávez E, Machín WJ, Alonso A, González V. Increased QT interval dispersion in diagnosis of acute coronary syndrome with atypical symptoms and EKG. MEDICC Rev. 2014;16(3-4):42-6. [ Links ]

    13. Chávez-González E, Alonso Herrera A, Carmona Puerta R, Pérez Cabrera D, Ramos Ramírez RR, Gómez Paima W, et al. Dispersión del QRS como índice de disincronía en el bloqueo de rama izquierda y de sincronía tras la terapia de resincronización cardíaca, una variable de respuesta exitosa. CorSalud [Internet]. 2015 [citado 21 Jul 2018];7:106-16. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors /article/view/28/73 [ Links ]

    14. Chávez-González E, Moreno-Martínez FL. QRS dispersion is better than QRS duration for predicting response to cardiac resynchronization therapy. Hellenic J Cardiol. 2016;57(5):366-7. [ Links ]

    15. Donoiu I, Târtea GC, Chávez-González E. Is there a utility for QRS dispersion in clinical practice? J Mind Med Sci [Internet]. 2017[citado 21 Jul 2018];4(2):132-41. Disponible en: https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1080&context=jmms [ Links ]

    1. WHO. A global brief on hypertension: Silent killer, global public health crisis. Geneva: World Health Organization; 2013. [ Links ]

    2. Ministerio de Salud Pública. Anuario Estadístico de Salud 2017. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2018. [ Links ]

    3. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev Cuban Med [Internet]. 2017 [citado 30 Abr 2018];56(4):242-321. Disponible en: http://scielo.sld.cu/pdf/med/v56n4/med01417.pdf [ Links ]

    4. Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-16. [ Links ]

    5. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-67. [ Links ]

    6. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435-43. [ Links ]

    7. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. [ Links ]

    8. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. [ Links ]

    1. Vineberg A, Miller G. Internal mammary coronary anastomosis in the surgical treatment of coronary artery insufficiency. Can Med Assoc J. 1951;64(3):204-10. [ Links ]

    2. Sewell WH. Results of 122 mammary pedicle implantations for angina pectoris. Ann Thorac Surg. 1966;2(1):17-30. [ Links ]

    3. Cunningham JM, Gharavi MA, Fardin R, Meek RA. Considerations in the skeletonization technique of internal thoracic artery dissection. Ann Thorac Surg. 1992;54(5):947-50. [ Links ]

    4. Gurevitch J, Kramer A, Locker C, Shapira I, Paz Y, Matsa M, et al. Technical aspects of double-skeletonized internal mammary artery grafting. Ann Thorac Surg. 2000;69(3):841-6. [ Links ]

    5. He GW, Taggart DP. Spasm in arterial grafts in coronary artery bypass grafting surgery. Ann Thorac Surg. 2016;101(3):1222-9. [ Links ]

    6. Keeley SB. The skeletonized internal mammary artery. Ann Thorac Surg. 1987;44(3):324-5. [ Links ]

    7. Satdhabudha O, Noppawinyoowong N. A randomized comparison of flow characteristics of semiskeletonized and pedicled internal thoracic artery preparations in coronary artery bypass. J Cardiothorac Surg [Internet]. 2017 [citado 26 May 2018];12(1):28. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434624 /pdf/13019_2017_Article_589.pdf [ Links ]

    8. Ji Q, Xia L, Shi Y, Ma R, Shen J, Lai H, et al. In Situ Skeletonized Right Internal Mammary Artery Bypass Grafting to Left Anterior Descending Artery: Feasibility, Mid-Term Efficacy, and Risk Factors for Graft Failure. Int Heart J. 2018;59(1):35-42. [ Links ]

    9. Gatti G, Dell'Angela L, Maschietto L, Luzzati R, Sinagra G, Pappalardo A. The impact of diabetes on early outcomes after routine bilateral internal thoracic artery grafting. Heart Lung Circ. 2016;25(8):862-9. [ Links ]

    10. Robinson BM, Paterson HS, Naidoo R, Dhurandhar V, Denniss AR. Bilateral internal thoracic artery composite Y grafts: Analysis of 464 angiograms in 296 patients. Ann Thorac Surg. 2016;101(3):974-80. [ Links ]

    11. Luzurier Q, Le Guillou V, Lottin M, Vermeulin T, Marini H, Petel T, et al. Is the risk of wound infection related to bilateral internal thoracic artery graft potentiated by age? Ann Thorac Surg. 2016;102(4):1239-44. [ Links ]

    12. Sahar G, Shavit R, Yosibash Z, Novack L, Matsa M, Medalion B, et al. The physiologic and histologic properties of the distal internal thoracic artery and its subdivisions. J Thorac Cardiovasc Surg. 2015;149(4):1042-50. [ Links ]

    13. Harky A, Mohammad HA, Garner M, Ali M, Alani MS. Anomalous right internal thoracic artery terminating in the right superior pulmonary vein. Ann Thorac Surg. 2017;104(4):e323-4. [ Links ]

    14. Sajja LR, Mannam G. Internal thoracic artery: Anatomical and biological characteristics revisited. Asian Cardiovasc Thorac Ann. 2015;23(1):88-99. [ Links ]

    15. Onan B, Yeniterzi M, Onan IS, Ersoy B, Gonca S, Gelenli E, et al. Effect of electrocautery on endothelial integrity of the internal thoracic artery: ultrastructural analysis with transmission electron microscopy. Tex Heart Inst J. 2014;41(5):484-90. [ Links ]

    16. Martínez Comendador JM, Castaño M, Álvarez JR. Biología y resultados de la arteria mamaria interna. Cir Cardiov. 2011;18(4):269-75. [ Links ]

    17. Honda K, Okamura Y, Nishimura Y, Uchita S, Yuzaki M, Kaneko M, et al. Graft flow assessment using a transit time flow meter in fractional flow reserve-guided coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2015;149(6):1622-8. [ Links ]

    18. Hwang HY, Koo BK, Yeom SY, Kim TK, Kim KB. Endothelial shear stress of the saphenous vein composite graft based on the internal thoracic artery. Ann Thorac Surg. 2018;105(2):564-71. [ Links ]

    19. Saha KK. Graft spasm _ The Achilles heel of arterial grafts. Indian Heart J. 2017;69(5):571-2. [ Links ]

    20. Kociszewska K, Malinowski M, Czekaj P, Deja MA. What is the source of anticontractile factor released by the pedicle of human internal thoracic artery? Interact Cardiovasc Thorac Surg. 2015;21(3):301-7. [ Links ]

    21. Manenti A, Roncati L. Nervous network of skeletonized internal thoracic artery. Ann Thorac Surg. 2013;95(4):1511-2. [ Links ]

    22. Picichè M. Noncoronary collateral myocardial blood flow: The human heart's forgotten blood supply. Open Cardiovasc Med J. 2015;9:105-13. [ Links ]

    23. Al-Atassi T, Toeg HD, Chan V, Ruel M. Coronary Artery Bypass Grafting In: Sellke FW, del Nido PJ, Swanson SJ, eds. Sabiston & Spencer: Surgery of the chest. 9ª ed. Philadelphia: Elsevier; 2016. p. 1551-88. [ Links ]

    24. Ahmed S, Raman SP, Fishman EK. CT angiography and 3D imaging in aortoiliac occlusive disease: Collateral pathways in Leriche syndrome. Abdom Radiol (NY). 2017;42(9):2346-57. [ Links ]

    25. Hutchison SJ. Coarctation and Atresia of the Aorta. In: Hutchison SJ, Eagle KA, Diethrich EB, Peterson MD. Aortic Diseases Clinical Diagnostic Imaging Atlas. Philadelphia: Elsevier; 2009. p. 271-96. [ Links ]

    26. Andreas M, Zeitlinger M, Hoeferl M, Jaeger W, Zimpfer D, Hiesmayr JM, et al. Internal mammary artery harvesting influences antibiotic penetration into presternal tissue. Ann Thorac Surg. 2013;95(4):1323-9. [ Links ]

    27. Pasrija C, Ghoreishi M, Shah A, Rouse M, Gammie JS, Kon ZN, et al. Bilateral internal mammary artery use can be safely taught without increasing morbidity or mortality. Ann Thorac Surg. 2018;105(1):76-82. [ Links ]

    28. Nakahara Y, Yoshida S, Kanemura T, Yamagishi S, Tochigi S, Osaka S. Bilateral internal thoracic artery grafts in hemodialysis: A single-center propensity score analysis. Ann Thorac Surg. 2018;105(1):153-9. [ Links ]

    29. Hudson CL, Moritz AR, Wearn JT. The extracardiac anastomoses of the coronary arteries. J Exp Med. 1932;56(6):919-25. [ Links ]

    31. Sever AJ, Patel C, Albeer Y, Darian VB. The technique and benefits of angiographic embolization of inferior epigastric arteries prior to pedicled TRAM flap breast reconstruction: Results from a single center. Cardiovasc Intervent Radiol. 2017;40(12):1845-50. [ Links ]

    32. Nezic DG, Bojovic ZR, Milicic MD, Antonic ZD, Boricic MI, Micovic SV. Mid-term patency of the inverted left internal thoracic artery conduit. J Card Surg. 2014;29(6):790-3. [ Links ]

    33. Schwabegger AH. Deformities of the anterior thoracic wall. In: Congenital Thoracic Wall Deformities Diagnosis, Therapy and Current Developments. New York: Springer-Verlag; 2011. p. 3-56. [ Links ]

    34. Cheng K, Rehman SM, Taggart DP. A review of differing techniques of mammary artery harvesting on sternal perfusion: Time for a randomized study? Ann Thorac Surg. 2015;100(5):1942-53. [ Links ]

    35. Ding WJ, Ji Q, Shi YQ, Ma RH, Wang CS. Incidence of deep sternal wound infection in diabetic patients undergoing off-pump skeletonized internal thoracic artery grafting. Cardiology. 2016;133(2):111-8. [ Links ]

    36. Papaspyros S, Zamvar V. Operative Techniques: Coronary Artery Bypass Graft Surgery. In: Lanzer P, ed. PanVascular Medicine. Berlin: Springer-Verlag; 2015. p. 2351-8. [ Links ]

    37. Vineberg AM, Becerra A, Chari RS. The influence of the Vineberg sponge operation upon the hydrostatics of the myocardial circulation in health and disease: Evidence of luminal ventricular circulation in the beating heart. Can Med Assoc J. 1961;85(20):1075-90. [ Links ]

    38. Parissis H, Chughtai Z, Soo A. Two questions on bilateral internal mammary artery usage. Asian Cardiovasc Thorac Ann. 2013;21(6):751-5. [ Links ]

    39. Schipper RJ, Lobbes MB, Dikmans RE, Beets-Tan RG, Smidt ML, Boetes C. Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging. Insights Imaging. 2013;4(2):177-84. [ Links ]

    40. Punjabi PP, Chan KMJ. Coronary artery bypass grafting. In: Punjabi PP, ed. Essentials of Operative Cardiac Surgery. Switzerland: Springer International Publishing; 2015. p. 67-79. [ Links ]